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'Nothing has such power to broaden the mind as 
the ability to investigate systematically and truly 
all that comes under thy observation in life.' 
Marcus Aurelius, Roman Emperor, c. 161 A.D. 
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Abstract 
 
 
 
Small non-coding RNAs (sRNAs) constitute a significant portion of the 
transcriptome in eukaryotes. Many of these sRNAs regulate gene expression. Next-
generation sequencing (NGS) has revealed a plethora of previously uncharacterised 
sRNAs with potential biological function, a number of which originate from longer 
RNAs. Here, the biogenesis of sRNAs derived from the non-coding Y RNAs 
(YsRNAs) was characterised as a model for understanding this emerging class of 
sRNA fragments. Y RNAs are highly conserved, 100 nt long molecules involved in 
DNA replication which bind to the autoimmune proteins Ro60 and La. 
 
YsRNAs are produced in cells undergoing apoptosis. Here, it was demonstrated 
that YsRNAs are generated from the 5’ and 3’ ends of all four Y RNAs in stressed 
and unstressed cells. Furthermore, production of these fragments was observed in 
both cancerous and non-cancerous cells. Although YsRNAs have been proposed to 
have gene silencing activity, experiments done here found that YsRNAs do not 
enter the microRNA pathway and are not generated by the gene silencing-related 
protein Dicer. Furthermore, experiments established that the enzyme which 
produces fragments from tRNAs, angiogenin, was also not responsible for YsRNA 
generation. 
 
Using mammalian cultured cells along with gene knockout and RNA interference 
(RNAi) technology, it was determined that RNase L contributed to YsRNA 
generation. Furthermore, the Y RNA binding protein Ro60 was shown to be 
essential for YsRNA production through a model of RNase protection. Analysis of 
deep sequencing data in Ro60 knockout cells revealed that many other sRNAs are 
also dependent on Ro60. 
 
Finally, a ‘high definition’ (HD) protocol to improve NGS detection of sRNAs was 
tested. The HD protocol was found to be better at detecting sRNAs than current 
methods. This will facilitate more efficient detection of novel sRNAs in the future. 
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1.1 Overview: A genome governed by RNA 
 
One of the most striking discoveries in recent times was the discovery of 
just how few genes there are in the human genome (Lander & International Human 
Genome Sequencing Consortium, 2001; Collins & International Human Genome 
Sequencing Consortium, 2004). Compared to the predicted 100,000 protein coding 
genes originally estimated, only 20,687 were finally identified recently following 
the completion of the ENCODE (Encyclopaedia of DNA Elements) project 
(Bernstein & ENCODE Project Consortium, 2012). Paradoxically, the human 
proteome is likely to hold an estimated 500,000 unique protein variants based on 
investigations into the yeast and fruit fly genomes (Ghaemmaghami et al., 2003; 
Brunner et al., 2007). The complexity of the proteome relative to the modest 
repertoire of bona fide genes is now becoming clear.  
There is an overlapping arrangement of genetic information which is 
achieved by several mechanisms (Tuck & Tollervey, 2011). Firstly, variable 
transcription start sites for the same locus can give rise to transcripts which share a 
common sequence but are functionally independent. Secondly, genes can be 
differentially ‘spliced’ to give rise to varied isoforms. Thirdly, a single transcript 
can contain several genetic units which are differentially processed, and serve 
separate biological roles, (such as miRtrons - microRNAs which are present within 
the introns of protein-coding genes). And finally, transcripts with one function can 
be cleaved to give rise to smaller transcripts with distinct functions. This is notably 
demonstrated by small RNAs derived from longer RNAs. 
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RNA acts as an intermediary in the 'central dogma' of gene expression (the 
expression of genes from DNA to RNA, then to protein). However, the vast 
majority of cellular RNA is non-coding. Indeed, most of the genome in complex 
organisms is transcribed into non-coding RNA rather than protein coding 
transcripts (Mattick & Makunin, 2006). Only 1.5% of the human genome is protein 
coding yet around 80% is transcribed into RNA (Birney & ENCODE Project 
Consortium, 2007), making non-coding RNA a dominant feature in the cellular 
landscape. It has become increasingly apparent that the role of RNA in cellular 
processes is much more significant than first thought (Sharp, 2009). There are a 
vast number of distinct families which make up the 'RNA world' (Gilbert, 1986), 
having diverse roles such as gene silencing, intermediates during gene expression, 
structure formation, non-protein based enzymes and splicing.  
Two characteristic features of these RNA families are the length and 
secondary structure of the RNA molecules. The structure of an RNA molecule is 
important to its function and depends on intramolecular sequence complementarity 
between nucleotide bases. It is sometimes misleading to think of each RNA family 
as a discrete group of molecules, as there can be significant interchangeability 
between groups. For instance, some transfer RNAs (tRNAs) and small nucleolar 
RNAs (snoRNAs) can enter small interfering RNA (siRNA)-like pathways 
(Pederson, 2010; Brameier et al., 2011).  
Y RNAs are one such family of non-coding RNAs. Y RNAs can be 
considered as a model of firstly, how a non-coding RNA can have a significant 
biological role in cellular biology, and secondly, how RNA fragmentation can 
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significantly increase the spectrum of distinct genetic units within the cell, giving 
rise to an overlapping arrangement of genetic information. 
 
1.2 Evolution, structure and biogenesis of Y RNAs 
 
 Y RNAs were discovered following two investigations into the 
autoimmune disorder Systemic Lupus Erythematosus (SLE) (Lerner & Steitz, 1979; 
Lerner et al., 1981), which is characterised by the inflammation of connective 
tissue. Lerner and colleagues aimed to uncover nuclear and cytoplasmic targets of 
the antibodies involved in this autoimmune response. They achieved this by 
immunoprecipitating cell extracts from mouse derived Ehrlich ascites tumour cells 
using serum from SLE patients containing antibodies to the Ro and La proteins. 
First, they investigated using only nuclear cell extracts from Ehrlich ascites, and 
identified a group of small non-coding nuclear RNA (U RNA) containing 
ribonucleoproteins (RNPs) as auto-antibody targets (Lerner & Steitz, 1979). In a 
later study in 1981, they used total extracts from the Ehrlich ascites along with 
serum containing antibodies to the Ro and La proteins (Lerner et al., 1981). It was 
in this second set of experiments that they identified small cYtoplasmic RNAs 
contained in RNPs to which they designated the prefix Y, to distinguish them from 
their nUclear U RNA counterparts (Lerner et al., 1981). 
 There are four principal Y RNA molecules (Figure 1.1) denoted Y1, Y3, 
Y4 and Y5 (Y2 is now considered to be a truncated form of Y1) (Wolin & Steitz, 
1983). Y RNAs show high evolutionary conservation within the animal kingdom, 
and there is evidence that orthologs also exist in prokaryotes (Chen et al., 2000; 
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Mosig et al., 2007; Perreault et al., 2007), suggesting that these genes may have an 
important function. Y3 shows the highest conservation in vertebrate species (Farris 
et al., 1995). It is thought that the Y RNA family evolved from a common ancestral 
gene, which, through gene duplication, gave rise to Y1/Y3 in one lineage and 
Y4/Y5 in the other (Mosig et al., 2007).  
Many animal species do not contain the full Y RNA complement. For 
example, many rodents only possess Y1 and Y3 (Pruijn et al., 1993), although both 
the mouse and rat genomes have a redundant 'fossil' Y5 RNA gene that is no longer 
expressed (Perreault et al., 2007). In frogs, the Y5 gene has been further duplicated 
to give Yα (Mosig et al., 2007). Interestingly, Y RNA genes have not been 
detected in the genome of the fruit fly Drosophila melanogaster, although putative 
Y RNA genes have been predicted in the mosquito genome (Perreault et al., 2007). 
The first identifiable Y RNA in invertebrates was the single, ceY RNA of 
Caenorhabditis elegans (Vanhorn et al., 1995). Interestingly the human Ro protein 
could bind to ceY RNA, but the equivalent Ro homologue in the nematode could 
not bind the human Y RNAs (Vanhorn et al., 1995). Stem-bulge RNAs (sbRNAs) 
in the Caenorhabditis elegans have also been shown to be highly homologous to 
vertebrate Y RNAs, and contain a protein-binding motif for the Y RNA-associated 
protein Ro60 (Boria et al., 2010). The Ro protein has not been detected in plants or 
fungi, and presumably these organisms also lack Y RNAs (Perreault et al., 2007). 
However, a Ro ortholog (Rsr – Ro sixty related) has been documented in the 
eubacterium Deinococcus radiodurans and has been shown to bind an RNA which 
resembles a Y RNA (Chen et al., 2000). As the Ro ortholog is a rare occurrence in 
prokaryotes it is likely that the gene has been acquired via horizontal gene transfer 
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from a eukaryotic organism (Chen & Wolin, 2004), with the ortholog having the 
ability to bind to an endogenous, Y RNA-like molecule. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Predicted secondary structure of the four human Y RNAs. 
 
All Y RNAs have at least two main stems separated by a large internal pyrimidine-rich 
loop. The most conserved region between the Y RNAs is the stem at the 3'/5' end. This 
is where the Ro60 protein binds, and involves the important Cytosine bulge which is 
crucial for this interaction (Pruijn et al., 1991). Both enzymatic cleavage and chemical 
modification experiments have been used to determine these structures shown (Wolin 
& Steitz, 1984; van Gelder et al., 1994). Figure reproduced from Christov et al., 2006. 
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Y RNAs are controlled by RNA polymerase III promoters (Wolin & Steitz, 
1983) and are transcribed into short, 84-113 nt RNAs which fold back on 
themselves to form distinct hairpin-containing structures (Figure 1.1). These 
structures largely reflect the minimal-free energy calculated predictions, but 
important structural features have also been determined in different studies via 
both enzymatic cleavage and nucleotide chemical modification experiments (Wolin 
& Steitz, 1984; van Gelder et al., 1994). Different RNases were used to 
differentiate between single stranded and double stranded (such as RNase VI) 
regions (van Gelder et al., 1994). Dimethlysulfate, CMCT and kethoxal treatments 
were used to chemically modify nucleotides in order to determine the exact 
positions of the bases, using primer extension assays to detect the modified 
nucleotides (van Gelder et al., 1994). As a general trend, the Y RNA secondary 
structures have a minimum of 2 stems each. Another structural characteristic is a 
large single stranded pyrimidine-rich loop which separates the stems (Wolin & 
Steitz, 1983). This central loop is present in all studied Y RNAs and shows high 
structural stability despite being the region with the least sequence conservation 
(Teunissen et al., 2000). The region with the highest sequence conservation 
between the Y RNAs is the main stem at the 5'/3' end. Y RNAs have a 3' poly (U) 
tail and a 5' triphosphorylated guanine residue (pppG), except for Y5 which has 
pppA (Hendrick et al., 1981).  
 Each of the four Y RNA genes are independently expressed, although, they 
tend to be clustered within the genome. For instance, in humans, the four Y RNA 
genes (hY1, hY3, hY4 and hY5) are all located on chromosome 7 (Maraia et al., 
1994b), with Y1 being expressed from the opposite strand (Mosig et al., 2007). 
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Unusually for pol III transcripts, the Y RNA genes are found as single copies in the 
human genome (Wolin & Steitz, 1983). 
 Although Y RNAs interact with a range of proteins, which will be 
discussed in detail later, a defining trait of Y RNAs is their ability to bind the 60 
kDa protein Ro60 (Hendrick et al., 1981; Lerner et al., 1981; Wolin & Steitz, 1984) 
and the 47 kDa La protein (Hendrick et al., 1981). The typical Y RNA life cycle 
begins with the Y RNA, and two key genes (Ro60 and La) being transcribed in the 
nucleus. The Ro60 and La transcripts are exported to the cytoplasm where they are 
translated into proteins, which are subsequently imported back into the nucleus. As 
Y RNA transcription is terminated, the newly synthesised transcript associates with 
La, followed by Ro60 (Peek et al., 1993). The entire Ro RNP complex is then 
transported to the cytoplasm. It has been shown however, that Ro60 binding is not 
always necessary for Y RNAs to be functionally active in some pathways (Langley 
et al., 2010). 
 Y RNAs are expressed in all human cells (Pruijn et al., 1993), although the 
cellular composition of the different Y RNAs varies between cell types. 
Interestingly, red blood cells only possess hY1 and hY4 and lack hY3 and hY5 
(O'Brien & Harley, 1990). As erythrocytes are anucleated cells, this indicates 
different functions for Y1/Y4 and Y3/Y5. Differential Y RNA expression between 
human tissue types has also been documented. Y RNAs are present in high levels 
in heart and brain tissues, and lower levels in the liver (Wolin & Steitz, 1984).  
It has been calculated via Northern blot that approximately 59% of the Y 
RNA population in HeLa cells (immortalised cervical cancer cells) is made up of 
Y5, 26% of Y4, 12% of Y3, and around 3% is composed of Y1 (Gendron et al., 
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2001). More recent analysis of Y RNA abundance via qPCR in HeLa cell extract 
gave a similar result (Christov et al., 2006), although the relative abundance of Y4 
RNA was estimated to be around 3-4 fold lower than that reported by Gendron et 
al, with Y1 and Y3 showing comparatively higher expression levels than Y4 RNA. 
The strikingly high expression levels of hY5 RNA and the relatively modest levels 
of hY4 RNA reported (Gendron et al., 2001; Christov et al., 2006) is not consistent 
with a report which showed that the hY5 gene promoter is not as efficient as the 
hY4 gene promoter (Maraia et al., 1996).  
As well as having four actively expressed Y RNAs, the human genome also 
has around 1,000 pseudogenes derived from these Y RNAs which are distributed 
over all 23 human chromosomes (Perreault et al., 2005). The number of Y RNA 
pseudogenes in humans and chimpanzees is much greater than that of rodents. 
These pseudogenes are capable of retrotransposition via the L1 (Long interspersed 
nuclear element-1) transposition machinery (Perreault et al., 2005). The biological 
role of these pseudogenes is unknown. 
 
1.3 Y RNA binding proteins 
 
Y RNAs were first discovered owing to their association with proteins 
recognised by autoantibodies from immune sera of patients with systemic lupus 
erythematosus (SLE) (Lerner et al., 1981). Y RNAs form complexes within the 
cell with either single or multiple proteins, forming Y RNA ribonucleoproteins (Y 
RNPs). When Ro60 is bound to Y RNAs this complex may also be referred to as 
the Ro ribonucleoprotein complex (Ro RNP), and the two terms are often 
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interchangeable. The most researched Y RNA binding proteins to date are the 60 
kDa protein Ro60 and the 47 kDa La. 
 
1.3.1 General anatomy of the Y RNA Ribonucleoprotein (Y RNP) 
 
Almost as soon as Y RNAs were discovered, it was demonstrated that two 
key proteins targeted by autoimmune patients, Ro60 and La, both could bind to Y 
RNAs within the cell (Figure 1.2) (Hendrick et al., 1981). Both Ro60 and La have 
an RNA binding motif of around 80 amino acids (Pruijn et al., 1991). 
Reconstitution experiments demonstrated that Ro particles also possessed the La 
determinant and that RNAs which bind Ro60 and La were generated by RNA 
polymerase III (Hendrick et al., 1981). In this study, it was also shown that the La 
protein interacts with all pol III transcripts following transcription. The interaction 
of La with pol III transcripts was later shown to be due to binding to the 3’ 
polyuridylate stretch on these nascent transcripts (Stefano, 1984; Pruijn et al., 1991; 
Slobbe et al., 1992). La also binds to the 3’ polyuridine tail of Y RNAs (Figure 1.2) 
(Pruijn et al., 1991), which unlike most pol III transcripts, is retained following 
maturation. This allows the retention of La by the Y RNA, whereas most pol III 
transcripts lose this tail during maturation (Mamula et al., 1989; Boire & Craft, 
1990). Preliminary studies indicated that La RNPs were primarily localised to the 
nucleus and that Ro particles were mainly cytoplasmic (Hendrick et al., 1981). 
Each mammalian cell was found to have around 10
5
 copies of the Ro RNP, a level 
which equates to approximately to 1% of the number of ribosomes (Hendrick et al., 
1981). 
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Figure 1.2. Molecular depiction of the Y RNP showing typical Y RNA-protein 
interactions.  
 
The Ro60 protein, which binds to the most conserved region (the 3'/5' stem) on the Y 
RNA (Wolin & Steitz, 1984) is a major component of the complex. The bulged 
cytidine residue essential for Ro60 binding is shown as a kink in the lower 5’ stem. 
Another key protein of the Y RNP, the 47 kDa La, binds to the 3'-poly(U) tail (Pruijn 
et al., 1991). Other reported binding proteins include Nucleolin, hnRNP I & K and 
L5 protein which primarily bind to the large internal loop of the Y RNA (Fabini et 
al., 2000). 
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The Ro60 binding site on the Y RNAs is the lower double stranded stem 
region where the 3’ and 5’ ends of the RNA meet (Figure 1.2) (Wolin & Steitz, 
1984). This stem is characterised by a bulged cytidine residue which is essential for 
Ro60 binding (Wolin & Steitz, 1984; Pruijn et al., 1991). The binding site was 
determined via RNase protection assays followed by immunoprecipitation of 
digested particles using anti-Ro60 antibodies. However, it was noted that the 
RNase protection experiments would not necessarily reveal other Ro60 binding 
sites which are easily released following RNase treatment, as very high 
concentrations of pancreatic ribonulcease were used (Wolin & Steitz, 1984). 
Deletion mutant experiments later showed the bulged C-residue to be essential for 
Ro60 binding (Pruijn et al., 1991). An intact Ro60 binding site on the Y RNAs is 
required for nuclear export of the Y RNAs (Simons et al., 1996).  
The size of the Ro RNPs was initially estimated to be between 93-150 kDa 
(Wolin & Steitz, 1984) but was later found to be between either 230-350 kDa 
(Boire & Craft, 1990) or 150-550 kDa (Fabini et al., 2000). In all studies, it was 
acknowledged that this size was greater than the sum of the molecular masses of 
Ro60, La and a 33 kDa RNA molecule, hinting that other molecular determinants 
were present in Y RNPs. The affinity of Y RNAs for Ro60 is disrupted at a 
relatively low ionic strength using 500 mM salt, which is similar for most nucleic 
acid binding proteins (Boire & Craft, 1990). La binding is slightly more resilient 
and dissociates after exposure to around 700 mM salt (Boire & Craft, 1990). Y 
RNPs also elute at different salt concentrations during anion exchange experiments, 
with hY5 RNP being eluted at lower salt concentrations of around 200 mM NaCl 
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(Boire et al., 1995) and hY RNPs 1-4 being eluted at higher salt concentrations 
nearer 300 mM (Boire & Craft, 1990; Boire et al., 1995).  
The heterogeneity of Y RNPs is further demonstrated by the presence of 
autoantibodies in sera from lupus patients which specifically recognised hY5 RNPs 
(Boire & Craft, 1989). Indeed, further experimentation identified the presence of 
antibodies in these sera which targeted the RNA component of Y5 RNPs rather 
than the bound proteins (Boulanger et al., 1995). Immunoprecipitation experiments 
of in vitro transcribed hY5 showed that the region next to the Ro60 binding site on 
the 5’/3’ end of the RNA was the region possessing the epitope recognised by IgG 
α-hY5 antibodies. Interestingly, one study has shown that hY5 RNP has been 
found to be primarily nuclear compared with the exclusively cytoplasmic hY 
RNAs 1-4, and that the signal for nuclear retention resides in the Y5 RNA itself 
(Gendron et al., 2001). 
The literature is divided on the percentage of Y RNAs that are complexed 
with the Ro protein. The first demonstration that most Y RNAs are bound by Ro60 
was demonstrated in mouse cells (Wolin & Steitz, 1983). Extracts from mouse 
cells were immunoprecipitated with anti-Ro antibodies and it was found that all of 
the mY RNAs were depleted from the supernatant. Later, this was repeated in 
human cells (Peek et al., 1993), which gave similar results supporting that most Y 
RNAs are stably associated with Ro60. However, recent experiments which used 
qPCR to detect remaining Y RNAs following RoRNP immunoprecipitation have 
argued that 50% of the Y RNAs are not bound by either Ro60 or La (Langley et al., 
2010). This discrepancy might be due to the varying specificity of the antibodies 
used by these groups and the differential sensitivity of the techniques employed 
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(Northern blot versus qPCR) to test the amount of remaining Y RNA following 
immunoprecipitation.  
A different investigation found that all Y RNAs are bound by La in vivo, 
but not necessarily all Y RNAs are bound by Ro60 (Fabini et al., 2000). 
Furthermore, coprecipitation of recent, novel Y RNA binding proteins was more 
efficient with α-La antibodies than with α-Ro60 antibodies (Fabini et al., 2000). 
On the other hand, the level of endogenous Y RNAs is dependent on the presence 
of the Ro60 protein. For example, there is a significant decrease in the level of the 
single Y RNA present in Caenorhabditis elegans (the 105nt long ceY RNA) in 
ROP-1 (the Ro60 homologue) mutants (Labbe et al., 1999). This decrease in ceY 
RNA levels is rescued by transgenic expression of ROP-1. Indeed, the levels of 
mY1 and mY3 are significantly diminished in Ro60
-/-
 mouse embryonic stem cells 
(Chen et al., 2003). 
Although Ro60 may bind a significant proportion of the Y RNAs in the cell, 
the Moloney murine leukemia virus (MLV) has been shown to selectively 
encapsidate host mY1 and mY3 RNAs, even in a Ro60
-/-
 background (Garcia et al., 
2009). The function of this selective uptake of Y RNAs is unknown, but implies 
that Ro60 is not necessarily required for Y RNA function, which was further 
confirmed in chromosomal DNA-replication studies (Langley et al., 2010), 
discussed in detail later. 
Subcellular localization experiments involving both antibody staining and 
enucleation analysis were used to determine Y RNP and Y RNA distribution (Peek 
et al., 1993). Antibody based immunofluorescence gave conflicting results 
depending on the method of fixation used. When either Hep-2 or HeLa cells were 
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fixed using methanol/acetone, it was shown that monoclonal Ro60 and La antibody 
staining was speckled in the nucleus but was stronger in the cytoplasm. Conversely, 
paraformaldehyde fixation gave the opposite result (Peek et al., 1993). However, 
nuclear and cytoplasmic fractioning experiments resolved this issue, and revealed 
that the Y RNAs are specifically localised to the cytoplasm, whereas the La and 
Ro60 proteins are present in both the nucleus and the cytoplasm (Peek et al., 1993). 
In the nucleus, neither Ro60 or La was found coupled to Y RNAs, whereas most Y 
RNAs were found protein bound in the cytoplasm. Approximately 30-50 % of free, 
non-RNA bound Ro60 and La was found to be in the nucleus depending on the cell 
line analysed (Peek et al., 1993).  
Microinjection experiments in Xenopus laevis using either in vitro 
transcribed Y RNAs (denoted xY3, xY4, xY5 and xYα) or in vitro translated Ro60 
and La showed that Y RNAs accumulate in the cytoplasm (Simons et al., 1994). 
Most of the microinjected La went to the nucleus and a substantial amount of Ro60 
was also imported to the nucleus, where both proteins were shown to associate 
with the Y RNAs (Simons et al., 1994).  
 
1.3.2 Ro60 
 
Ro60 is an important autoantigen in SLE and SS (Sjögren's Syndrome) 
patients (Ohlsson et al., 2002) and is evolutionarily conserved (Deutscher et al., 
1988; Slobbe et al., 1991). Mice lacking Ro60 develop symptoms characteristic of 
autoimmune disorders, including photosensitivity and skin lesions (Xue et al., 
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2003). Ro60 is essential for the stability of Y RNAs, as there is a thirty-fold 
reduction in mY1 and mY3 in Ro60 knockout cells (Xue et al., 2003). 
The first identifiable function of Ro60 was its involvement in non-coding 
RNA quality control (O'Brien & Wolin, 1994; Shi et al., 1996). It was shown that 
in Xenopus laevis, 5S rRNA variants which had 8-10 nt additions at their 3’ ends 
were bound by Ro60. These extensions are a result of RNA polymerase III failing 
to recognise the first of three transcription termination signals. Variant 5S rRNAs 
fold differently compared to their wild-type counterparts, forming an alternative 
helix. It is this specific, altered helix which allows Ro60 to recognise and bind to 
variant 5S rRNA (Shi et al., 1996). As well as having extensions, variant 5S 
rRNAs have internal mutations (Shi et al., 1996).  These isoforms are inefficiently 
processed and are eventually degraded. When mutant and wild-type 5S rRNAs are 
injected into Xenopus oocytes, Ro60 specifically associates with the mutant variety 
(O'Brien & Wolin, 1994). It was later shown that Ro60 binds several RNAs with 
single stranded 3’ tails (which are normally removed during maturation) which 
include pre-tRNAs and U6 snRNA (Fuchs et al., 2006) as well as misfolded U2 
snRNAs (Chen et al., 2003). Although the process of how mutant 5S rRNA 
associated with Ro60 are eventually degraded is not clear, it appears to be an 
important quality control pathway. ROP-1 (the Ro60 homologue) mutants in 
Caenorhabditis elegans display a five-fold increase in the level of variant 5S rRNA 
compared to wild-type strains (Labbe et al., 1999). 
Ro60 also plays a role in cell survival following high ultraviolet light (UV) 
exposure. Solar ultraviolet radiation overexposure can be extremely damaging to 
cells, and has severe health effects on target organs including the eyes, skin and 
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immune system (Lucas et al., 2006). In some cases UV damage results in the 
development of terminal melanoma (Narayanan et al., 2010). 
It has been demonstrated that the prokaryote Deinococcus radiodurans, 
which shows high resilience during contact with DNA mutagens, has an ortholog 
of Ro60 called Rsr (Ro sixty-related) (White et al., 1999). Furthermore, it has been 
shown that when this bacterium is exposed to damaging UV irradiation, Rsr is 
upregulated in the cell, and binds to a Y RNA-like molecule which also shows a 
corresponding increase in expression (Chen et al., 2000). Bacterial strains lacking 
the Rsr gene show decreased survival rates following UV irradiation than their 
wild-type counterparts. Another study demonstrated that mouse embryonic stem 
(ES) cells with a Ro60
-/-
 genotype also show higher mortality rates following UV 
exposure compared to wild-type ES cells (Chen et al., 2003). It was found that 
mouse Ro60 and Y RNAs accumulate in the nucleus following UV treatment. 
Taken together, these findings imply an important role for Y RNAs and the 
associated Ro60 in survival following UV damage. This role might involve entry 
into a DNA damage response pathway, or preventing newly transcribed RNAs 
from misfolding or crosslinking with nuclear proteins during UV exposure (Chen 
et al., 2003). Indeed, the dynamic subcellular distribution of Ro60 during cellular 
stress (for example oxidative stress or UV irradiation) is thought to be modulated 
by Y RNA binding (Sim et al., 2009), which in turn makes Y RNAs key molecules 
in the first line of response to damaging stress stimuli. 
X-ray crystallography studies revealed the structure of Ro60 (Stein et al., 
2005). Ro60 is a toroid shaped protein with two domains; a Willebrand factor A 
domain and an RNA binding α-helical HEAT-repeat ring domain. The inner ring of 
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the HEAT-repeat domain is positively charged and is 10-15 Å across, and binds to 
the single stranded 3’ ends of misfolded RNAs. The outer ring binds the double 
stranded RNA portion of the misfolded RNA, but also binds Y RNAs (Stein et al., 
2005). The outer binding site for Y RNAs and the duplex portion of misfolded 
RNAs overlap meaning that there is a competition for the same binding site. This 
suggests that Y RNAs regulate access of misfolded RNAs to Ro60. The RNA 
binding surface is extensive and Ro60 was shown to scavenge for not only 
misfolded, but also correctly folded non-coding RNAs which failed to complex 
with appropriate binding proteins (Fuchs et al., 2006). 
 As well as regulating Ro60’s interaction with other small cytoplasmic 
RNAs, Y RNAs also control the subcellular localisation of Ro60 by governing its 
access to the nucleus (Sim et al., 2009). Ro60 mutants which are unable to bind to 
Y RNAs are shuttled to the nucleus, as disassociation with Y RNAs reveals a 
nuclear localisation signal on the surface of the protein (Sim et al., 2009). In the 
nuclei, Ro60 can then access misfolded RNAs (O'Brien & Wolin, 1994; Chen et al., 
2003). Interestingly, it was also found that cellular stresses such as UV light 
exposure or oxidative stress (such as hydrogen peroxide exposure) result in nuclear 
accumulation of Ro60 in mouse cells (Sim et al., 2009). Therefore, a key function 
of the Y RNAs is making Ro60 available for RNA quality control following events 
which induce cellular damage.  
 In the eubacterium Deinococcus radiodurans, the Ro60 ortholog Rsr shows 
increased expression following nutrient starvation (Wurtmann & Wolin, 2010). 
Furthermore, the exoribonuclease polynucleotide phosphorylase (PNP) associates 
with Rsr during cellular stress in order to mediate rRNA decay (Wurtmann & 
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Wolin, 2010). However neither an increase in Ro60 levels during cellular stress, 
nor an association with exoribonucleases have been reported in eukaryotes. Indeed, 
the most recent tandem affinity purifications of Ro60 failed to identify any 
ribonuclease association (Sim et al., 2012). 
 
1.3.3 The La protein 
 
The La autoantigen is a very abundant, primarily nuclear, protein which is 
highly evolutionarily conserved, and is composed of 408 amino acids (Hendrick et 
al., 1981; Chambers et al., 1988; Scherly et al., 1993; Topfer et al., 1993; Bai et al., 
1994). The La protein is around 50-fold more abundant then Ro60 (Peek et al., 
1993), and binds RNAs using its N-terminal domain (Pruijn et al., 1991). This 
binding is regulated through phosphorylation of the carboxy-terminal domain 
which decreases the affinity of La for the 3’ polyuridine tail (Francoeur et al., 1985; 
Pfeifle et al., 1987). La binds to all RNA polymerase III transcripts, including pre-
tRNAs, pre-5S RNA (Rinke & Steitz, 1982) and also some viral encoded RNAs 
such as the Epstein-Barr virus-encoded ribonucleic acids EBER 1 and EBER 2 and 
the adenovirus-associated ribonucleic acids VAI and VAII (Rosa et al., 1981). La 
is thought to function by releasing nascent pol III RNAs from the DNA template 
allowing multiple rounds of transcription to take place (Gottlieb & Steitz, 1989; 
Maraia et al., 1994a) . 
The La binding site favours the nuclear retention of Y RNAs, as 
demonstrated by the creation of hY1 deletion mutants, and their injection into 
Xenopus oocytes (Simons et al., 1996). Here, La binding to hY1 was shown to 
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slow down export of the Y RNA to the cytoplasm by approximately six hours. 
Human Y RNAs remain bound to La once in the cytoplasm (Boire & Craft, 1990; 
Peek et al., 1993), however in Xenopus association of La is lost following nuclear 
export, perhaps due to 3’ end shortening which is known to occur in pre-5S rRNA 
(Simons et al., 1994; Simons et al., 1996). Y RNA binding to La also appears to be 
important for Y RNA stabilisation. Experiments in C. elegans have shown that 
RNAi depletion of La results in a gradual decrease in Y RNA levels over a 72 hour 
period (Aftab et al., 2012). As mentioned, Ro60 binding has also been shown to be 
important for Y RNA stability (Chen et al., 2000; Xue et al., 2003). This makes Y 
RNA retention by these two proteins in the cytoplasm highly likely. 
La has had many implicated biological functions, many of which are 
controversial or lack significant functional evidence. For example, it was proposed 
that La acts as a transcription termination factor and facilitates the re-initiation of 
pol III transcription (Gottlieb & Steitz, 1989; Maraia et al., 1994a). However, in 
yeast and vertebrate systems where La was depleted, pol III function was 
unaffected (Yoo & Wolin, 1994; Lin-Marq & Clarkson, 1998). A more established 
role for La is in protection of pol III transcripts from exonuclease digestion prior to 
maturation, after which La is displaced (Kufel et al., 2000; Xue et al., 2000). La 
appears to act as a molecular chaperone for nascent RNAs as it only binds targets 
temporarily and assists correct assembly and fate of these immature transcripts 
(Xue et al., 2000).  
The La protein also has a role in pre-tRNA maturation, specifically in 
processing the 5’ end of pre-tRNAs (Fan et al., 1998). Indeed, this is a further 
example of the protein’s RNA chaperone activity. La stabilises pre-tRNAs and 
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arranges the RNA in a specific structure which allows endonucleolytic cleavage 
and ultimately, 3’ end maturation (Yoo & Wolin, 1997). During tRNA maturation, 
5’ end processing precedes 3’ end processing. The N-terminal region of La binds to 
the 3’ poly(U) of the pre-tRNA whilst the C-terminal end of the protein interacts 
with the 5’ tail. When La is phosphorylated at the C-terminus, binding to the 5’ end 
of the pre-tRNA is inhibited, allowing processing by the ribonuclease RNase P, 
whilst the 3’ end remains protected (Fan et al., 1998). Indeed, La has been shown 
to have a phosphorylation-dephosphorylation cycle. During apoptosis, the La 
protein is completely dephosphorylated and around 25% of La proteins are cleaved 
(Rutjes et al., 1999b). The proposed transcriptional activity of La is inhibited by 
phosphorylation (Maraia et al., 1994a). Dephosphorylated La (which is active in 
pol III transcription) inhibits 5’-end processing of pre-tRNAs (Fan et al., 1998). 
This phosphorylation cycle is disrupted during apoptosis (Rutjes et al., 1999b), and 
therefore deactivation of La may serve as a key step facilitating cell death. 
 La has controversially been implicated in regulating translation of both 
viral and cellular mRNAs. Various studies have used crosslinking analysis and 
found that La binds to the 5’ untranslated region of the poliovirus RNA 
(Meerovitch et al., 1993) and also to mRNA encoding the endogenous X-linked 
inhibitor of apoptosis protein (XIAP) (Holcik & Korneluk, 2000). In the latter 
study, La was shown to bind to the internal ribosome entry site (IRES) and 
facilitate translation, which was inhibited when the availability of functional La 
was reduced. However the role of La in translation has been disputed, owing to the 
extremely high concentrations of La required to re-initiate translation in several La 
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immunodepletion experiments, and the lack of functional evidence of its 
involvement in this process (Wolin & Cedervall, 2002). 
 Finally, the La protein appears to play a role in the gene silencing pathway 
of animal cells. The RNA interference (RNAi) pathway is governed by the RNA-
induced silencing complex (RISC). RISC is composed of a small RNA 
complementary to an mRNA target, as well as an effector protein called Argonaute 
which causes target cleavage or translational silencing (Bartel, 2004). RISC 
turnover, or the rate at which mRNA targets are cleaved and released, has been 
shown to be dependent on the La protein (Liu et al., 2011). Specifically, La 
promoted the multiple turnover of RISC via association with the Argonaute protein, 
AGO2, and by facilitating the release of cleaved mRNA targets. La associates with 
AGO2 in an RNA-dependant manner (Liu et al., 2011). 
 
1.3.4 Ro52 
 
As well as Ro60 and La, another protein which showed reactivity with 
autoimmune sera is Ro52. Early investigations claimed that Ro52 was part of the Y 
RNP complex, binding to the Y RNA via Ro60 (Ben-Chetrit et al., 1988; Slobbe et 
al., 1991; Slobbe et al., 1992). However, additional fractionation and co-
immunoprecipitation experiments demonstrated that Ro52 does not bind to any of 
the Y RNAs, Ro60 or La (Kelekar et al., 1994; Boire et al., 1995). Ro60 and Ro52 
also show differential patterns of cellular localisation; Ro60 was shown to be 
predominantly cytoplasmic whereas Ro52 showed mainly nuclear staining 
(Kelekar et al., 1994). Unlike Ro60 and La, Ro52 does not have an RNA 
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recognition motif (RRM) (Kelekar et al., 1994). Furthermore, it has been 
demonstrated that owing to the zinc finger and leucine zipper motifs of Ro52, this 
protein binds DNA rather than RNA targets (Frank et al., 1995). 
 
1.3.5 hnRNP I & K 
 
Most of the additional Y RNA binding proteins discovered since Ro60 and 
La have been shown to interact via the pyrimidine-rich central loops of these 
molecules (Figure 1.2). Using in vitro transcribed biotinylated Y RNAs in 
reconstitution experiments with various HeLa cell S100 extracts, several novel Y 
RNA binding proteins between 53 kDa and 80 kDa were identified which bound 
preferentially to Y1 and Y3 (Fabini et al., 2000). The identity of two of these 
proteins was later identified via mass spectrometry to be the heterogeneous nuclear 
ribonucleoproteins, hnRNP I & K, which bind to a subset of the human Y RNAs 
via the large central loop, as demonstrated by deletion mutant experiments (Fabini 
et al., 2001). The hnRNP I protein was shown to be a stable component of Y RNPs 
1 and 3. However, hnRNP K appeared to bind only transiently to hY1 and hY3 
which were devoid of Ro60 and La (Fabini et al., 2001). The hnRNP I protein was 
shown to bind a minor fraction of the hY1 and hY3 population (10-20%), and 
required the presence of La, which presumably acts as a molecular chaperone to 
assist RNA folding and subsequent recognition. It was noted that both hnRNP I 
and La have been implicated in similar mRNA processing events, such as 
translation, and suggested that the Y RNAs may serve as carriers for these 
molecules (Fabini et al., 2001). 
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1.3.6 RoBPI 
 
The Ro RNP binding protein (RoBPI) was discovered as a Y RNP 
component via a ribonucleoprotein interaction assay based on the yeast-three 
hybrid system (Bouffard et al., 2000). Using recombinant Ro60 and Y RNAs, it 
was shown that RoBPI only interacted with Ro60 and hY5 together, and not with 
any one of these components alone. The 559 amino acid RoBPI is approximately 
65 kDa, has three RNA recognition motifs (RRM) and displays nuclear 
colocalisation with Ro60, La and hY5 (Bouffard et al., 2000). The RoBPI protein 
is structurally similar to mRNA splicing factors, and therefore like La and hnRNP I 
& K, appears to be involved in controlling expression of coding and non-coding 
genes. As the hY5 RNP has been shown to be predominantly nuclear in humans 
and mouse compared with the cytoplasmic hY RNPs 1-4 (Gendron et al., 2001), is 
targeted by distinct autoantibodies in autoimmune patients (Boulanger et al., 1995), 
as well as eluting in a separate fraction to hY RNPs 1-4 during anion exchange 
chromatography (Boire et al., 1995), RoBPI may contribute to this molecular 
uniqueness of hY5 which separates it from the other Y RNPs.  
  
1.3.7 Nucleolin 
 
Nucleolin is a protein which is localised to the nucleolus and has been 
shown to be involved in multiple steps of the ribosome biogenesis pathway 
(Ginisty et al., 1999). Immunopreciptiation of Ro60 and La autoantigens followed 
by mass spectrometry of associated proteins revealed that nucleolin also appears to 
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be complexed to hY1 and hY3 RNPs (Fouraux et al., 2002). Both matrix-assisted 
laser desorption/ionization time-of-flight (MALDI-TOF) and quadruple time-of-
flight (Q-TOF) mass spectrometry were used to confirm that the novel binding 
protein was indeed nucleolin. Again, like several other novel Y RNA related 
proteins, nucleolin was shown to bind the pyrimidine-rich internal loop of these Y 
RNAs, and it can do so in concert with hnRNP I. The structure, and not the 
sequence of the central loop on the Y RNAs, was shown to be the key determinant 
of nucleolin binding (Fouraux et al., 2002). As nucleolin has been shown to shuttle 
between the nucleus and cytoplasm of cells (Borer et al., 1989), it was proposed 
that nucleolin acts as a carrier molecule of hY RNA1 & 3 (Fouraux et al., 2002).  
 
1.3.8 L5 
 
In depth analysis about Ro60’s involvement in RNA quality control 
revealed an RNP-RNP interaction between Y5 RNA-Ro60 and 5S rRNA bound to 
the ribosomal protein L5 (Hogg & Collins, 2007). Using a novel RNP purification 
method it was shown that Y5 RNA specifically targets Ro60 to misfolded 5S 
rRNAs by interacting with the L5 protein via its internal pyrimidine rich loop, 
which in turn is bound to ribosomal RNA. Y5 RNA then acts as a ‘gatekeeper’ for 
the surface of Ro60, helping to discriminate between correctly and incorrectly 
folded substrates (Hogg & Collins, 2007). 
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1.3.9 ZBP1 
 
The most recently identified,  novel Y RNA binding protein is the zipcode-
binding protein ZBP1 (Sim et al., 2012). The 68 kDa ZBP1 protein has been 
shown to be involved in mRNA localisation and translation regulation (Ross et al., 
1997; Huttelmaier et al., 2005). ZBP1 was shown to copurify with Ro60 and Y3 
RNA in mouse cells, and this association is increased in cells exposed to UV light. 
Nuclear accumulation of the mY3/Ro60/ZBP1 complex was also more pronounced 
following UV light exposure (Sim et al., 2012). Under non-stressed conditions, 
Ro60 and mY3 were shown to be localised to the cytoplasm by ZBP1, and the Y3 
RNP complex accumulated in the nucleus when ZBP1 was depleted (Sim et al., 
2012). 
 
1.4 The role of Y RNAs in chromosomal DNA replication 
 
 The propagation of life relies on the efficient and timely replication of the 
cell’s genetic material. During cell division in all organisms, parental DNA gives 
rise to two identical daughter strands, each inheriting one original strand from the 
parent in a semi-conservative fashion. In eukaryotes, chromosomal DNA 
replication is tightly regulated and is closely linked to the cell cycle, occurring in S 
phase. 
 The current model of DNA replication is already well reviewed in the 
literature (Takeda & Dutta, 2005; Pospiech et al., 2010), but I will briefly 
summarise key molecular events here in order to facilitate the understanding of the 
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role of Y RNAs in this process. Eukaryotic cells start DNA replication via the 
assembly of the multiprotein pre-replicative complex (pre-RC) in G1 phase of the 
cell cycle. This is initiated with the assembly of the six subunit origin recognition 
complex (ORC), which in turn recognises specific sites where DNA replication 
initiation occurs - called autonomously replicating sequences (ARS). The Cdc6 and 
Cdt1 proteins then interact with the ORC and facilitate the recruitment of the 
minichromosome maintenance proteins Mcm2-7. Together these proteins form the 
pre-RC in G1 phase nuclei. Activation of the pre-RC and the formation of DNA 
replication forks occurs during the transition to S phase and involves a second 
group of factors. These proteins include the two kinases Cdk2 and Cdc7. Other 
initiation factors are then recruited, including Cdc45, Mcm10, the GINS complex 
and replication protein A (RPA). Origin DNA is then unwound and the three DNA 
polymerases (DNA pol α, DNA pol δ and DNA pol ε) are recruited and eventually 
commence replication. 
 Early studies which investigated the biochemistry of DNA replication 
employed cell fusion experiments, such as those famously conducted by Rao and 
Johnson in 1970 (Rao & Johnson, 1970). Using this technique, it was shown that S 
phase cells contain factors which could induce G1, but not G2 phase nuclei, to 
prematurely trigger DNA replication. More recently, the development and 
optimisation of a human cell-free system to study DNA replication was established 
which has resulted in further replication factors being uncovered (Krude et al., 
1997; Krude, 2006). In this cell-free system, isolated cell cycle-arrested template 
nuclei synchronised in late G1 phase are prepared which are licensed to replicate, 
but lack active DNA replication forks. Then, by adding cytosolic extracts from 
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proliferating cells containing initiation factors or combinations of specific cellular 
fractions, novel DNA replication factors can be identified by seeing if arrested 
nuclei can then initiate DNA replication (Krude, 2006). 
 Using this cell-free system Krude and colleagues identified the noncoding 
Y RNAs as essential factors for chromosomal DNA replication (Christov et al., 
2006). When the cytosolic extract from actively proliferating cells was fractionated 
by anion exchange chromatography, this gave rise to two essential fractions called 
QA and QB. QB was further separated into fractions ArFT and ArE. Fractions QA, 
ArFT and ArE together were sufficient to initiate DNA replication when added to 
template nuclei. Surprisingly, fraction ArE was found to be composed mainly of 
nucleic acids rather than proteins, and it was from this fraction that Y RNAs were 
purified. The QA and ArFT fractions alone were not sufficient to significantly 
drive DNA replication in isolated nuclei from human somatic cells, with only 15 % 
of nuclei replicating in the presence of these two factors (Christov et al., 2006). 
However when the purified Y RNAs were added along with these two protein 
fractions, the proportion of replicating nuclei increased in a dose-dependent 
manner to 50 % (Christov et al., 2006). Furthermore, targeted depletion of Y 
RNAs from the cytosolic extract inhibited DNA replication. A degree of functional 
redundancy with regards to the Y RNAs was found in this system as addition of 
any of the four Y RNAs to the depleted extract was sufficient to reinstate DNA 
replication. This requirement for Y RNAs for DNA replication was also seen in 
mouse cell nuclei, where interestingly, human Y RNAs could also initiate mouse 
DNA replication indicating that these factors are evolutionarily conserved. Non-
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vertebrate Y RNAs could not reconstitute DNA replication in vertebrate systems 
(Gardiner et al., 2009). 
 Importantly, the sequence and structure of the Y RNAs were shown to be 
the contributing factors which initiated DNA replication (Christov et al., 2006). A 
conserved double stranded 9 base pair motif sequence in the upper stem of the Y 
RNAs identified in screens of hY1 mutants was sufficient to drive DNA replication 
in the presence of protein fractions QA and ArFT (Gardiner et al., 2009). This 
motif was found to have a consensus sequence of 5’-GUAGUGGG-3’ on the 5’ 
strand and 5’-CCCACUGCU-3’ on the 3’ strand. This motif was not found in non-
vertebrate Y RNAs. The addition of this double stranded sequence alone was 
sufficient to drive DNA replication without the requirement of the other protein 
binding domains of the Y RNA (again, in the presence of QA and ArFT). 
Interestingly, the same results were not observed with the addition of this sequence 
in a DNA from. 
Although Y RNAs can be complexed with cellular proteins such as Ro60, 
La and nucleolin, none of the associated Y RNA binding proteins are required for 
DNA replication, and addition of any of these proteins does not affect the 
percentage of actively replicating nuclei in the cell-free system (Langley et al., 
2010). It was found via real-time PCR that around 50 % of cellular Y RNAs were 
not bound by Ro60/La/Nucleolin, and it was argued that it is the non-protein bound 
portion of Y RNAs which have a role in DNA replication. This would leave the 
Ro60/La/Nucleolin bound Y RNAs to carry out distinct functions such as 
scavenging for misfolded RNAs.  
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In order to investigate exactly how Y RNAs facilitate chromosomal DNA 
replication, Krude and colleagues degraded Y1 and Y3 RNA in a cell-free system 
and monitored replication track extension rate (or the rate at which nascent DNA is 
polymerised) (Krude et al., 2009). They found that Y RNAs are required for the 
establishment and initiation of DNA replication forks, but are not required for the 
elongation of actively replicating DNA. Additionally, the stability of the DNA 
replication fork was not affected by depleting the Y RNA population. The 
reduction in the amount of single stranded nascent DNA by degrading Y3 RNA 
could be negated by the addition of Y1 RNA – further supporting the functional 
redundancy of Y RNAs in this process. In another study, using fluorescently 
labelled Y RNAs, it was shown that Y RNAs act in a ‘catch and release’ 
mechanism whereby Y RNAs associate with the unreplicated euchromatin in the 
late G1 phase of the cell cycle, and are displaced once initiation has taken place 
(Zhang et al., 2011). Around 20-70% of hY RNAs associate with nuclei in G1 
phase cells whereas only 4-10 % associate in G2. It was further shown that hY1, 
hY3 and hY4 co-localise with each other on euchromatin sites, but not with hY5 - 
which was enriched in nucleoli. Although it was previously shown that the upper 
stem region alone was sufficient to reconstitute DNA replication in template nuclei 
(Gardiner et al., 2009), it was demonstrated that the loop domain of the Y RNAs 
was required for targeting Y RNAs specifically to euchromatic sites. Y RNA 
mutants where only the upper stem maintained a wild-type sequence showed non-
specific site binding across the nucleus including heterochromatic regions (Zhang 
et al., 2011). 
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 Human Y RNAs appear to associate with DNA replication factors. This 
was demonstrated by conducting RNA pull-down assays where agarose beads are 
coupled to the 3’ termini of the Y RNA (Zhang et al., 2011). All 4 Y RNAs 
interact with members of the origin recognition complex (ORC 2 & 3 interacted 
with hY1, 3, 4 & 5 and ORC 4 & 6 interacted with hY1, 3 & 5 only). Furthermore, 
Cdt1, Cdc6, and the DNA unwinding protein DUE-B all interacted with the Y 
RNAs. None of the proteins associated with DNA replication elongation such as 
Mcm2-7, CMG and the DNA polymerases bound to the Y RNAs supporting earlier 
work that these non-coding RNAs are specifically involved in the initiation stage 
of replication (Krude et al., 2009; Zhang et al., 2011). 
 Finally, the most recent work with regards to Y RNAs and chromosomal 
DNA replication showed that the Y RNAs only act as licensing factors after the 
midblastula transition (MBT) stage of development (Collart et al., 2011) and not 
before. Using inhibitory morpholino nucleotides, it was demonstrated that Y RNAs 
are not needed for DNA replication in Xenopus and zebrafish embryos and egg 
extracts prior to MBT. After this stage, Y RNA specific morpholino nucleotide 
treated embryos died shortly before gastrulation. The lack of requirement for Y 
RNAs to facilitate in DNA replication prior to MBT may facilitate the need to 
replicate the cell’s DNA rapidly during early developmental stages. After this 
developmental stage, DNA replication takes significantly longer - such as in post-
MBT cells. 
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1.5 Y RNAs in cancer 
 
Cancer is a complex genetic disease which results in uncontrolled cell 
proliferation and tissue invasion. It can have multiple genetic origins, but 
essentially it arises as a result of the overexpression or mutation of proto-
oncogenes (normal genes which have the ability to cause cancer) and the 
underexpression of tumour suppressors (Dalmay, 2008). Cancer development is a 
multistep process that involves six hallmark events: uncontrolled proliferation, 
apoptosis evasion, tissue invasion, the ability to grow without external biochemical 
signals, the ability to ignore anti-growth signals and sustained angiogenesis 
(Hanahan & Weinberg, 2000). Owing to the widespread and intricate role of small 
RNAs (sRNAs) in cellular processes, aberrant sRNA expression may promote 
cancer progression. The profiles of microRNAs (miRNAs), which are one type of 
sRNA, are significantly altered in breast cancer cells compared with normal breast 
tissue (Iorio et al., 2005). Understanding how sRNA profiles influence disease 
processes will aid the diagnosis and treatment of a variety of disorders. For 
example, as some cancer cells have distinct miRNA profiles, rapid diagnosis of 
disease type can be achieved via microarray or quantitative PCR (qPCR) (Dalmay, 
2008). Additionally, miRNA-mimics or miRNA inhibitors can be used to target 
specific microRNAs in order to prevent certain disorders. For example, the use of 
locked nucleic acid (LNA) in therapeutic studies has already been demonstrated 
(Elmen et al., 2008). 
As discussed, Y RNAs function in chromosomal DNA replication, 
implicating them in the control of cell proliferation, a characteristic which is 
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aberrant and uncontrolled in cancer. Indeed, it has been shown that if HeLa cells 
are transfected with siRNAs against hY1, there is a significant reduction in cell 
proliferation and a subsequent decrease in the number of cells in the S phase of the 
cell cycle (Christov et al., 2006).  Furthermore, transfection of siRNAs against hY1 
and hY3 into a range of different carcinoma cells (including bladder, prostate, 
cervical and lung) results in a similar reduction in cell proliferation (Christov et al., 
2008). This makes Y RNAs promising targets for future pharmalogical treatments 
in cancer patients. 
A study by Christov et al. also demonstrated using real-time PCR that all Y 
RNAs in humans are significantly upregulated in bladder, cervical, colon, kidney, 
lung and prostate cancers compared to the equivalent non-diseased tissues 
(Christov et al., 2008). The greatest level of hY1, hY3 and hY4 overexpression 
was seen in kidney tumours, and the highest hY5 levels were observed in lung 
tumours. The authors propose that Y RNAs are novel cancer biomarkers, and could 
be utilized for diagnosis in the future.  
 A more recent study has shown that small RNAs derived from full length Y 
RNAs are present in solid tumours (Meiri et al., 2010). Notably, 25 nt long RNAs 
derived from hY1, hY3 and hY5 were present in solid tumour samples at levels 
comparable with the cancer associated miRNA, miRNA-21, however, no 
microRNA-like function of these Y RNA products was shown (Meiri et al., 2010).  
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1.6 Y RNAs in apoptosis 
  
 Apoptosis is a highly regulated and well-orchestrated mode of cell death 
which is quite different from uncontrolled cell death which is disorganised and can 
be damaging to neighbouring cells (Taylor et al., 2008). Apoptosis is carried out by 
a family of proteases called caspases which initiate a molecular cascade resulting 
in important structural components of the cell being degraded. These include 
genomic DNA, the nuclear lamina and mitochondrial components. The entire 
process is self-contained and occurs without allowing the release of 
immunostimulatory molecules that may harm other cells. The resulting products of 
degradation are removed by phagocytic white blood cells. Mutations that impair 
apoptotic pathways can lead to cancer. 
 Apoptosis appears to strongly involve Ro RNPs. Firstly, it is well 
documented that the Ro60, Ro52 and La autoantigens cluster at the surface of 
apoptotic cells (Casciola-Rosen et al., 1994; Ohlsson et al., 2002). Specifically, 
Ro52 is found surface-exposed in small apoptotic blebs whereas the larger 
apoptotic bodies contain cell surface La and also Ro60. Intriguingly, La is 
dephosphorylated and cleaved at the C-terminus by caspase-3 during apoptosis 
(Rutjes et al., 1999b). La is known to play a role in preventing apoptosis by 
activating the translation of the X-linked inhibitor of apoptosis protein (Holcik & 
Korneluk, 2000). 
 The RNA component of Ro RNPs also appears to be altered during 
apoptosis. Human Y RNAs are rapidly and specifically cleaved during apoptosis in 
a caspase-dependant manner, and this occurs under the duress of a range of 
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apoptotic stimuli (Rutjes et al., 1999a). The Y RNA fragments produced during 
apoptosis are approximately 22-25 nts, with a larger fragment of 31 nts also being 
generated. The 31 nt fragment was still found bound to Ro60 and La, whereas the 
shorter fragments could only be immunoprecipitated by Ro60 antibodies, 
suggesting that the La binding site on these fragments was lost (Rutjes et al., 
1999a). Interestingly, the degradation of these Y RNAs is one of the first 
phenotypes of apoptotic cells, with cleavage products being detectable only 1.5 
hours after apoptosis induction. This makes Y RNA cleavage detection via qPCR 
an effective tool in assaying programmed cell death progression in cell samples 
(Asselbergs & Widmer, 2003). Other RNAs such as tRNAs and snRNAs were 
found to remain intact in the study by Rutjes et al., implying a specificity for Y 
RNAs (Rutjes et al., 1999a). Furthermore, this cleavage can be inhibited by 
apoptosis inhibitor proteins such as Bcl-2. The most conserved region of the Y 
RNAs, the main stem at the 3'/5' end, remains bound to the autoantigens after 
cleavage, with Ro60 having the strongest affinity for the degradation products 
(Rutjes et al., 1999a).  
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1.7 Small RNA biology 
 
1.7.1 The advent of ‘deep sequencing’ and the discovery of the ‘small RNA 
world’ 
 
 The birth of small non-coding RNA biology (sRNAs) (RNAs < 200nt) 
came with the discovery that small double stranded RNA molecules can bind to 
complementary mRNA targets and inhibit their expression into proteins (RNA 
interference – RNAi) (Lee et al., 1993; Fire et al., 1998; Hamilton & Baulcombe, 
1999). Since then, the advent of small RNA sequencing techniques based on 3’ and 
5’ adapter ligation and subsequent reverse transcription PCR (RT-PCR) (Elbashir 
et al., 2001) have allowed ‘deep sequencing’ of RNA samples. Various ‘Next-
generation sequencing’ (NGS) platforms such as Illumina (Solexa) and 454 
pyrosequencing have been developed which have increased the number of 
sequence ‘reads’ which can be obtained, to hundreds of millions per sample 
(Metzker, 2010). The improvement of this technology, the reduction of running 
costs and increase in availability has resulted in the discovery of millions of novel 
small RNAs (Wittmann & Jaeck, 2010). This in turn has completely revolutionised 
our view of how the cell controls the flow of genetic information and the 
hierarchical structure by which this is established.  
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1.7.2 MicroRNAs (miRNAs): A small RNA case study 
 
 MicroRNAs are some of the most abundant, well studied small RNAs, and 
have long been the focus of thousands of deep sequencing studies. MicroRNAs 
(miRNA) are endogenously produced post-transcriptional regulators which are 
imperfectly complementary to the 3'UTR (untranslated region) of their targets. 
They are ~22nt in length and form distinct, stem loop structures as a result of 
imperfect self-complementarity, (Lau et al., 2001). MiRNAs are thought to 
regulate at least 30%, and maybe as much as half of mammalian protein coding 
genes (Filipowicz et al., 2008), with each miRNA being able to regulate up to 100 
targets (Brennecke et al., 2005). Unlike siRNAs which direct cleavage of their 
mRNA targets, animal miRNAs are thought to primarily inhibit translation of their 
semi-complementary transcripts by firstly inhibiting 5' methylguanosine cap-
dependant translation initiation and then by deadenylation of the mRNA (Fabian et 
al., 2009), resulting in degradation by the exosome (Doma & Parker, 2007). 
 Most microRNAs are transcribed by RNA polymerase II (Lee et al., 2004), 
and following transcription, the miRNA folds into a dsRNA conformation 
containing a stem-loop structure at one end. This primary microRNA (pri-miRNA), 
which can be hundreds or thousands of nucleotides in length, can contain a variety 
of different miRNA species which will eventually be separated from each other 
(Filipowicz et al., 2008). In the nucleus, the pri-miRNA is enzymatically cleaved 
by the 650 kDa Microprocessor complex (Denli et al., 2004) which is composed of 
the RNase III-like enzyme Drosha, and the RNA binding protein, DGCR8 (or 
pasha in the case of Drosophila). The resultant precursor-miRNA (pre-miRNA) is 
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around 60-80 nt, and is characterised by a 2 nt overhang at its 3' end. The role of 
the Microprocessor complex is redundant in some miRNA species, where the pre-
miRNA forms a debranched intron and is generated during splicing. These 
'mirtrons' such as miR-1004, can be transported directly to the cytoplasm (Ruby et 
al., 2007).  
Following nuclear processing, the pre-miRNA is exported into the 
cytoplasm by the RanGTP dependant exportin-5 located in the nuclear envelope 
(Bohnsack et al., 2004). In the cytoplasm, another RNase III enzyme Dicer, along 
with the HIV-1 transactivating response RNA binding protein (TRBP), process the 
pre-miRNA into a 20-22 nt miRNA/miRNA* duplex (Chendrimada et al., 2005). 
Although Dicer is involved in the canonical microRNA maturation pathway, 
studies have demonstrated that a number of miRNAs circumvent the use of Dicer 
altogether (Cheloufi et al., 2010; Cifuentes et al., 2010). Pre-miR-451 in mouse 
and zebrafish for example does not require Dicer as part of its biogenesis, but 
instead requires the slicer activity of Ago2 for its maturation.  
The miRNA duplex contains a guide miRNA and a passenger miRNA*. 
The miRNA is semi-complementary to its mRNA target, and contains a 2-8 nt 
'seed' region at its 5' end. The seed region of the miRNA has a near perfect degree 
of complementarity to the miRNA recognition element (MRE) at the 3' UTR of the 
mRNA (Brennecke et al., 2005). The passenger miRNA* strand is usually 
discarded, however recent studies have shown that several species of miRNA*s 
can be actively selected for RISC incorporation (Ghildiyal et al., 2010). TRBP also 
functions as a recruiting factor by bringing the DICER-miRNA complex and the 
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Argonaute protein (AGO) based silencing complex (RISC) together, thereby 
forming the RISC loading complex (RLC) (Gregory et al., 2005).  
Once loaded into RISC, the process of gene silencing can take place. There 
is still an uncertainty about how exactly miRNA gene silencing is executed in 
animals, and the prevalence of translational repression and storage in cytoplasmic 
foci versus mRNA transcript degradation (Guo et al., 2010; Djuranovic et al., 
2012). 
 
1.8 Small RNAs derived from longer RNAs  
 
1.8.1 Filtering of deep sequencing data reveals extensive RNA fragmentation 
 
 Since 2008, there has been an abundance of deep sequencing studies which 
have identified small RNA fragments derived from longer RNAs, and this has been 
the subject of several excellent reviews (Wittmann & Jaeck, 2010; Rother & 
Meister, 2011; Tuck & Tollervey, 2011). Previous deep sequencing studies 
overlooked these fragments, as they were filtered out of data sets as assumed 
degradation products. For example, small nucleolar RNAs (snoRNAs), which are 
involved in ribosome biogenesis, have been shown to give rise to RNA fragments 
which can act as microRNAs (Ender et al., 2008; Brameier et al., 2011).  The first 
snoRNA-derived RNA (sdRNA) was discovered in HEK293 cells by deep 
sequencing of immunoprecipitated AGO1 & AGO2 associated RNAs (Ender et al., 
2008). This sdRNA was found to be processed by dicer (but independent of Drosha) 
and its RNAi function demonstrated by luciferase assay. However other sdRNAs 
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show potential dicer-independent maturation (Brameier et al., 2011). Further 
sdRNA discovery confirmed that these 18-35nt RNAs primarily mapped to the 5’ 
and 3’ stem of the full length snoRNA parent (Brameier et al., 2011).  
 Indeed, sRNA fragments from rRNAs, snoRNAs, snRNAs and tRNAs 
seem to give fragments predominantly from the 5’ and 3’ ends of mature parental 
RNA transcripts (Li et al., 2012). This seems to occur asymmetrically in human 
and mouse cells, with one end appearing more prominently in sequencing studies 
(similar to microRNA/ microRNA* level bias) (Li et al., 2012). 
 Additional AGO immunoprecipitation and deep sequencing studies 
uncovered small RNA fragments derived from ribosomal RNAs (rRNA), small 
nuclear RNAs (snRNAs), vault RNAs (vRNAs), transfer RNAs (tRNAs) and even 
messenger RNAs (mRNAs), all of which associated with the silencing protein 
family (Burroughs et al., 2011).  
 Vault particles are cellular organelles thought to be involved in nuclear 
export and play a role in multidrug resistance. They contain the 88-98 nt non-
coding vault RNAs (vRNAs). It was shown that these vRNAs can be cleaved to 
give rise to small 23nt vault-derived sRNAs (svRNAs), independent of dicer 
processing (Persson et al., 2009). Intriguingly, one of these svRNAs associates 
with an Argonaute protein (part of the RNAi silencing machinery) and can 
downregulate the mRNA encoding enzyme CYP3A4 which has a role in drug 
metabolism (Persson et al., 2009). 
 An analysis of a large collection of publically available, independent deep 
sequencing datasets has revealed that long non-coding RNAs (lncRNAs) can be 
processed into sRNA fragments (Jalali et al., 2012). The sRNA clusters 
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predominantly mapped to the 3’ end of lncRNAs. Interestingly, lncRNA-derived 
sRNA fragments were shown to be differentially processed in a variety of cell and 
tissue types, implying functionality rather than being simple products of 
degradation (Jalali et al., 2012). 
 
1.8.2 tRNA fragmentation 
 
 To date, the most well studied sRNA fragments studied are those derived 
from the tRNAs. The first reports of tRNA cleavage came in a study which showed 
that tRNA cleavage in Escherichia coli occurs following infection by 
bacteriophage T4 (Levitz et al., 1990). A more recent deep sequencing study in an 
animal system has found that sRNA fragments derived from tRNAs are more 
abundant than microRNAs (or certainly a close second), and are not simply the 
product of degradation pathways (Cole et al., 2009; Lee et al., 2009). 
There are two distinct classes of tRNA fragments; the tRNA regulatory 
fragments (tRFs) and the stress induced tRNA-derived RNAs (tiRNAs or ‘tRNA 
halves’). The tRFs are composed of three types of fragments (17-26nt) which were 
first discovered during deep sequencing of prostate cancer cell lines (Lee et al., 
2009). The tRF-1 species is released by RNAse Z (ELAC2) from the 3’ trailer of 
pre-tRNAs as part of tRNA maturation (Lee et al., 2009) and tRF-3 and tRF-5 
fragments are generated from mature tRNAs by dicer from the 3’ end and 5’ end of 
the mature tRNA respectively (Cole et al., 2009; Lee et al., 2009). RNAi mediated 
knockdown of one of the tRFs, tRF-1001, resulted in reduced cell proliferation 
(Lee et al., 2009). Although tRFs have been shown to be dicer dependant and some 
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tRFs can associate with Argonaute proteins (Cole et al., 2009; Haussecker et al., 
2010), the gene silencing capability of tRFs still requires further validation. 
Although modest gene silencing by tRFs has been observed despite widespread 
Argonaute association, the mechanism of tRF function is still under debate. It has 
been argued that rather than acting as bona fide microRNAs, tRFs globally 
modulate gene silencing by competing for AGO binding, thereby regulating 
AGO’s availability to bind with microRNAs (Haussecker et al., 2010). However, 
the latest research has shown that AGO2 associated 3’ tRFs are complementary to 
retroviral sequences in the human genome and can target these transcripts via 
RNAi (Li et al., 2012). 
 The second class of tRNA fragments is the stress induced tRNA-derived 
RNAs (tiRNAs). These tiRNAs, or ‘tRNA halves’ are longer than tRFs (31-40 nts) 
and are generated via cleavage in the anticodon loop of mature tRNAs following 
various stress stimuli (Thompson et al., 2008; Fu et al., 2009; Yamasaki et al., 
2009). Both 5’ and 3’ end derived tRNA halves can be detected. A variety of stress 
conditions, including nutrient depletion, hypoxia, hypothermia, heat shock and 
ultraviolet light irradiation have been shown to yield tiRNAs extremely rapidly 
(within 20 minutes) (Fu et al., 2009; Yamasaki et al., 2009). A low level of tiRNAs 
was also detected in unstressed cells (Thompson et al., 2008). Furthermore, this 
cleavage is not a mechanism to simply reduce the number of available tRNAs as 
only a small proportion of the full-length tRNA population are targeted (Fu et al., 
2009; Yamasaki et al., 2009).  
 The RNase A family member, angiogenin, was found to be the nuclease 
responsible for stress induced tRNA cleavage (Fu et al., 2009). Angiogenin is 
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bound to the ribonuclease inhibitor RNH1 under normal conditions. When 
angiogenin was overexpressed in cells there was an increase in tiRNA production 
(Fu et al., 2009) and when RNH1 was targeted via siRNA, a similar result was 
observed (Yamasaki et al., 2009). It was demonstrated that the function of tiRNAs 
was to inhibit translation. Specifically, transfection of 5’ tiRNAs (but not 3’ 
tiRNAs) inhibited protein synthesis and RNH1 depletion promoted translational 
arrest (Yamasaki et al., 2009). 
 Angiogenin-induced tiRNA fragments were shown to specifically target the 
initiation stage of translation. Protein synthesis is inhibited by tiRNAs association 
with the translational silencer YB-1, and subsequent displacement of the 
eukaryotic initiation factor eIF4G/eIF4A (Ivanov et al., 2011). A subset of these 
tiRNAs (5′-tiRNAAla and 5′-tiRNACys) were found to be the most potent translation 
inhibitors, and uncapped mRNAs were found to be preferentially targeted. This 
specific targeting of certain mRNAs suggests that tiRNAs reprogramme gene 
expression in stressed cells (Yamasaki et al., 2009). 
 To complicate the picture of tRNA cleavage fragment biogenesis and 
function further, a recent study has shown that several RNases, including 
angiogenin can also give rise to ~20nt fragments derived from the 3’ end of mature 
tRNAs (Li et al., 2012). These 3’tRFs can associate with AGO2 and direct gene 
silencing. It is truly surprising that multiple sRNAs can be derived from tRNAs 
with such diverse modes of function. 
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1.8.3 Y RNA-derived small RNAs 
 
 Over the last two years, there has been a flurry of publications where Y 
RNA-derived small RNAs have been detected in deep sequencing studies. Next-
generation sequencing of different human tumour samples identified 25nt Y RNA 
fragments from hY1, hY3 and hY5 which were more abundant than many 
microRNAs (Meiri et al., 2010). These fragments, which were first described 
during studies in apoptotic cells (Rutjes et al., 1999a), were suggested to have a 
function due to their high abundance and sequence stability, and not simply due to 
the protective properties of Ro60 which remains bound to the fragments after 
cleavage (Meiri et al., 2010). These Y RNA fragments were also detected in the 
serum of healthy people in this study. 
 The study by Meiri et al. investigated the potential gene silencing capability 
of Y RNA fragments using the luciferase assay, but no silencing activity was 
demonstrated. However, the possibility that these fragments could still be acting as 
microRNAs has not been ruled out, and has been the subject of a recent review 
(Verhagen & Pruijn, 2011). Verhagen and Pruijn hypothesised that Y RNAs could 
be acting as pre-miRNAs in disguise and suggest that Dicer might potentially 
process the full length Y RNAs into microRNA molecules. This hypothesis has yet 
to be tested in the laboratory. 
 Plant siRNA and miRNA targets can be discovered by detecting degraded 
or cleaved mRNAs, as cleavage is the primary RNAi response in plants. This so 
called ‘degradome’ analysis (Addo-Quaye et al., 2008) is a technique that is 
seldom applied to animal systems owing to the assumed prevalence of translational 
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repression over cleavage in animal gene silencing. However, Bracken et al. applied 
the technique to mouse embryo and adult tissues (Bracken et al., 2011). As well as 
detecting microRNA-mediated cleavage products, fragments from endonucleases 
other than AGO2 were also identified. Multiple instances of cleavage events 
occurring in non-coding RNAs (ncRNAs) were found, including reads 
corresponding to both the 3’ and 5’ stems of the Y RNAs (Bracken et al., 2011). 
Intriguingly, as the methods used in this study only selected for RNAs with 
polyadenylated tails, the results show that these Y RNA cleavage products must 
have been polyadenylated, implying either selective biochemical stabilisation, or 
indeed, targeting for degradation in vivo. Polyadenylation is essential for the 
function and stabilisation of mRNA transcripts in the cytoplasm, but paradoxically 
is also a marker for degradation of some sRNAs by the exosome in the nucleus 
(LaCava et al., 2005).  
 Finally, a variety of sRNAs have been sequenced in a population of ‘shuttle 
RNAs’ present in the vesicles released by immune cells (Nolte-'t Hoen et al., 2012).  
RNA cleavage products derived from vault RNAs, tRNAs and Y RNAs were 
detected, whereas microRNAs were significantly underrepresented in the shuttle 
RNA population. Y RNAs were some of the most abundant RNAs present in the 
immune vesicles, with both 28 nt fragments and full-length Y RNAs being 
detected. The authors were astonished by the similarity by which Y RNAs were 
assimilated into immune cell-derived vesicles (Nolte-'t Hoen et al., 2012), and the 
nature by which they are selectively packaged into viruses which was reported 
previously (Garcia et al., 2009). They speculate that the Y RNAs could play a role 
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in sorting of regulatory RNAs into these vesicles, in stabilising the RNA during 
export or in guiding shuttle RNAs to specific locations in vesicle-targeted cells. 
 
1.9 Aims and objectives of the thesis 
 
 Like many microRNA research laboratories, our laboratory (under 
Professor Tamas Dalmay) also came across Y RNA fragments in one of our deep 
sequencing data sets. Originally looking for stress-induced microRNAs, we 
stumbled across Y RNA-derived sRNAs which were upregulated under certain 
stress stimuli. Previous reports have only described these fragments, and have 
never studied them in detail. Here I aimed to characterise the nature, occurrence, 
biogenesis and potential function of these Y RNA fragments, which I will refer to 
here on in as ‘YsRNAs’. In reading the thesis, it should be appreciated that 
understanding the biology of YsRNAs would not only shed light on these specific 
molecules, but would hopefully serve as a model for the emerging class of elusive 
30-40nt sRNA fragments already observed, with potential universal biological 
function. 
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Chapter 2 
Materials and Methods 
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2.1 Cell culture 
 
2.1.1 Cell lines and growth media 
 
MCF7, HeLa, HepG2 and HEK293 cells were cultured in Dulbecco’s 
modified Eagle’s medium (Gibco, 10938) supplemented with 10% fetal bovine 
serum (FBS) (PAA, A15-101), 1% L-Glutamine (Gibco, 25030) and 1% Penicillin-
Streptomycin (Gibco, 15140).  
MCF10A cells were purchased from the American Type Culture Collection 
(ATCC) and were cultured in MEGM Bulletkit medium (Lonza, cc-3150) 
supplemented with 100ng/mL cholera toxin (Sigma, C8052).  
DLD-1 wild-type and DLD-1 dicer
-/-
 exon 5 deletion cell lines were 
purchased from Horizon Discovery (Cambridge, UK). Both the DLD-1 cell lines, 
and HCT116 were cultured in DMEM/F-12 + Glutamax (Gibco, 31331), 
supplemented with 10% FBS and 1% Penicillin-Streptomycin. The dicer
-/-
 
genotype was confirmed by Northern blot analysis using a probe for microRNA-21 
which was done for each experiment. 
Wild-type and RNase L
-/-
 mouse embryonic fibroblast cells (MEF) were 
provided by Professor Robert H. Silverman’s laboratory (Zhou et al., 1997). The 
MEF cells were grown in RPMI 1640 + GlutaMAX media (Gibco, 61870), 
supplemented with 10% FBS and 1% Penicillin-Streptomycin. The genotype was 
checked for each experiment via polymerase chain reaction (PCR) (see following 
section).  
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The wild-type and Ro60
-/-
 mouse embryonic stem (mES) cell lines were 
provided by Professor Sandra L. Wolin’s laboratory (Chen et al., 2003). The mES 
cells were cultured in Knockout DMEM (Gibco, 10829), supplemented with 15% 
ES cell FBS (Gibco, 10439), 1% L-Glutamine and 1% Penicillin-Streptomycin, 1% 
mem Non-essential amino acids (Gibco, 11140), 100 u/mL ESGRO leukaemia 
inhibitory factor (Millipore) and 0.1 mM 2-Mercaptoethanol (Sigma, M7522). 
Stem cells were grown in flasks prepared with CELLstart CTS substrate (Gibco), 
or on gelatinised plates prepared with 0.1% gelatin solution (Millipore, ES-006-B) 
according to the manufacturer’s instructions. The Ro60-/- genotype was confirmed 
for each experiment via Western blot (see section 2.11 on antibodies). 
Frozen stocks of cells were prepared in 1 ml cryovials by adding 2.5 - 5 x 
10
6
 cells in a solution containing 80 % media, 10 % additional FBS and 10 % 
dimethyl sulfoxide (DMSO) (Sigma). After addition of DMSO, cryovials were 
placed in an isopropanol bath at -80°C and left overnight. The following morning, 
cryovials were transferred to a liquid nitrogen filled Dewar for storage.  
 
2.1.2 PCR genotyping of RNase L
-/-
 cell lines 
 
The RNase L
-/-
 cell lines were created by using a targeting vector to insert 
the neomycin resistance gene (neo) in the reverse orientation into the RNase L 
gene (Figure 2.1) (Zhou et al., 1997). In order to confirm the genotype of these 
cells, PCR analysis of extracted DNA from RNase L
-/-
 and wild-type cells was 
done using primers which map a stretch of DNA flanking the neo gene (Figure 2.1). 
PCR products for insertional mutants should be 2.1 kb and 900 bp for wild-type 
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cells. A ‘no DNA’ control was also performed. DNA was extracted from mutant 
and wild-type cells (4 x 10
6
 cells each) using the DNeasy blood and tissue kit 
(Qiagen). PCR primers used were RNase L (Hind2) 5’-GGAGGAGAAGCTTT 
ACAAGGTG-3’ and RNase L (F1) 5’- GCATTGAGGACCATGGAGAC-3’. 
PCRs were performed using Phusion Hot Start high-fidelity polymerase (NEB). 
PCR cycling parameters were: 98°C for 2 min, followed by 44 cycles of: 98 °C (30 
s), 54 °C (30 s), 68 °C (5 min). This was then followed by 72 °C (10 min), and 
finally a 4 °C end temperature. PCR products were analysed on a 1 % agarose gel 
made with 0.5 x Tris/Borate/EDTA buffer (TBE) and stained with ethidium 
bromide (EtBr). Samples were electrophoresed in a glycerol/bromophenol blue 
loading buffer. A 100 bp DNA molecular weight ladder was used for fragment size 
analysis (Roche, 11721933001). 
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2.1.3 Passaging and cell growth conditions 
 
All cells were grown in a 37 °C, 5 % CO2 humified incubator and were 
only allowed to grow to ~75 % confluency prior to passaging. 
All cell lines, except mES and MCF10A cells, were passaged using 0.25% 
Trypsin - ethylenediaminetetraacetic acid (EDTA) (Gibco). This was achieved by 
removing cell media from a flask of growing cells, and replacing with a volume of 
trypsin sufficient to cover the entire surface of the flask. Cells were incubated with 
trypsin for 3 minutes at 37 °C at which point all cells had dissociated from the flask 
 
Figure 2.1 Map for the 5’ end of the RNase L gene and primer binding sites in mouse 
embryonic fibroblast cell lines. 
 
RNase L
-/-
 cells were made by insertional inactivation using the neomycin resistance 
gene (neo) into the 5’ end of the RNase L gene (Zhou et al., 1997). Genotype of both 
wild-type and mutant cells was achieved via PCR using the primers shown in blue. 
PCR products for insertional mutants should be 2.1 kb and 900 bp for wild-type cells. 
Fragment sizes were assessed on agarose gels. Image courtesy of the Silverman 
laboratory. 
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surface. After agitation of the flask by tapping and shaking to dislodge any 
remaining adhered cells, the trypsin digestion reaction was stopped by adding an 
equal volume of appropriate growth media to the flask, followed by gentle mixing. 
Cells were counted using a haemocytometer. 
Following cell dissociation from the flask and cell counting, cells were 
centrifuged to a pellet at 1,500 rpm (363 x g) for 2 min. The supernatant media was 
subsequently removed, and cells were resuspended in fresh growth media, and re-
seeded at a 1/10 dilution in order to achieve an appropriate confluency in the newly 
passaged flask. 
 For mES and MCF10A cells, 0.05 % Trypsin-EDTA was used. In the case 
of MCF10A cells, 0.1 % soybean trypsin inhibitor (Gibco, 17075-029) in 
phosphate buffered saline solution (Gibco, 14190) was used to neutralise the 
trypsin, as opposed to culture media.  
 
2.2  siRNAs and transfection 
 
All transfections were carried out on cells (~ 60 % confluency) in 6-well 
cell culture plates (Nunc) using Lipofectamine 2000 reagent (Invitrogen, 11668) 
and Opti-MEM + GlutaMAX (Invitrogen, 51985) according to the manufacturer’s 
instructions. Cells were seeded at 150,000 cells/well in a 6-well plate the day 
before transfection reactions in media without antibiotics.  
All siRNAs were used at a final concentration of 50 nM, and were 
transfected twice over a 48 hour period. Transfection reactions were allowed to 
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progress for 5 hours, after which the siRNA/Optimem media was replaced with the 
appropriate growth media. 
All siRNAs used were purchased from Qiagen: The negative control siRNA 
used in all experiments was the ALLStars negative control (Qiagen, 1027281), 
sequence not disclosed. Ro60 siRNA: FlexiTube siRNA Ro60 (Hs TROVE2) 
(Qiagen, SI03239628), (+)5’-GGUAGUAUACUCAACGCUATT-3’, (-)5’-UAGC 
GUUGAGUAUACUACCCA-3’. La siRNA (custom designed): (+)5’-GAAACAG 
ACCUGCUAAUACTT-3’, (-)5’-GUAUUAGCAGGUCUGUUUCTT-3’, already 
used in a previous study (Sommer et al., 2011). Two siRNAs were used together to 
target nucleolin: siRNAs used were FlexiTube siRNA nucleolin (Qiagen, 
SI00300923), (+)5’-GCUAUGGAGACUACACCAGTT-3’, (-)5’-CUGGUGUA 
GUCUCCAUAGCTT-3’, and (Qiagen, SI02654925), (+)5’-GGAAAUGGCCAA 
ACAGAAATT-3’, (-)5’-UUUCUGUUUGGCCAUUUCCTT-3’. Two siRNAs 
were used together to target RNase L: siRNAs used were FlexiTube siRNA RNase 
L (Qiagen, SI00129493), (+)5’-AGACUACACUAGUCCAUAATT-3’, (-)5’-
UUAUGGACUAGUGUAGUCUGG-3’ and (Qiagen, SI03079279), (+)5’-CUA 
UGAUUGGCAAACUCAATT-3’, (-)5’-UUGAGUUUGCCAAUCAUAGGG-3’. 
hAgo2 siRNA (custom designed): (+)5’-GCACGGAAGUCCAUCUGAAUU-3’, 
(-)5’-UUCAGAUGGACUUCCGUGCAC-3’. Angiogenin siRNA: Flexitube 
siRNA (Qiagen, SI02780197) (+)5’-CGUUGUUGUUGCUUGUGAATT-3’, (-)5’ 
UUCACAAGCAACAACAACGTT-3’. RNH1 siRNA: Flexitube siRNA (Qiagen, 
SI03164805) (+)5’CGGUUAGCAACAACGACAUTT-3’, (-)5’-AUGUCGUU 
GUUGCUAACCGTG’3’. 
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2.3 Poly(I:C) treatment 
 
Polyinosinic:polycytidylic acid potassium salt (PolyI:C) (Sigma, P9582) 
was prepared in distilled H20, and was used at a final concentration of 10 µg/ml. 
Poly(I:C) was transfected into cells using Lipofectamine 2000 reagent and Opti-
MEM + GlutaMAX as already described. Poly(I:C) transfection media was 
removed from cells after 5 hours of incubation and replaced with fresh media. 
Cells were harvested for RNA/Protein extraction 3 hours after this media change (8 
hours after exposure to poly(I:C).  
For experiments where gene knockdown was required prior to poly(I:C) 
stress treatment, the following experimental plan was implemented: day 1: cells 
were seeded, day 2: first siRNA transfection, day 3: second (repeat) siRNA 
transfection, day 4: poly(I:C) transfection followed by RNA and protein extraction 
after 8 hours. 
 
2.4 RNA extraction 
 
Total cellular RNA was extracted from cells using the phenol based Trizol 
reagent (Invitrogen, 15596) according to the manufacturer’s instructions, with 
amendments to the protocol mentioned below. Specifically, 1 ml of Trizol was 
used per 3 wells in a Nunc 6-well plate. Growth media was removed via pipette, 
and Trizol added, followed by a brief 1 min incubation period at room temperature. 
This was followed via vigorously pipetting the Trizol up and down in order to 
dissolve cells. For cells treated with poly(I:C) where most of the cells were floating 
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in the growth media, the media was first centrifuged in order to obtain a pellet of 
cells. The cell pellet was then dissolved in Trizol along with any remaining cells 
which were still adhered to the bottom of the well.  
All stages of RNA extraction following treatment of cells with Trizol were 
performed under ‘RNase-free’ conditions. All pipettes, bench surfaces, gloves and 
other consumables were treated with RNaseZAP (Sigma) prior to RNA extraction 
in order to avoid enzymatic degradation of the extracted RNA.  
Trizol used to dissolve cells (1 ml) was centrifuged at 13,000 rpm for 5 min 
at 4°C to remove insoluble debris. After transfer of the supernatant to fresh 
centrifuge tubes, 200 µl chloroform was added and vortexed vigorously for 15 s, 
followed by 2 min incubation at room temperature. The solution was then 
centrifuged at 13,000 rpm for 15 min. The aqueous phase from the Trizol–
chloroform step was added to excess Isopropanol (1 ml) as this has been found to 
be more effective at precipitating small RNAs (unpublished data). Additionally, 
RNA precipitation was carried out for at least 2 h at -20°C, which also improves 
sRNA precipitation. After precipitation, 1 µl GlycoBlue (Ambion, AM9515) was 
added and mixed via vortexing prior to centrifugation in order to improve 
formation and visualisation of the RNA pellet. RNA pellets were washed in 1 ml 
75 % ethanol. Air-dried RNA pellets were resuspended in 30 µl of analytical 
reagent grade H20 (Fisher Scientific) and stored at -80°C.  
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2.5 Assessment of RNA quality and concentration 
 
RNA quantification was achieved using the Nanodrop 2000 
spectrophotometer (Thermo Scientific). Sample purity was assessed using the 
260/280 ratio, which should be ~2.0 for RNA. RNA quality and integrity was 
evaluated by analysing 1µl of RNA on a 1.5 % agarose gel made with 0.5 x 
Tris/Borate/EDTA buffer (TBE) and stained with ethidium bromide (EtBr). RNA 
was added to a 95 % formamide based gel loading buffer; Gel loading buffer II 
(Ambion, 8546G), and denatured for 2 min at 70°C. Following 20-30 min 
electrophoresis at 120 V, the 28S and 18S ribosomal bands were observed by eye 
in order to assess RNA degradation. 
 
2.6 Protein extraction and quantification 
 
Proteins were extracted from cells using RIPA buffer (Sigma, R0278) 
supplemented with protease inhibitor (Sigma, P8340) according to the 
manufacturer’s instructions. Specifically, 300 µl of RIPA buffer was used per 3 
wells in a Nunc 6-well plate. Growth media was first removed, followed by 
washing the adhered cells with cold Phosphate Buffered Saline (PBS) (Gibco, 
14190). After removal of PBS, RIPA buffer was added to cells, followed by 
vigorous ‘scratching’ of cells with an upturned 1 ml pipette tip. The RIPA buffer 
was then incubated on ice for ~ 5 min. Protein lysate was then clarified by 
centrifugation at 8,000 x g for 10 min at 4°C. This was followed by flash freezing 
the lysate using liquid nitrogen. For cells treated with poly(I:C), the growth media 
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was first centrifuged to obtained a cell pellet from the floating cells, as already 
described, followed by RIPA buffer treatment. 
Protein quantification was done using the Pierce bicinchoninic acid (BCA) 
protein assay kit (Thermo Scientific, 23227) following the manufacturer’s protocol. 
Detection of colour change due to Cu
+
 production by the BCA reagent was 
achieved using the Wallac 1420 VICTOR2 multilabel, multitask plate reader. A 
standard curve was generated for each quantification by determining the absorption 
of Bovine Serum Albumin (BSA) solutions of known concentrations in triplicate. 
Standard curves and experimental sample concentrations were generated and 
calculated in Microsoft Excel. 
 
2.7 Small RNA Northern blotting 
 
2.7.1 Polyacrylamide gels for small RNA Northern blotting  
 
In order to detect small RNAs, total cellular RNA (1-10 µg) was separated 
on a 15 % denaturing polyacrylamide gel using the mini PROTEAN III system 
(Bio-Rad) using 1.0 mm gel plates. To make a single gel, 2.1 g urea was dissolved 
in 1.25 ml distilled water and 0.5 ml 5 x TBE in a 50 ml centrifuge tube (with ~20 
s microwaving to facilitate dissolving of the urea). Following this, 1.85 ml 40 % 
acrylamide/bis solution 19:1 (Bio-Rad) was added to the centrifuge tube, and the 
final volume was increased to 5ml using distilled water. After gentle mixing of the 
acrylamide-urea solution via several tube inversions, acrylamide polymerisation 
was achieved by adding 2.5 µl tetramethylethylenediamine (TEMED) and 50 µl of 
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a 10 % ammonium persulfate (APS) solution. This solution was pipetted into the 
gel cast rapidly, followed by adding a 10 well comb with 1.0 mm thickness. 
Additionally, it was found that the quality of the wells could be improved by 
applying constant pressure to the top of the gel plates during polymerisation by 
using small bulldog clips. This technique should only be used with urea based gels 
as application of the clips to standard non-urea polyacrylamide gels can cause a 
formation of a gap between the gel and the cover plate during polymerisation. 
 For experiments involving poly(I:C), 1 µg total RNA per lane was 
typically sufficient to detect Y RNA cleavage fragments. RNA samples were added 
to 95 % formamide based Gel loading buffer II (Ambion, 8546G) and denatured 
for 2 min at 70°C prior to gel loading. Electrophoresis was done in 0.5 x TBE 
buffer at 110 V for ~ 2 h. 
 
2.7.2 Northern blotting of RNA 
 
Following gel electrophoresis, gels were stained with ethidium bromide 
(EtBr) and imaged on a UV transilluminator (UVP) to check successful RNA 
separation. Transfer of RNA to nylon membrane was performed as previously 
described (Pall et al., 2007). Briefly, semi-dry transfer was achieved by placing the 
gel on a piece of 9 cm x 7 cm nylon hybridisation membrane (Amersham Hybond-
NX, GE Healthcare) pre-soaked in 0.5 x TBE. The gel and membrane were 
sandwiched between layers of filter paper (BLT2, Munktell), with three pieces of 9 
cm x 7 cm on either side, also pre-soaked in 0.5 x TBE. The layers of filter paper, 
gel and membrane were arranged in a semi-dry electroblotter (Scie-Plas, V20-
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SDB), removing excess buffer and air bubbles by rolling the surface with a 50 ml 
centrifuge tube. Transfer was done at 3 mA/cm
2
 for 45 min at 4°C. For example, 
250 mA for a single 9 cm x 7 cm membrane at constant Amps. This equates to 
approximately 15-20V for 45-60 minutes at 4°C.  
 
2.7.3 Carbodiimide-mediated cross-linking of RNA 
 
RNA was chemically cross-linked to Hybond-NX as previously described 
(Pall et al., 2007). It was proposed by Pall et al. that 3-(N-morpholino) 
propanesulfonic acid (MOPS) should be used instead of tris-based buffers during 
the gel making and running process, as it was thought that tris might interfere with 
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC)-mediated cross-linking. 
This is not the case, as discovered by researchers in the laboratories of Professor 
Tamas Dalmay, and Professor Sir David Baulcombe. Indeed, use of TBE buffers 
instead of MOPS actually results in superior gels and ‘crisper’ band detection 
following oligonucleotide hybridisation, as demonstrated by side-by-side 
comparisons in the Dalmay laboratory (data not shown). 
Cross-linking solution was prepared by adding 122.5 μl 12.5 M 1-
methylimidazole to 10 ml distilled water, with the pH adjusted to pH 8 using 10 µl 
HCL. This solution was added to 0.373 g EDC (Sigma), giving a 0.13 M solution. 
The final volume was adjusted to 12 ml final using distilled water. 
A piece of filter paper slightly larger than the nylon membrane was then 
soaked in the EDC solution, with excess solution subsequently removed. The nylon 
membrane was then placed onto the EDC soaked filter paper, with the RNA-side 
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facing up. This was then wrapped in Saran wrap and incubated at 60°C for 1-2 h. 
The membrane was then washed twice in distilled water in order to remove excess 
cross-linking solution. 
 
2.7.4 Pre-hybridisation of Northern blot 
 
Membranes were placed into hybridisation tubes with the RNA side facing 
the inside of the tube. A volume of UltraHyb-Oligo hybridisation buffer (Ambion) 
was added which was sufficient to cover the membrane. The tubes were then 
placed in a HB-1000 hybridisation oven (UVP), rotating at 37°C for 1 h. 
 
2.7.5 Northern blot probe synthesis 
 
Antisense DNA oligonucleotide probes were labelled with [-32P]-ATP 
(Perkin Elmer, NEG-502A-500UC) using 1 µl of T4 polynucleotide kinase (PNK) 
(Invitrogen). Specifically, 3 µl of -ATP (~ 1.4 MBq) was used to label 2µl of 10 
µM oligonucleotide (without a 5' phosphate) using the ‘forward’ reaction buffer. 
The solution, with a final volume of 20 µl, was incubated at 37°C for 1 h. 
Following incubation, unincorporated nucleotides were removed by first, diluting 
the reaction solution with an equal volume of distilled water, and applying the -
32
P oligonucleotide labelled solution to a home-made Sephadex G-25 (GE 
Healthcare) spin column, and centrifuging at 2,000 rpm for 2 min. The eluate was 
then added to the hybridisation buffer in the tube containing the Northern blot 
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following pre-hybridisation. Probe hybridisation was conducted at 37°C in a 
rotating oven overnight.  
Sephadex G-25 columns were made by piercing the base of a 0.5 ml 
centrifuge tube with a 0.8 mm x 40 mm (21 G x 1
 
 
 in) needle (Becton Dickinson) 
(only inserting half of the ‘face’ of the needle through the tube), and placing this 
tube into a larger 1.5 ml centrifuge tube. A few drops of glass bead solution was 
added to the 0.5ml centrifuge tube, followed by 300-400 µl Sephadex G-25. 
Column formation was achieved by centrifugation at 2,000 rpm for 2 min. 
 
2.7.6 Post-hybridisation washing of Northern blots and signal detection 
 
After overnight incubation, hybridisation buffer containing the -32P 
labelled probe of interest which had not hybridised to the membrane was discarded. 
The nylon membrane was then subjected to 2 x 30 min washing steps using a 0.2 x 
Saline-Sodium Citrate (SSC), 0.1 % Sodium Dodecyl Sulphate (SDS) solution at 
37°C. Membranes were then wrapped in Saran wrap, and signal was detected using 
phosphorimager screens (Fujifilm). The Bio-Rad molecular imager, FX proplus, 
was used for signal visualisation. Membranes could be re-used by stripping 
hybridised radioactive oligonucleotides by placing membranes in a solution of 
boiling 0.1 % SDS, with shaking for 30 min - 1 h. 
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2.8 Quantitative Northern blotting and statistical analysis of band 
intensities 
 
In order to calculate the concentration of an endogenous sRNA, 
oligonucleotides with the same sequence as the endogenous target were designed 
and purchased either in DNA form (Sigma) or RNA form (Dharmacon). Serial 
dilutions of synthetic sequences for a given target with concentrations ranging 
from 0.1 fmoles – 75 fmoles (depending on the experiment) were loaded on a 15 % 
denaturing polyacrylamide gel and subjected to Northern blotting. Between 0.1-10 
µg of total cellular RNA from an experimental sample was also run on a Northern 
blot. Both the serial dilution and experimental blots were hybridised to a probe 
with a complementary sequence to the target of interest in the same hybridisation 
tube, and exposed to phosphorimager screens together for the same time period. 
Signal strength of band intensities was quantified using the Quantity One software 
(Bio-Rad). Background signal strength was first removed from each of the raw 
values of the bands. A calibration curve was then created using Microsoft Excel for 
the serial dilution of synthetic targets. This calibration curve was then used to 
calculate the concentration of sRNA in the experimental target. 
 For analysis of Y RNA fragmentation from full length Y RNAs, signal 
strength intensities for a given Y RNA/YsRNA were normalised by dividing by the 
band intensity values of U6 snRNA (loading control) for each respective lane.  
For statistical analysis comparing the ratios of particular band intensities, t-
tests and Z-tests were performed by Dr Irina Mohorianu from the School of 
Computing Sciences, University of East Anglia. 
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2.9 Oligonucleotide probe sequences for Northern blot hybridisations 
 
2.9.1 Antisense DNA oligonucleotide probe sequences (Sigma): 
 
Y5 3' end: 5’-AGCTAGTCAAGCGCGGTTGTGGGGG-3’, 
Y4 3’ end: 5’-AGCCAGTCAAATTTAGCAGTGGGGG-3, 
Y3 3’ end: 5’-TAGTCAAGTGAAGCAGTGGGAG-3’, 
Y1 3’ end: 5’-AGACTAGTCAAGTGCAGTAGTGAGAA-3’,  
Y5 5' end: 5’-TAACCCACAACACTCGGACCAACT-3’,  
Y4 5' end: 5’-TAACCCACTACCATCGGACCAGCC-3’, 
Y3 5' end: 5’-AACACCACTGCACTCGGACCAGCC-3’, 
Y1 5' end: 5’-TAACTCACTACCTTCGGACCAGCC-3’, 
miR-21: 5’-TCAACATCAGTCTGATAAGCTA-3’,  
miR-25: 5’-TCAGACCGAGACAAGTGCAATG-3’, 
miR-93: 5’-CTACCTGCACGAACAGCACTTTG-3’, 
tRNA Met 5’ end: 5’-AGCACGCTTCCGCTGCGCCACTCTGCT-3’,  
U6 snRNA: 5’-GCTAATCTTCTCTGTATCGTTCC-3’. 
 
2.9.2 Locked nucleic acid (LNA) modified oligonucleotide probes (Exiqon): 
 
LNA is a modified RNA nucleotide which has a high binding affinity for 
RNA and results in an increased sensitivity when detecting target molecules. The 
LNA oligonucleotides used here contained DNA nucleotides with an LNA 
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molecule substituted every third base (denoted by a ‘+’ prefixed to the base which 
was substituted with LNA).  
 
Y5 (LNA) ‘loop’ probe: 5’- G+AGA+CAA+TGT+TAA+ATC-3’ 
 
2.10 Western blotting 
 
2.10.1 Polyacrylamide gel electrophoresis of proteins 
 
For protein electrophoresis, 10 µg of total protein was boiled in 1.5 ml 
centrifuge tubes for 5 min at 100°C in an equal volume of Laemmli buffer (Sigma), 
and then returned to ice. Proteins were separated on a precast NuPAGE 4-12 % 
Bis-Tris polyacrylamide gel (Invitrogen) using the XCell Surelock mini-cell 
electrophoresis system (Invitrogen). Electrophoresis was performed at 120 V in 
NuPAGE Mops SDS running buffer (NP0001). The protein size markers used were 
Kaleidoscope pre-stained standards (Bio-Rad, 161-0324) and Precision Plus 
protein standards (Bio-Rad, 161-0374).  
 
2.10.2 Blotting of proteins 
 
Proteins were transferred to Immun-blot Polyvinylidene fluoride membrane 
(PVDF), 0.2 µm (Bio-Rad, 162-0177). PVDF was first wetted in methanol. The gel 
and six pieces of filter paper (BLT2, Munktell), were wetted in NuPAGE transfer 
buffer (Invitrogen, NP0006-1) supplemented with 20 % methanol. The PVDF was 
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also wetted in transfer buffer following methanol ‘activation’. The wetted gel was 
put on the PVDF and placed between pieces of filter paper (3 pieces each side). 
The layers of gel, PVDF and filter paper were then secured between layers of 
transfer buffer soaked sponge pads. The entire complex was than arranged in the 
XCell II blot module (Invitrogen) and filled with transfer buffer. Transfer was done 
at 300 mA for 45 min at 4 °C. 
Following protein transfer to PVDF membrane, the membrane was then 
washed three times in phosphate buffered saline (made using Dulbecco `A’ Tablets, 
Oxoid). To avoid non-specific antibody hybridisation, the PVDF membrane was 
blocked for 1 h in a 5 % milk solution (Marvel) in PBS, supplemented with 0.1 % 
Tween20 (PBS-Tween). 
 
2.10.3 Western blot antibody hybridisation 
 
Western blot membranes were hybridised to the appropriate primary 
antibody at dilutions recommended by the manufacturers. Hybridisations were 
performed in 10 ml of 5 % milk, 0.1 % PBS-Tween in 50 ml centrifuge tubes 
rotating at 4 °C overnight in a hybridisation oven. The following day, membranes 
were washed three times for 15 min in PBS-Tween (0.1 %), without milk. 
Hybridisation of horseradish peroxidise (HRP) conjugated secondary antibodies, at 
dilutions specified by the manufacturers, was achieved in 5 % milk PBS-Tween in 
50 ml centrifuge tubes rotating at room temperature for 1 h. After hybridisation 
with the secondary antibody, membranes were washed three times as before in 
PBS-Tween. 
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Antibody signal was detected using enhanced chemiluminescence (ECL) 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, 34080). 
The membrane was then incubated in activated substrate for 30 s - 3 min and then 
quickly removed and wrapped in Saran wrap. The Glow Writer Pen (Diversified 
Biotech) was used to mark on the Saran the positions of the size markers. Signal 
was detected using the Fujifilm darkbox (LAS-3000). After signal visualisation, 
PVDF membrane was stripped of antibodies using ReBlot Plus Strong antibody 
stripping solution (Millipore) according to the manufacturer’s instructions. 
 
2.11 Antibodies for Western blotting 
 
All antibodies were used at dilutions recommended by the manufacturer. 
Antibodies used were: human Ro60 (Santa Cruz, sc-20961), La (Abnova, 
H00006741-M01), Nucleolin (abcam, ab13541), Ago2 (abcam, ab57113), β-actin 
(abcam, ab6276), Angiogenin (abcam, ab10600 and Santa Cruz, sc-1408) and 
RNase L (abcam, ab13825). For detection of Ro60 in mouse, a previously 
described home-made antibody from the Wolin laboratory was used (Chen et al., 
2003). Secondary antibodies used were: Rabbit polyclonal Secondary Antibody to 
Mouse IgG - H&L (HRP) (Abcam, ab6728) used for detecting mouse Ro60, La, 
Nucleolin, RNase L, angiogenin (abcam antibody) and β-actin primary antibodies. 
Anti-Rabbit IgG (whole molecule)–Peroxidase antibody produced in goat (Sigma, 
A0545) for detecting human Ro60 primary antibody. Finally, donkey anti-goat 
IgG-HRP (Santa Cruz, sc-2020) was used for detecting angiogenin (Santa Cruz 
antibody). 
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2.12 Y5 expression construct 
 
The Y5 expression construct (pY5) was created by another PhD student in 
the lab, Carly Turnbull. Using the forward primer: 5’-
AATACTAGTGAAGATCCATGGAGGTACATC-3’ and the reverse primer 5’-
GTAAACGTTGTCTACTACTGTTATTAGTGC-3’ the hY5 gene, including 
endogenous promoter and terminator sequences, was amplified from HeLa 
genomic DNA and cloned into the pGEM-T Easy vector (Promega). The sequence 
was checked by Sanger sequencing on both the sense and antisense strands using 
the pUC/M13 forward (5’-CGCCAGGGTTTTCCCAGTCACGAC-3’) and 
pUC/M13 reverse (5’- TCACACAGGAAACAGCTATGAC-3’) primers. 
The pY5 construct was transfected (1 µg per well in a 6-well plate with a 1 
ml volume) using Opti-MEM + GlutaMAX and Lipofectamine 2000 reagent as 
already described. 
 
2.13 Angiogenin expression construct 
 
The angiogenin expression construct (pcDNA-ANG) was a gift from 
Xiaofei Zheng’s laboratory (Fu et al., 2009). The sequence was checked by Sanger 
sequencing on both the sense and antisense strands using the T7 (5’-
TAATACGACTCACTATAGGG-3’) and SP6 (5’ATTTAGGTGACACTATAG-
3’) primers.  
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The pcDNA-ANG construct was transfected (0.5 µg per well in a 6-well 
plate with a 1 ml volume) using Opti-MEM + GlutaMAX and Lipofectamine 2000 
reagent as already described. 
 
2.14 Plasmid purification 
 
Plasmids were transformed into super competent DH5α bacterial cells via 
heat shock. This was done using a 25s heat shock at 42 C, followed by addition of 
1 ml of  super optimal broth medium supplemented with 20 mM glucose (SOC) 
with a one hour recovery period in a 37C shaker incubator. Bacteria were then 
plated and colonies containing the desired plasmid were selected for on Luria broth 
(LB) plates with 100 µg/ml ampicillin. Plasmid recovery was achieved via a 
purification kit (Qiagen) following inoculation of a single bacterial colony in 5 ml 
LB with 100 µg/ml ampicillin. All bacterial handling and plating was done using 
aseptic techniques. 
Following sequence confirmation, desired plasmids were purified to high 
concentration using large scale 'midiprep' plasmid purification (Qiagen). 
Concentration and quality of DNA was assessed using the Nanodrop 2000 
spectrophotometer (Thermo Scientific). A sample absorbance 260/260 nm ratio 
was checked, which should be ~1.8 as an indication that the analysed sample is 
'pure' DNA. 
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2.15 Dideoxynucleotide chain termination (Sanger) sequencing 
 
Following plasmid purification, sequences were checked via 
dideoxynucleotide chain termination (Sanger) sequencing using the Big Dye 
terminator kit (Applied Biosystems). The Big Dye sequencing reaction contained 1 
μL of recovered plasmid, 1 μL of BigDye, 1 μL of Half Big Dye, 1 x sequencing 
buffer and 1 μL of sequencing primer in a 10 μL reaction. The polymerase chain 
reaction (PCR) used to generate dideoxynucleotide termination products was 
performed using the following cycling parameters: 96 C (4 min) followed by 25 
cycles of: 96 C (30 s), 50 C (15 s), 60 C (4 min). This was followed by a 4 °C 
holding temperature. The PCR reactions were sent to the Genome Analysis Centre, 
Norwich where the sequencing reactions were run. Sequence analysis was 
performed using the FinchTV software, version 1.4.0 (Geospiza).  
 
2.16 Anion exchange chromatography of non-stressed and poly(I:C) treated 
cells 
 
MCF7 cells were plated in 175 cm
2
 flasks (4 flasks per experiment) and 
allowed to grow to 70 % confluency. Flasks were either treated or not-treated with 
poly(I:C). For poly(I:C) treated flasks, cells were harvested 24 h after poly(I:C) 
induction, using 0.25 % Trypsin-EDTA as already described. Following trypsin 
neutralisation and pellet formation, cells were washed in cold Phosphate Buffered 
Saline (PBS) (Gibco, 14190). Following PBS washing and cell pellet formation via 
centrifugation (from 4 flasks combined), cells were lysed in 1 ml of column buffer 
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(20 mM Tris/HCl pH 7.5, 300 mM NaCl, 5 mM MgCl2, 5 mM DTT) 
supplemented with RNase inhibitor at 1 µl/ml (Promega) and protease inhibitor at 
5 µl/ml (Sigma, P8849). This was achieved via pressure/suction induced lysis 
using a 2ml syringe and a 0.5 mm x 16 mm (25 G x 
 
 
 in) needle (Becton 
Dickinson). A lysate was created by drawing the cell-lysis buffer mixture through 
the needle into the syringe and expelling the fluid back into the collection tube ten 
times. Insoluble material was removed by centrifugation at 16,000 g for 5 min at 
4 °C. 
Anion exchange was performed by a postdoctoral researcher in the 
laboratory, Dr Tibor Csorba. The extracts were separated using a 
diethylaminoethanol (DEAE) -anion exchange column (Pharmacia). Fractions from 
the anion exchange column were eluted in increasing salt concentrations between 
100 mM and 800 mM. RNA was extracted from every second fraction and 
separated on a 15 % denaturing polyacrylamide gel and subjected to Northern 
blotting as already described. 
 
2.17 Ago2 pull-down assay 
 
Ago2 immunoprecipitation (pull-down) was performed by a postdoctoral 
researcher in the laboratory, Dr Francisco Esteban Nicolas. Four flasks of 175 cm
2
 
confluent MCF7 cells were treated with trypsin and washed twice with PBS. Cells 
were lysed using 2 ml of Lysis Buffer (Promega, E3971) plus 2.5 mg/ml of heparin 
(Sigma). Lysate was spun down for 10 min at 10,000 rpm and the supernatant was 
moved to a clean tube. Then 10 μl of primary antibody Ago2 (Abcam, ab57113) 
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was added followed by incubation and rocking for 4 hours at 4ºC. Following this, 
50μl of protein A beads were blocked in 2 ml of lysis buffer plus 2.5 mg/ml of 
heparin for 1 h. Beads were spun down (2,000 rpm, 3 min) and mixed with the 
lysate, followed by incubation and rocking for 1 h at 4ºC. This was then washed 
three times followed by spinning the beads down and resuspension in 500 μl of 
lysis buffer with heparin 5 mg/ml. Then there was a final wash only with lysis 
buffer. This was eluted three times with 100 μl of glycin/HCl pH=2.3 100 mM. 
These three elutions were pooled and neutralized with 75 μl of Tris/HCl pH 9.0 
(1M). This was then purified with 1.2 ml of trizol. 
 
2.18 Angiogenin in vitro cleavage experiments 
 
Experiments using recombinant angiogenin protein to cleave total cellular 
RNA or cell lysate were based on previous experimental designs (Fu et al., 2009; 
Li et al., 2012). Recombinant human angiogenin powder (R&D Systems, 265-AN-
050) was made up to a 10 µM (140 µg/ml) stock solution in a filter sterilised buffer 
(PBS containing 0.1 % bovine albumin), and used at a working concentration of 1 
µM. Recombinant RNase A (Ambion, AM2269) (73 µM stock, 1 mg/ml) was used 
at a working concentration of either 1 µM or 1.5 nM. The experimental 
‘angiogenin buffer’ (30 mM HEPES pH 6.8, 30 mM NaCl, 0.0001 % BSA) was 
adjusted to pH 7 and then filter sterilised. The working buffer in the absence of any 
RNase was used as a control. 
Reactions were performed at 100 µl final volumes using 20 µg total RNA 
per reaction in 1.5 ml centrifuge tubes. For experiments using cell lysates, cells 
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were first dissociated from tissue culture flasks using trypsin. The cells were then 
washed in PBS, and then 2 x 10
6
 cells were lysed in 90 µl of angiogenin buffer 
using pressure/suction induced lysis with a 2ml syringe and a 0.5 mm x 16 mm (25 
G x 
 
 
 in) needle. The number of cells used was based on the assumption that one 
representative mammalian cell contains ~ 10 pg RNA (Tang et al., 2011). This 
would equate to 20 µg RNA per 2 x 10
6
 cells, which would make the in vitro 
cleavage RNA and cell lysate experiments comparable. After addition of 
angiogenin or RNase A, reactions were incubated on a heating block at 37 C for 
between 2 min – 1h. Reactions were stopped by addition of 1 ml Trizol. RNA was 
then extracted as already described. 
 
2.19 Adjustment of pH and filter sterilisation of buffers 
 
The pH of solutions and buffers was measured using the Suntex 
microprocessor pH meter SP-2200, applying dropwise addition of concentrated 
HCl or NaOH to adjust the pH value. Buffers and solutions which could not be 
autoclaved were filter sterilised by passing liquid through 0.2 µm filters (Sartorius 
Stedim Biotech) using a syringe. 
 
2.20 Mouse organ dissection and subsequent RNA isolation 
 
 All mice were provided by the Disease Modelling Unit, School of 
Biological Sciences, University of East Anglia. Adult male and female mice (~ 2 
months old) from BALB/c or C57BL/6 strains were sacrificed by a technician. 
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This was done humanely by cervical dislocation at the same time of the morning 
each time a mouse was used. Dead mice were quickly dissected (within 30 min of 
sacrifice) following brief sterilisation of the fur with 100 % ethanol. All dissection 
instruments used were autoclaved and sterile. Organs dissected were the brain, 
heart, both lungs, liver, both kidneys and femoral muscle from the left leg. Once 
extracted, organs were quickly cut into slices where at least one dimension was no 
more than 0.5 cm across. These tissue samples were placed in 5 volumes of 
RNAlater solution (Sigma) and kept on ice. Prior to RNA extraction, tissue 
fragments for each organ were removed from RNAlater solution and weighed on a 
digital scale. The mass of tissue fragments for each organ was used to calculate the 
volume of Trizol (Invitrogen) required to extract RNA as recommended by the 
manufacturer. Tissues were ground in Trizol using sterile pestle and mortars, 
applying liquid nitrogen intermittently. RNA pellets were resuspended in 200 µl of 
distilled H20 for each organ. 
 
2.21 Purification of sRNA (<200 nt) from total RNA 
 
 In order to isolate the sRNA fraction (<200 nt) from tissues, organs and cell 
culture extracts, 20 µg of total RNA was processed using the mirVana miRNA 
Isolation kit (Ambion). The small RNA fraction was eluted in a 50 -100 µl volume 
of distilled H20. This RNA was then concentrated via ethanol precipitation and 
resuspended in 10 µl distilled H20, giving a total recovery of ~ 2 µg sRNA from 20 
µg total RNA. 
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2.22 Concentrating RNA via ethanol precipitation or vacuum drying 
 
In order to concentrate RNA, two techniques were employed. Where only a 
small concentration was required (~ 20 µl reduction in volume), vacuum 
concentration was used. RNA solutions were centrifuged in the Eppendorf 
Concentrator 5301 in open-capped 1.5 ml centrifuge tubes. The rate of reduction in 
volume during centrifugation is approximately 1 µl/min. 
Where a greater volume concentration was required, ethanol precipitation 
was implemented. Taking a 100 µl volume of RNA, 12.5 µl of 3 M sodium acetate, 
375 µl 100 % ethanol and 2 µl GlycoBlue (Ambion, AM9515) was added and 
briefly vortexed. This solution was incubated at -80°C for 2 h, followed by 
centrifugation at 13,000 g for 20 min. The supernatant was then removed and 
followed by washing with 95 % ethanol. The air-dried RNA pellet was then 
resuspended in the desired volume of distilled H20. 
 
2.23 Small RNA library preparation  
 
Total RNA was isolated via Trizol extraction (Invitrogen) and small RNA 
was enriched using the mirVana miRNA Isolation kit (Ambion) as already 
described. Small RNA libraries were created using the TruSeq Small RNA 
preparation kit (Illumina, RS-200-0012 & RS-200-0024) using variable index 
primers (barcodes) to allow for multiplexing of samples. The protocol provided by 
the manufacturer was used to create libraries with amendments specified below.  
For the mouse organ sequencing experiments, 500 ng input sRNA was used per 
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reaction, and for the mouse embryonic stem cells/Ro60
-/-
 experiments, 2 µg input 
sRNA was used. Two biological repeats were done for both the mouse organ 
experiment and for the mES/Ro60
-/-
 experiment.  
Reactions were performed using half the volumes recommended by the 
manufacturer up to the reverse transcription (RT) stage, at which point full 
recommended reaction volumes were used. Truncated T4 RNA ligase 2 (NEB) was 
used for 3’ adapter ligation, and SuperScript II reverse transcriptase (Invitrogen) 
for creation of cDNA. PCR amplification of cDNA was achieved using Phusion 
Hot Start high-fidelity polymerase (NEB) using 4 µl of the RT reaction in two PCR 
reactions with different cycle numbers, with 20 µl final volume. The PCR 
conditions provided in the manufacturer’s protocol were used except 15 & 17 
cycles were used for the mouse organ library preparation, and 17 & 19 cycles for 
the mouse embryonic stem cells/Ro60
-/-
 experiment. These cycling parameters 
were optimised for library preparation of the 30-40mer sRNA fraction. The two 
separate PCR reactions for each sample were pooled for gel extraction. 
DNA libraries were separated on 8 % polyacrylamide gels and stained 
using SYBR gold. The 30-40mer class of sRNAs were isolated by cutting the 
appropriate portion of the gel with a sterile razor blade using the size markers 
provided by the kit as a guide. 
 
2.24 Illumina (Solexa) sequencing and bioinformatics 
 
Libraries were sent to Baseclear (Netherlands) where they were checked on 
a BioAnalyser (Agilent DNA 1000 chip) and quantified. Libraries were then 
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pooled and sequenced using the HiSeq 2000 system (Illumina) with a 50 cycle read 
length. The sequencing was done using two different lanes for each experiment. 
For the mouse organ experiment, the two biological repeats (6 organs from 2 
different mice) were sequenced on different lanes. For the mES/Ro60
-/-
 experiment, 
sequencing was performed in duplicate such that each sample was sequenced on 
each of 2 lanes. Data analysis was done by Dr Helio Pais, Matthew Beckers and Dr 
Irina Mohorianu from the School of Computing Sciences, University of East 
Anglia. 
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Chapter 3 
Y RNAs are fragmented into Y RNA-derived sRNAs in 
a range of cell types under stressed and non-stressed 
conditions 
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3.1 Introduction 
 
 Cells need to respond to adverse conditions brought about by 
environmental change or internal fluctuations in biochemical states. This ‘stress’ 
response needs to be implemented quickly and efficiently in order to restore 
cellular homeostasis. One of the ways cells respond to stress is by altering the 
expression of microRNAs, which in turn tailors gene expression in order to adapt 
to new environmental conditions (Leung & Sharp, 2010). In the laboratory of 
Professor Tamas Dalmay, we study microRNAs in both animal and plant systems. 
Previous work in the Dalmay laboratory has demonstrated that plants use 
microRNAs to respond to stress. Specifically, it was shown that miR-395 in 
Arabidopsis is upregulated in response to sulphur starvation in different cell types 
(Kawashima et al., 2009), a nutrient which is essential for the synthesis of some 
amino acids. Increased miR-395 levels results in the differential regulation of 
sulphate transporter proteins which in turn facilitates the favoured translocation of 
sulphate to plant shoots (Kawashima et al., 2009; Kawashima et al., 2011). 
 A different study in the Dalmay laboratory aimed to uncover novel stress 
related microRNAs in animal cells. Here, postdoctoral researcher Dr Francisco 
Esteban Nicolas implemented a range of stress stimuli on the common breast 
cancer cell line, MCF7. These included heat shock, double heat shock, nutrient 
starvation, viral infection and a control. In order to mimic viral infection, 
polyinosinic:polycytidylic acid (Poly I:C) – an immunostimulant structurally 
similar to double-stranded RNA, was transfected into cells. RNA was then 
extracted from all stressed and control cells and subjected to Solexa (Illumina) 
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sequencing. The RNA size class corresponding to ~22 nt miRNAs was selected for 
library preparation. Strikingly, only three microRNAs were identified as being 
differentially regulated during stress. MiR-1246, miR-1979 and miR-1975 showed 
a significant increase in abundance in cells subjected to poly(I:C) treatment only. 
Further investigation via a literature search and using the Basic Local Alignment 
Search Tool – BLAST (Altschul et al., 1990) revealed that the 25 nt miRs-1979 
and 1975 were in fact fragments derived from non-coding RNAs called Y RNAs.  
Y RNAs were first discovered during investigations into systemic lupus 
erythematosus (SLE) as they were found to associate with the autoantigen Ro60 
(Lerner et al., 1981). Y RNAs have since been implicated in biological processes 
such as chromosomal DNA replication (Christov et al., 2006) and RNA quality 
control (O'Brien & Wolin, 1994).  
The Dalmay laboratory found that miR-1979 was derived from the 3’ end 
of human Y3 RNA (hY3) and miR-1975 was derived from the 3’ end of human Y5 
RNA (hY5). Indeed, a study published shortly after we discovered this also noted 
that these putative miRNAs were actually Y RNA fragments (Meiri et al., 2010), 
and they were subsequently removed from the microRNA online database, 
miRBase. Interestingly, these Y RNA fragments were first described 11 years prior 
to our discovery in cells undergoing apoptosis, where Y RNAs appeared to be 
specifically targeted for degradation (Rutjes et al., 1999a). No study has yet looked 
at these Y RNA-derived sRNAs (YsRNAs) in detail. 
 In this chapter, the aim was to characterise the nature and occurrence of Y 
RNA fragmentation in a range of animal cell lines. YsRNAs mapping to both the 3’ 
and 5’ ends of all four Y RNAs were identified in Solexa (Illumina) sequencing 
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data. The YsRNAs were detected in stressed cells via small RNA Northern blot 
and were also detected in non-stressed cells at levels comparable with microRNAs.  
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3.2 Results 
 
3.2.1 Y RNAs give rise to fragments originating from their 5’ and 3’ ends 
 
 Preliminary work by Dr Francisco Esteban Nicolas comparing poly(I:C) 
treated and untreated MCF7 cells utilised Solexa sequencing libraries which 
selected for 19-24 nt sRNAs. It was in these experiments that YsRNAs were shown 
to be upregulated during poly(I:C) treatment. Following Northern blot validation, it 
was noted that several of these candidates also showed larger bands, ~30 nt. It was 
then decided that new libraries should be made which would include this longer 
size class of small RNAs. 
MCF7 cells were subjected to a stress treatment by transfecting cells with 
poly(I:C). The effect of poly(I:C) on cell morphology can be seen in figure 3.1. 
Untreated MCF7 cells displayed a polygonal shape typical of other epithelial cells 
and were adhered to the cell culture flask. After poly(I:C) treatment (8h post-
transfection – when RNA was harvested), many cells had disassociated from the 
flask and displayed a shrunken, spherical morphology with blebbing of the plasma 
membrane, typical of cells undergoing apoptosis (Figure 3.1). RNA was then 
extracted from poly(I:C) treated and untreated cells and cDNA libraries were 
generated for the 19-33 nt size range of small RNAs. A size distribution of 
sequences revealed an expected peak around 22 nt representing the microRNA 
population, and an unexpected peak of around 30-33 nt (Figure 3.2). Following 
Solexa sequencing, 21,837,679 redundant reads were obtained for the poly(I:C) 
treated dataset, of which 79 % mapped to the genome. Out of the total number of 
101 
 
reads, this included 490,826 unique (non-redundant) reads of which 33 % mapped 
to the genome. The discrepancy between the percentage of mapped reads for 
redundant and unique sequences was owing to the presence of a small proportion 
of sequences with very high read counts which could be mapped. The 50 sequences 
with the highest read counts made up 83 % of the mapped reads (34 % of which 
were microRNAs, and 56 % of which were tRNA, snoRNA and rRNA fragments). 
Sequence reads were normalised using the total redundant read numbers which 
mapped to the genome. 
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Figure 3.1 Morphological effect of poly(I:C) on MCF7 cells. 
 
Photographs of normal MCF7 cells prior to treatment, and 8 h after poly(I:C) 
transfection (when RNA/protein samples were harvested). Photographs taken 
down a microscope lens at 20 X magnification (top photographs) and 10 X 
magnification (bottom photographs). Untreated MCF7 cells (left panels) looked 
normal for healthy epithelial cells, with a typical polygonal shape and were firmly 
attached to the cell culture flask in discrete patches. After 8 h following 
transfection with poly(I:C) (right panels), many cells had disassociated from the 
flask, with adhered cells looking more spherical and shrunken in size, with 
blebbing of the plasma membrane (indicated by arrows) characteristic of 
apoptosis. Scale bar represents 20 µm (approximate size). 
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Reads corresponding to YsRNAs were detected which were derived from 
all four human Y RNAs. When mapped to the Y RNA structures, these sequences 
corresponded exactly to the 5’/3’ stems of the Y RNAs, and included some of the 
single stranded region of the large internal pyrimidine rich loop (Figure 3.3A). No 
sequences corresponding to the remaining loop region were detected. 
 
Figure 3.2 Size distribution of sequences from MCF7 cells treated with poly(I:C) 
or not treated (control).  
 
RNA was extracted from poly(I:C) and untreated MCF7 cells. Libraries of 19-33 
nt were then generated (work by Dr Francisco Esteban Nicolas) and sequenced 
using Solexa sequencing technology. Two peaks are clearly visible: a peak of ~22 
nt representing the microRNA population, and a peak of around ~30 nt which 
includes Y RNA fragment sequences. 
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Figure 3.3 YsRNA sequences detected in poly(I:C) treated MCF7 cells by Solexa 
sequencing. 
 
(A) Y RNA structures (adapted from Christov et al., 2006) with the principle 
YsRNAs generated following poly(I:C) treatment highlighted in yellow. The Y 
RNA fragment size is also shown. (B) YsRNA read counts (normalised as reads per 
million using redundant reads mapping to the genome). The number of reads for the 
principle cleavage fragment generated is shown first. Read counts for the summed 
abundance of the consensus sequence and detected Y RNA fragment variants, 
(sequences with a +/- 2 nt deviation and up to 2 mismatches from the consensus 
sequence), is shown in brackets. The lack of detected variants for some YsRNAs 
(for example, both Y5sRNAs), may be due to bioinformatic or sequencing bias 
rather than lack of biological occurrence. Y RNA reference sequence obtained from 
NCBI database. Y RNA length differences between (A) and (B) is owing to 
heterogeneous poly-U tails as result of transcription by RNA Pol III. 
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The YsRNAs ranged in size from 27-32 nt, with the exception of the Y4-5’ 
fragment which had a shorter length of 18 nt (Figure 3.3A). The fragments from 
the 5’ and 3’ ends of each Y RNA with the highest read counts were selected for as 
the ‘YsRNA consensus sequence’ for each fragment (Figure 3.3B). Fragments with 
a +/- 2 nt deviation and up to 2 mismatches from the consensus sequence were also 
selected for analysis, and will be referred to as ‘YsRNA variants’. 
The Y5-3’ fragment had the highest read count, showing 1,553 reads per 
million reads (RPM) for the consensus sequence (Figure 3.3B). This was followed 
by the Y4-3’ fragment with 746 RPM and Y5-5’ fragments with 357 RPM. All 
other YsRNAs had read counts which were around 5-20 fold less than these three, 
with the exception of the Y4-5’ fragment which had a very low read count of 1 
RPM. Half of the eight different YsRNA species had a number of YsRNA variants 
with significant read counts, (summed abundance of read counts for the consensus 
sequence and YsRNA variants is shown in brackets in figure 3.3B).  
The Y1-3’ variants showed the highest proportion of sequences contributing 
to the summed abundance of variants and consensus read counts, with 41 % of 
total fragment reads coming from YsRNA variants. Neither of the Y5-3’ or Y5-5’ 
YsRNAs gave rise to variants using the criteria used. 
As a comparison, the normalised read counts of two microRNAs expressed 
in poly(I:C) treated MCF7 cells were calculated, taking into account reads with a 
+/- 1 nt deviation from the microRNA sequence in miRBase. The normalised read 
counts for miR-25 was 215 RPM and for miR-93 was 621 RPM. The read numbers 
for the two microRNAs were similar to the read numbers for the YsRNAs. 
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3.2.2 Detection of YsRNAs via Northern blot 
 
In order to see whether these YsRNAs were bona fide small RNAs and not 
merely unspecific degradation products, the fragments were validated via Northern 
blot. Initially, the Y5-3’ YsRNA was focused on as it had significantly higher read 
counts compared to the other YsRNAs. Total RNA was extracted from both 
untreated and poly(I:C) treated MCF7 cells and analysed on a Northern blot, 
probing with a sequence complementary to the 3’ end of Y5 RNA (Figure 3.4A). 
In the lane for untreated MCF7 cells, a single band corresponding to ~80 nt was 
detected. In the lane with RNA from poly(I:C) treated cells, the same ~80 nt band 
was present, along with two additional smaller bands. A band of 32 nt with a very 
strong signal was present, and a weaker band of 24 nt was also present. The size of 
these fragments was confirmed using size markers (Figure 3.4B). Comparing the 
Northern blot with the sequencing data, the larger 32 nt YsRNA fragment 
corresponded with the principle Y5 3’ fragment and the 24 nt fragment 
corresponded with the Y5 3’ stem minus the single stranded tail sequence (Figure 
3.4C). This 24 nt fragment was also present in the sequencing data at 289 RPM. 
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3.2.3 Y5 RNA 3’ fragments are generated under stress in a range of cell 
types 
 
 In order to see whether YsRNAs could be generated under poly(I:C) stress 
in cells other than MCF7, a range of human cell lines were cultured and either 
treated with poly(I:C) or not treated. These included the cancerous cell lines HeLa 
 
Figure 3.4 Y5 RNA fragment validation (3’ end). 
 
(A) Northern blot analysis of Y5 RNA fragmentation following poly(I:C) stress 
treatment. Full length Y5 RNA gives rise to two smaller fragments. (B) Validating 
size of Y5 YsRNAs using size markers. Solexa sequencing data showed a 32 nt Y5 
3’ fragment was the principle fragment and a 24 nt fragment with an overlapping 
sequence was produced at a lower abundance. 31 nt size marker used instead of 32 
nt as preliminary analysis hinted that the longer Y5 3’ fragment was 31 nt. (C) The 
32 nt and 24 nt fragments mapped to the full length Y5 RNA highlighted in yellow 
and red. The two fragments share the same sequence and differ by the single 
stranded 3’ tail shown in red. 
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(cervical cancer cells), DLD-1 (colorectal adenocarcinoma cells), HCT116 
(colorectal carcinoma cells) and HepG2 (hepatocellular carcinoma). Y RNAs have 
been shown to be upregulated in a range of cancerous tissues (Christov et al., 
2008), and YsRNAs also have a higher abundance in tumour samples (Meiri et al., 
2010). Therefore, two non-cancerous cell lines: HEK293 (embryonic kidney cells) 
and MCF10A (mammary epithelial cells), were investigated to see whether 
YsRNA generation was cancer specific. Total RNA was extracted from poly(I:C) 
treated and untreated cells and analysed via Northern blot, probing for the Y5 RNA 
3’ fragment (Figure 3.5). Northern blots for all cancerous and non-cancerous cell 
lines showed a single band representing full length Y5 RNA for untreated cells. All 
poly(I:C) treated cells also shared this ~80nt band, along with the two shorter 
bands representing YsRNAs. The band of 32 nt had a stronger signal than the band 
of 24 nt which was usually weaker and less defined. Upon closer inspection, it was 
also noted that YsRNA were also detectable at very low levels in some of the 
untreated cells. 
 
3.2.4 Y5 RNA 3’ fragments are produced in non-stressed cells at microRNA-
like levels 
 
Only a short exposure time was sufficient to detect Y5 RNA and its 
cleavage products on a phosphorimager screen after poly(I:C) treatment, and only 
1 µg of total RNA was required to detect the YsRNAs. This could have resulted in 
fragments which were produced at low levels being overlooked. Indeed, weakly 
produced YsRNAs appeared to be detectable in non-stressed cells (Figure 3.5). 
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Therefore, 10 µg total RNA from untreated MCF7 cells was analysed on a 
Northern blot with a Y5 RNA 3’ specific antisense probe, using 0.1 µg RNA from 
poly(I:C) treated cells as a size marker for the YsRNAs (Figure 3.6). The 
hybridised Northern blot was also left to expose for a longer time period (7 days 
instead of 7 h) in order to detect possible YsRNAs in cells grown under normal 
conditions. Intriguingly, the longer Y5 3’ fragment (32 nt) was clearly visible in 
non-stressed cells after Northern blot signal was left to develop for a week (Figure 
3.6). An siRNA with no target in the human genome was transfected as a control to 
test the effect of Lipofectamine 2000 on YsRNA generation. YsRNA generation 
mildly increased under these conditions (Figure 3.6). 
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Figure 3.5 Multiple cell lines show Y5 RNA fragmentation during poly(I:C) treatment.  
 
Total RNA extracts from various cell lines, either treated or untreated with the 
immunostimulant poly(I:C), were analysed by Northern blotting using a Y5-3’ antisense 
probe. These included the cancerous cell lines MCF7 (breast adenocarcinoma), HeLa 
(cervical cancer cells), DLD-1 (colorectal adenocarcinoma cells), HCT116 (colorectal 
carcinoma cells) HepG2 (hepatocellular carcinoma), as well as two non-cancerous cell 
lines; HEK293 (embryonic kidney cells) and MCF10A (mammary epithelial cells). The 
upper most band is the full length Y5 RNA (83 nt) and the two shorter bands are the Y5 
RNA 3’ cleavage products of 32 nt and 24 nt. A non-specific siRNA was transfected into 
MCF10A cells as a transfection control. The membranes were stripped and re-probed 
with a U6 specific probe to show equal loading.  
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Based on the Northern blot signal (Figure 3.6), the level of Y5sRNA 
production in untreated cells appeared to be on a par with other sRNAs found in 
the cell. Therefore, Y5 RNA cleavage products were quantified in non-stressed 
cells and compared to the levels of two microRNAs. Using a synthetic RNA 
oligonucleotide corresponding to the longer Y5sRNA, a dilution series was made 
(Figure 3.7). Dilution series were also made using oligonucleotides corresponding 
to miR-25 and miR-93. After Northern blot hybridisation and generation of a 
calibration curve, the normal physiological level of the longer Y5 sRNA was 
calculated at 0.27 femtomoles/µg total RNA. To determine whether this level was 
 
Figure 3.6 Y5 RNA fragments are produced in non-stressed cells. 
 
Total RNA (10 µg) from MCF7 cells grown under normal conditions was analysed 
on a Northern blot using a probe specific to the Y5 3’ RNA fragment. A non-
specific siRNA was transfected into MCF7 cells to see how the process of 
transfection affected YsRNA generation. A small amount of RNA (0.1 µg) from 
poly(I:C) treated cells was used as a YsRNA size marker. The top band in each of 
the three lanes represents full length Y5 RNA. The YsRNAs detected in non-
stressed cells are indicated with an arrow. 
 
 
112 
 
similar to other short non-coding RNAs, similar experiments were carried out for 
the two miRNAs. The level of miRNA-25 (0.34 femtomoles/µg of total RNA) and 
miRNA-93 (1.4 femtomoles/µg of total RNA) was similar to that of the Y5sRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 Quantification of endogenous Y5sRNA and microRNAs in untreated 
MCF7 cells. 
 
Serial dilutions were made using RNA oligonucleotides with the same sequence 
as the 32 nt Y5 3’ sRNA fragment. After probing with a Y5 3’ specific antisense 
probe, a calibration curve was created and then used to quantify the endogenous 
level of the Y5 3’ fragment in untreated MCF7 cells. Similar experiments were 
conducted for two microRNAs as a comparison (miR-25 and miR-93). The 
Y5sRNA was found to have a cellular concentration of 0.27 femtomoles/µg total 
RNA. This is comparable to microRNA levels in the cell such as miRNA-25 (0.34 
femtomoles/µg total RNA) and miRNA-93 (1.4 femtomoles/µg total RNA). For 
miRNA quantification, both experimental and serial dilution membranes were 
hybridised together and signal was developed and exposed under the same 
conditions. 
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3.2.5 Validation of other YsRNAs 
 
 In order to experimentally validate fragments generated from the other Y 
RNAs, oligonucleotide probes complementary to the 3’ ends of all the Y RNAs 
were used to analyse RNA from poly(I:C) treated RNA (Figure 3.8). The same 
membrane was re-probed, and a size marker was used to confirm the size of the 
YsRNAs generated.  
As there is considerable sequence complementarity between the 3’/5’ stems 
of the Y RNAs where the YsRNAs are derived (48 % sequence similarity based on 
a sequence alignment of the 25 nt from the last dsRNA stretch at the 3’ end of all 
the Y RNAs), the four YsRNA 3’ specific probes were tested using complementary 
sequences to check there was no cross-hybridisation of the different probes to the 
different Y RNAs (Figure 3.9). The four probes appeared specific and no cross-
hybridisation was detected for each probe used (Figure 3.9). 
 The sizes of the YsRNAs (3’ end) from all four Y RNAs largely agrees 
with the sizes derived from the Solexa sequencing data in Figure 3.3. The Solexa 
data indicates that Y1, Y3 and Y4 RNAs give 27 nt 3’ derived YsRNAs. The 
Northern blot analysis appears to agree with this (Figure 3.8). Similarly, the Y5 
YsRNA appears to be the longest, around 32 nt, which is also confirmed by 
Northern blot data (Figure 3.4B and 3.8).  
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Figure 3.8 Validation and comparison of YsRNAs from all four Y RNAs. 
 
MCF7 RNA from poly(I:C) treated cells was analysed via Northern blot. The 
same membrane was re-probed with oligonucleotides complementary to the 3’ 
ends of all the Y RNAs. Owing to the sequence similarity of the stem regions of 
the Y RNAs, the probes used to detect YsRNAs 1-5 were all tested to make sure 
there was no cross-hybridisation of the different probes to the different Y RNAs. 
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Figure 3.9 Specificity of the probes used to detect YsRNAs (3’ end derived). 
 
Due to the sequence complementarity between the stems of the Y RNAs where 
the YsRNAs are derived (48 % sequence similarity based on a sequence 
alignment of the 25 nt from the last dsRNA stretch at the 3’ end of all the Y 
RNAs), the four YsRNA 3’ specific probes were tested using complementary 
sequences to check there was no cross-hybridisation of the different probes to the 
different Y RNAs. The same membrane was used for all hybridisations. 
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3.3 Discussion 
 
 Previously, YsRNAs have been detected in cells undergoing apoptosis 
(Rutjes et al., 1999a) and were also found to be upregulated in cancerous cells 
(Meiri et al., 2010). These two findings seem to be contradictory because if 
YsRNAs were upregulated to assist the uncontrolled cell proliferation associated 
with cancer cells, why would they also be upregulated in cells undergoing cell 
death? As Y RNAs have been shown to be essential for DNA replication (Christov 
et al., 2006), one explanation could be that the fragmentation of Y RNAs somehow 
disrupts the controlled regulation of chromosomal DNA replication - which would 
certainly fit with the apoptosis scenario, as replication of genetic material is not a 
priority in cells undergoing cell death. In the case of increased fragmentation in 
cancerous cells, perhaps some oncogenic factor would replace the role of Y RNAs 
as initiators of DNA replication which would facilitate uncontrolled cellular 
proliferation? However, the fragmentation of Y RNAs appears to maintain the 
integrity of the 9 base pair motif sequence which has previously been shown to be 
essential for chromosomal DNA replication when in a double stranded form 
(Gardiner et al., 2009). As we do not know whether the 5’ and 3’ YsRNAs remain 
bound to each other following fragmentation, it is not clear what affect Y RNA 
fragmentation would have on the function of this 9 bp motif sequence. 
Alternatively, YsRNA generation and upregulation during cell stress could 
facilitate the reported quality control function of Ro60 (O'Brien & Wolin, 1994) 
resulting in a moderated chaperone activity so that Ro60 targets a different subset 
of misfolded RNAs generated under adverse conditions. 
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Here it was shown that all four Y RNAs give rise to fragments deriving 
from the 3’ and 5’ ends which has not previously been reported. Strikingly, this 
pattern of 3’/5’ fragmentation is identical to the fragmentation pattern of other 
sRNAs fragments derived from longer RNAs such as tRNA, snoRNA and rRNA 
fragments (Brameier et al., 2011; Li et al., 2012). Indeed, Li et al. found that the 
processing of sRNAs from these longer precursor molecules occurs asymmetrically, 
similar to microRNA/microRNA* strand level bias. Comparing the normalised 
read counts for YsRNAs, there also appears to be an asymmetric bias for either the 
5’ or 3’ YsRNA for each of the Y RNAs. With the exception of Y3 RNA, YsRNAs 
derived from the 3’ end have higher read counts than those from the 5’ end.  
The asymmetric processing of all the YsRNAs needs to be confirmed via 
Northern blot analysis. During library preparation for Solexa sequencing of stress 
induced microRNAs, sRNA populations were not dephosphorylated to remove 5’-
polyphosphates. The T4 RNA ligase used during library preparation can only ligate 
the 5’ adapter to 5’-monophosphates, which does not present a problem during 
microRNA library preparation as these molecules have a native 5’-monophosphate. 
However, with novel sRNAs, 5’-tri or diphosphates (or indeed other modifications) 
may be present, such as with the Y RNAs which all have a 5’-PPP. This would not 
present a problem with the 3’ YsRNAs, as following cleavage, a 5’ phosphate and 
3’ OH group would be present which is required for Solexa library preparation. 
The differential biochemical modifications at the termini of 5’ and 3’ YsRNAs 
may explain the high read counts from 3’ YsRNAs compared with 5’ YsRNAs. In 
retrospect, if it was known that the investigation would have developed into a non-
microRNA based project, the library preparation protocol would have been revised. 
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This would have involved firstly, dephosphoroylating all sRNAs using an enzyme 
such as alkaline phosphatase, followed by re-phosphorylation of a 5’-
monophosphate using polynucleotide kinase. Experimental strategies used for 
sequencing novel sRNAs with a variety of 5’ and 3’ end modifications has been 
well reviewed elsewhere (Zhuang et al., 2012). The reason why 5’ YsRNAs still 
had significant read counts in the experiment reported here despite not 
dephosphorylating/re-phosphorylating during library preparation may be due to the 
presence of a small population of Y RNAs with 5’ monophosphates, perhaps due to 
degradation or processing errors, or due to a varying dynamic range of 5’-
monophosphate containing Y RNAs within a given cellular population.  
In the case of some of the Y RNAs, two fragments with an overlapping 
sequence appear to be generated from the same strand. This is clearly demonstrated 
by weak, smeared bands shown in figure 3.8 which run near to the principally 
generated fragment. Specifically for the 3’ Y5sRNA, a 32 nt and a 24 nt fragment 
are both clearly present in the sequencing data and also appear on a Northern blot, 
with the 32 nt being much more abundant. As the 3’ tail region is the only 
difference between the longer and shorter fragments (Figure 3.4C), this differential 
fragment formation may be due to differential binding of the La protein which has 
been shown to bind to this region (Pruijn et al., 1991). This will be investigated in 
chapter 5. It remains to be seen if the longer and shorter Y5 3’ sRNAs both have 
biological functions. As the 32 nt Y5sRNA is produced at a much higher level, it is 
possible that the 24 nt Y5sRNA fragment is functionally redundant.  
The level of the longer Y5sRNA in normal, non-stressed cells was found to 
be comparable to some microRNAs (Figure 3.7). As microRNAs are thought to 
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regulate 30-50 % of mammalian protein coding genes (Filipowicz et al., 2008), this 
indicates that YsRNA molecules may have specific functions even in the absence 
of apoptosis. However, it cannot be ruled out that in a population of cultured cells, 
there may be a small number of cells that are undergoing apoptosis even if this is 
not evident under the microscope.  
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Chapter 4 
Biogenesis of Y RNA-derived small RNAs is 
independent of the microRNA pathway 
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4.1 Introduction 
 
 MicroRNAs are endogenously produced, small ~22 nt molecules which 
regulate gene expression by targeting protein coding transcripts and preventing 
their translation or inducing mRNA cleavage (Bartel, 2004). A detailed description 
of microRNA biogenesis and function can be found in chapter 1 (section 1.7.2).  
 Y RNA-derived sRNAs (YsRNAs) are generated in cells following 
poly(I:C) treatment, and are also produced in non-stressed cells, as demonstrated in 
chapter 3. These YsRNAs are similar in size to microRNAs. Indeed, other non-
coding RNAs which have biological functions which are unrelated to gene 
silencing, such as snoRNAs and tRNAs, have been shown to produce RNA 
fragments which can enter the microRNA pathway (Ender et al., 2008; Cole et al., 
2009). One group has tried to address the possibility that YsRNAs have gene 
silencing potential by using the Luciferase assay experiment (Meiri et al., 2010). 
Meiri et al. tried to see whether the activity of a Luciferase gene containing a 
complementary sequence to the YsRNAs could be reduced in cancerous cells 
which produce these fragments. No gene silencing activity was detected, although 
the authors did not rule out the possibility that these YsRNAs could act as 
microRNAs. Meiri et al. relied on endogenous YsRNA levels in Hep3B cells to 
mediate silencing and did not transfect artificial siRNA-like molecules containing 
YsRNA sequences. Therefore, the endogenous levels of possible miRNAs derived 
from Y RNAs might not have been high enough to detect silencing capability using 
the Luciferase assay system. Interestingly, two YsRNAs derived from the 3’ ends 
of Y3 and Y5 RNA were found in the microRNA database miRBase annotated as 
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miR-1979 and miR-1975 respectively. Both miR-1975 and miR-1979 have 
subsequently been removed from miRBase because they are derived from Y RNAs. 
A recent review has also discussed the hypothesis that Y RNAs might be 
processed into microRNAs (Verhagen & Pruijn, 2011). It was argued that Y RNAs 
and pre-miRNAs are both very similar in length and share a similar stem-loop 
secondary structure. It was noted that microRNA genes are found clustered in the 
genome, as are Y RNA genes which are within a single cluster on chromosome 
7q36. Verhagen and Pruijn (2011) also suggested that under stress conditions, 
Ro60 might be released from the Y RNAs and enter the nucleus, allowing Dicer to 
access the exposed Y RNAs and generate the YsRNAs. These fragments would 
then be available to bind to AGO proteins and mediate gene silencing. 
As the question of whether YsRNAs can act as microRNAs remains 
disputed and unresolved in the literature, this hypothesis was addressed 
experimentally here. Using human dicer
-/-
 cells it was shown that YsRNAs derived 
from all four Y RNAs are still produced following poly(I:C) treatment. 
Collaborative work also revealed that YsRNAs are in different complexes than 
microRNAs following analysis of cellular fractions from anion exchange 
chromatography, and that YsRNAs are not immunoprecipitated by Ago2. 
Therefore, it was concluded that YsRNAs do not enter the microRNA pathway. 
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4.2 Results 
 
4.2.1 Production of YsRNAs is Dicer independent 
 
 As the vast majority of microRNAs are produced from pre-miRNAs by the 
RNAse III enzyme Dicer, the generation of YsRNAs was investigated in dicer 
deficient cells (dicer
-/-
). Both wild-type DLD-1 and dicer
-/-
 DLD-1 cells were 
treated with the immunostimulant poly(I:C) in order to induce a stress response 
which has been shown to upregulate YsRNA generation (Chapter 3). Total RNA 
from these cells was then analysed by Northern blot, using antisense 
oligonucleotide probes for all of the YsRNAs (3’ end derived) (Figure 4.1A), and 
also using miR-21 to demonstrate the Dicer
-/-
 genotype (Figure 4.1B). 
 As expected, a single band representing the full length Y RNA was present 
in both wild-type and dicer knockout cells under normal conditions for all four Y 
RNAs. When transfected with poly(I:C), wild-type DLD-1 cells gave rise to the 
expected YsRNAs described in Chapter 3. A principle YsRNA was present for 
each Y RNA represented by the band with the strongest signal. Additionally, 
YsRNAs were also represented by the presence of weaker bands or a smeared 
signal. 
 For dicer knockout cells treated with poly(I:C), the YsRNA fragments from 
each of the four Y RNAs were still produced, even in the case of Y3sRNA which 
is only weakly produced in wild-type cells. Indeed, the production of YsRNA 
looked stronger in Dicer
-/-
 cells in the case of Y5sRNA and Y4sRNA. Interestingly, 
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in the case of Y1 RNA, the band intensities for the different YsRNAs slightly 
changed in dicer knockout poly(I:C) treated cells compared to the wild-type cells. 
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A 
 
B 
Figure 4.1 YsRNAs are produced in Dicer knockout cells. 
 
(A) Total RNA from wild-type or Dicer-/- DLD-1 (human colorectal 
adenocarcinoma cells) either treated or not treated with the immunostimulant 
poly(I:C) was analysed by Northern blot. Oligonucleotide probes antisense to each 
of the four YsRNAs (3’ end) were hybridised to the same Northern blot membrane 
in separate hybridisation reactions. Bands representing YsRNAs were generated 
following poly(I:C) treatment in both wild-type and Dicer 
-/-
 cells. (B) Genotyping 
of DLD-1 wild-type and Dicer
-/-
 cell lines via Northern blot. An oligonucleotide 
probe for microRNA-21 was used. MiR-21 was present in the wild-type cell line, 
but only the precursor miRNA was present in Dicer knockout cells. The membrane 
was stripped and re-probed for U6 RNA to show equal loading. 
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4.2.2 YsRNAs and microRNAs are in different protein complexes 
 
 MicroRNAs bind to Argonaute proteins within the RISC complex. 
Therefore, it was investigated whether YsRNAs are present in the same complex as 
miRNAs. Protein lysates from poly(I:C) treated cells were prepared, and then 
separated according to their net charge by anion exchange chromatography 
(chromatography done by Dr Tibor Csorba). Fractions were eluted at increasing 
salt concentrations and RNA was extracted from every second fraction. RNA 
derived from these fractions was then analysed by Northern blot (Figure 4.2). First, 
antisense oligonucleotide probes specific to the 3’ end of all 4 Y RNAs were used 
to analyse the RNA content of the different fractions. The full length Y RNAs were 
mainly detected in fractions 63-69 for Y1, Y3 and Y4 RNAs. In the case of Y5 
RNA, the full length molecule was eluted earlier, mainly in fractions 41-43. The 
YsRNAs from all Y RNAs appeared to reside mainly in fractions 39-49. 
Interestingly, the 32 nt Y5sRNA and the 24 nt Y5sRNA appeared in different 
fractions: the 32 nt Y5sRNA  mainly in 39-41 and the 24 nt Y5sRNA in fractions 
45-49 (Figure 4.2). 
 The RNA contained within the different protein fractions was also 
hybridised with a probe against miR-21. MiR-21 appeared to be eluted at a very 
low salt concentration (100mM), mainly in fractions 11-15 (Figure 4.2). Therefore 
YsRNAs and microRNAs are in different complexes. However, it was noted that a 
small amount of miR-21 and a small amount of both full length and fragmeted Y 
RNAs appeared together in fractions 67-69. 
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Figure 4.2 YsRNAs and microRNAs are in different complexes. 
 
Protein lysates of poly(I:C) treated MCF7 cells were separated by anion exchange 
chromatography. Fractions were eluted with increasing salt concentration between 
100 mM and 800 mM. RNA was extracted from every second fraction and analysed 
by Northern blot. Membranes were probed in different hybridisation reactions using 
antisense oligonucleotide probes to Y1, Y3, Y4 and Y5 RNAs (3’ end). The 
membrane was also probed for miR-21. MiR-21 is present mainly in fractions 11-
15. The YsRNAs are all mainly present in fractions 39-49. Interestingly for 
Y5sRNA, the longer 32 nt and shorter 24 nt fragments are in different fractions. 
Ro60 protein levels in the respective fractions were not analysed in this particular 
experiment for technical reasons. Arrows indicate full length Y RNAs, asterisks 
indicate YsRNAs. 
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4.2.3 YsRNAs are not generated by or associated with the Argonaute 2 
silencing protein 
 
 In addition to the Dicer knockout and anion exchange chromatography 
experiments, the Argonaute 2 (Ago2) protein was also investigated in relation to 
YsRNA biogenesis and function. Ago2 is a key component of the microRNA 
guided RNA-induced silencing complex (miRISC) and some pre-miRNAs can also 
be processed into mature microRNAs by Ago2 instead of Dicer (Cheloufi et al., 
2010).  
Firstly, Ago2 was depleted via siRNA in MCF7 cells, and the cells were 
then subjected to poly(I:C) treatment (Figure 4.3). The level of miR-21 in poly(I:C) 
treated cells which had been transfected with an siRNA against Ago2 was 
significantly lower compared to cells treated with poly(I:C) only, as expected. 
However, the level of Y5sRNA remained at a high level in both poly(I:C) treated 
cells with normal or depleted Ago2 levels. 
Secondly, another member of the Dalmay laboratory, Dr Francisco Esteban 
Nicolas conducted an Argonaute 2 (Ago2) immunoprecipitation experiment 
(Figure 4.4). Total cellular lysate from non-treated and poly(I:C) treated MCF7 
cells was analysed by Northern blot and hybridised to oligonucleotide probes 
complementary to Y3sRNA, Y5sRNA and miR-21. For the poly(I:C) treated 
sample, both the 32 nt and 24 nt Y5sRNA fragments were detected by the Y5 RNA 
probe, with a single band being detected by the Y3sRNA and miR-21 probes. Non-
treated MCF7 cells only showed a signal for miR-21 and not for either of the 
YsRNAs.  
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Following Ago2 immunoprecipitation, miR-21 was pulled-down in both 
treated and non-treated cells as expected (Figure 4.4). However, neither Y5sRNA 
nor Y3sRNA were immunoprecipitated by Ago2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 YsRNA generation is not affected by depletion of Ago2. 
 
The Ago2 protein was depleted in MCF7 cells via siRNA, followed by treatment 
of cells with poly(I:C). The abundance of miR-21 was assessed by Northern blot  
analysis which indicated that the level of the microRNA in cells transfected with 
the Ago2 siRNA was greatly reduced compared to cells treated with poly(I:C) 
only, as expected. However, when the same membrane was analysed with a Y5 
RNA specific probe, the abundance of Y5sRNA generation appeared unaffected 
by depletion of Ago2. 
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Figure 4.4 YsRNAs are not bound by the Ago2 silencing protein.  
 
Northern blot analysis of lysates from poly(I:C) treated and non-treated cells before 
and after immunoprecipitation by Ago2. Lysate samples shows that miR-21 was 
present in both samples, whereas the YsRNAs were only present in poly(I:C) 
treated samples. Following Ago2 immunoprecipitation, miR-21 was pulled down in 
both treated and non-treated cells. However, YsRNAs were not immunoprecipitated 
under either condition. This shows that YsRNAs are not present in the miRISC 
complex. Work by Dr Francisco Esteban Nicolas. 
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4.3 Discussion 
 
 Canonical microRNAs are generated from precursor stem-loop containing 
molecules (pre-miRs) and are processed into mature ~ 22nt RNAs by Dicer. These 
mature miRNAs are then loaded into the gene silencing complex (RISC) which 
contains one of four Argonaute effector proteins in mammals (Ago1-4) (Filipowicz 
et al., 2008). Although Agos 1-4 can all associate with microRNAs, only Ago2 is 
catalytically active (Meister et al., 2004). The precise roles of the other Ago 
proteins are not as clear. For example, Ago1 has been shown to associate with 
Dicer (Okamura et al., 2004), indicating a role in miRNA biogenesis, but Ago1 has 
also been implicated in heterochromatin silencing (Janowski et al., 2006). 
Long non-coding RNAs unrelated to pre-miRs have been shown to be 
processed into fragments which then enter the microRNA pathway (Ender et al., 
2008; Cole et al., 2009). Additionally, it has been proposed that fragments derived 
from the hairpin-containing Y RNAs could potentially enter the microRNA 
pathway (Meiri et al., 2010; Verhagen & Pruijn, 2011). In this chapter, this 
hypothesis was investigated. 
 Here, it was shown that YsRNAs are not generated by Dicer (Figure 4.1). 
Intriguingly, processing of the full length Y RNA 1-4 appears to be more 
pronounced in poly(I:C) treated cells without Dicer, and leads to greater YsRNA 
production (for example see Y5sRNA in Figure 4.1, lane 4). This might be 
explained by the fact that Dicer can process some of the poly(I:C), since it mimics 
dsRNA, thereby reducing the amount of poly(I:C) available to cause cell stress. In 
Dicer knockout cells, this would result in a higher poly(I:C) concentration, 
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resulting in a stronger stress response. However, this hypothesis does not explain 
the altered abundance between the different YsRNA products for Y1sRNA 
between wild-type and dicer
-/-
 poly(I:C) treated cells (see Figure 4.1, Y1 RNA 
lanes 2 and 4). 
 Some microRNAs can be generated independent of Dicer through direct 
Ago2 processing of pre-microRNAs (Cheloufi et al., 2010). Therefore other steps 
in the microRNA pathway needed to be investigated in order to see whether 
YsRNAs could act as microRNAs, starting with the protein complex in which the 
YsRNA resides. Anion exchange chromatography revealed that miRNAs and 
YsRNAs are mostly in very different complexes (Figure 4.2). However, it was 
noted that small amounts of miR-21, full length Y RNA and YsRNA appeared 
together in fractions 67-69. Generally, YsRNAs appear to be in a complex which is 
much more negatively charged than miRNAs. Intriguingly, YsRNAs from all four 
Y RNAs do not appear in exactly the same fraction, indicating potentially diverse 
functions. The Y1sRNAs appear to be principally eluted in fraction 47, (Figure 
4.2), Y3sRNA in fraction 45, Y4sRNA in fraction 43 and the longer Y5sRNA in 
fraction 41. The different protein association is quite striking considering that the 
stem of the Y RNAs from which the YsRNAs are derived is the most highly 
similar region between the Y RNAs. Additionally, Y1 and Y3 sRNAs are found in 
closely related fractions and Y4 and Y5 sRNAs are also in closely related fractions, 
but distinct to those of Y1/Y3 sRNAs. This might reflect the evolutionary origin of 
these two pairs of molecules. Y RNAs evolved from a common gene, which 
through gene duplication, gave rise to Y1/Y3 in one lineage and Y4/Y5 in the other 
(Mosig et al., 2007). 
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  Depletion of Ago2 in poly(I:C) treated cells by RNAi showed that, 
although the level of a common microRNA was greatly reduced, YsRNA levels 
were unaffected (Figure 4.3). This indicates that the slicer activity of Ago2 is not 
required for generation of YsRNAs from full length Y RNAs and secondly; 
YsRNAs do not bind to the Ago2 complex. If Ago2 levels are depleted, the amount 
of microRNA within the cell will be reduced (as shown in Figure 4.3). This could 
be a result of retardation of the microRNA biogenesis pathway due to inhibition of 
a key step downstream of Dicer, reducing the amount of microRNA which can be 
produced. Alternatively, increased turnover and degradation of non-Ago2 protected 
mature microRNAs could also result in miR depletion. Both scenarios could 
explain the drop in miR-21 abundance shown in figure 4.3.  
In order to investigate whether YsRNAs are actually associated with 
miRISC, immunoprecipitation experiments were performed. Ago2 
immunoprecipitation revealed that YsRNAs do not bind Ago2 (Figure 4.4), 
whereas miR-21 was shown to be complexed with this silencing protein. However, 
this experiment did not rule out a possible association of YsRNAs with Ago1, 3 or 
4. Nevertheless, taken together with the Dicer knockout and anion exchange 
chromatography experiments, as well as the Luciferase assay results from Meiri et 
al, these data demonstrate that YsRNAs are not microRNAs. The results from this 
chapter have subsequently been published by our laboratory (Nicolas et al., 2012). 
Interestingly, preliminary data by Verhagen and Pruijn showed that neither 
Ro60 nor La could be co-immunoprecipitated by anti-hAgo antibodies 
(unpublished). However, work in Gunter Meister’s lab has shown that Ro60 
preferentially interacts with Ago2 in Dicer knockout mouse embryonic fibroblasts 
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(MEFs) (Frohn et al., 2012). These results could explain the mildly increased 
YsRNA generation in dicer knockout cells, as when Ro60 binds to Ago2 under 
these artificial conditions, perhaps Ago2 inflicts slicer activity on Ro60-bound Y 
RNAs. Why Ro60 would bind Ago2 under dicer
-/-
 conditions is unclear, but may 
point towards a primordial RNA quality control mechanism whereby misfolded 
RNAs are processed by AGO, directed by Ro60. 
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Chapter 5 
YsRNA generation is dependent on the autoimmune 
protein Ro60 
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5.1 Introduction 
 
 Most RNAs within the cell can associate with proteins, forming 
ribonucleoproteins (RNPs). Y RNAs have been shown to bind to a range of cellular 
proteins with diverse cellular functions (Hendrick et al., 1981; Bouffard et al., 
2000; Fabini et al., 2000; Fabini et al., 2001; Fouraux et al., 2002; Hogg & Collins, 
2007; Sim et al., 2012). The Ro60 and La autoimmune proteins are the primary 
constituents in Y RNPs (Hendrick et al., 1981; Pruijn et al., 1991). Furthermore, 
the ribosome maturation related protein, nucleolin, has been shown to bind to a 
subset of the Y RNAs (Y1 and Y3), and potentially functions as a Y RNA nuclear 
export factor (Fouraux et al., 2002). Unlike Ro60 and La which bind to the lower 
stem and 3’ tail regions of Y RNAs respectively, nucleolin binds to the pyrimidine-
rich internal loop. 
 Long RNA molecules can be processed into shorter RNAs via enzymatic 
cleavage by proteins called RNases. There are eight canonical, catalytically active 
RNases in humans (numbered 1-8) (Sorrentino, 2010), but there are also many 
other proteins which have RNase activity, such as Ago2 - which has a domain 
similar to ribonuclease H (Song et al., 2004). RNA cleavage can occur at a specific 
region on the RNA molecule owing to recognition of a sequence or structural 
element by the enzyme (like with Dicer) or RNA cleavage can occur non-
specifically (like with RNase A).  
The biogenesis pathway of novel RNA fragments has recently started to be 
investigated. For example, angiogenin has been uncovered as being the nuclease 
responsible for the generation of stress-induced tRNA halves (Fu et al., 2009; 
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Yamasaki et al., 2009). These tRNA fragments then go on to inhibit protein 
synthesis by targeting the initiation stage of translation (Ivanov et al., 2011). 
However, it is possible that multiple RNases have a role in generating different 
functional RNA fragments under various stimuli. For instance, RNase L is an 
enzyme which is activated downstream of the 2’,5’-oligoadenylate pathway (OAS) 
as a part of the interferon induced antiviral response (Silverman, 2007). RNA 
degradation is one of the main mechanisms through which this antiviral response is 
mediated. RNase L cleaves RNA both from the host and invading virus and it is 
possible that some of the resultant RNA fragments are functional and not merely 
products of degradation. 
 Although YsRNAs have been shown to be generated by Dicer independent 
mechanisms and are not part of the microRNA pathway (see Chapter 4), the 
proteins involved in the biogenesis of these molecules remains unknown. In this 
chapter, the mechanism of YsRNA production was investigated experimentally. 
First, the enzyme angiogenin was investigated as a possible candidate owing to its 
role in generating tRNA halves. RNA in vitro cleavage experiments showed that 
angiogenin non-specifically degraded the Y RNAs, but specifically cleaved tRNAs 
to generate the previously reported tRNA halves. The stress induced enzyme 
RNase L also contributed to YsRNA generation, as determined by RNA 
interference (RNAi) and RNase L
 
knockout cell line experiments. Y RNA binding 
proteins were also specifically investigated by RNAi which showed that nucleolin 
had little effect on YsRNA generation whereas the La protein was a contributory 
factor in the biogenesis of Y5sRNAs. In order to elucidate the role of Ro60 in 
YsRNA biogenesis, gene knockdown, knockout and in vitro cleavage experiments 
138 
 
showed that Ro60 is essential for YsRNA generation. YsRNA production appears 
to be due to Ro60 protection of the lower stem region of the full length Y RNAs 
from a cocktail of stress induced cellular RNases. This was further supported by 
the failure to detect the pyrimidine-rich internal loop region of Y5 RNA using an 
LNA probe as this region would be detectable if a specific cleavage reaction took 
place. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
139 
 
5.2 Results 
 
5.2.1 Angiogenin non-specifically degrades Y RNAs but specifically 
generates tRNA halves 
 
 As angiogenin has been shown to be the RNase involved in generating 
tRNA halves from full length tRNAs, it was investigated as a possible candidate 
for generating the YsRNAs. First, siRNAs were used to knockdown angiogenin in 
MCF7 cells followed by poly(I:C) treatment. RNAi mediated knockdown was also 
applied to the angiogenin inhibitor (RNH1) in a similar experiment. Total RNA 
was then analysed by Northern blot (Figure 5.1A). As expected Y5sRNAs were 
produced in poly(I:C) treated cells. Y5sRNAs were not produced in cells treated 
with a negative control siRNA. RNAi mediated knockdown of  angiogenin (ANG) 
and RNH1 also failed to result in Y5sRNA generation. When poly(I:C) was 
transfected 48 h after both siRNA treatments, Y5sRNAs were still produced. 
Additionally, tRNA halves were produced from tRNA Methionine in all three 
poly(I:C) treated samples (Figure 5.1A). However, angiogenin could not be 
detected by Western blot using two different antibodies (Figure 5.1B). Despite 
failure to detect angiogenin by Western blot, tRNA halve generation can be used as 
an indicator of a functional angiogenin protein. Therefore, it was concluded that 
the angiogenin targeting siRNA did not knock down the expression level of 
angiogenin. 
 Another approach was taken in order to investigate angiogenin in relation 
to YsRNA biogenesis. An angiogenin expression construct (pcDNA-ANG) used in 
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a previous study (Fu et al., 2009) was transfected into MCF7 cells with or without 
subsequent poly(I:C) treatment (Figure 5.2). YsRNA generation appeared mildly 
increased in cells transfected with pcDNA-ANG compared to cells transfected with 
a negative control GFP expression construct (pcDNA-GFP). However, tRNA 
halves were not generated at sufficient levels in pcDNA-ANG transfected cells to 
indicate that angiogenin was present. As measurement of tRNA halves is an 
alternative method of measuring angiogenin activity instead of direct Western blot 
detection, actively expressing pcDNA-ANG could not be validated. 
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Figure 5.1 Targeting of angiogenin and the angiogenin inhibitor (RNH1) via RNAi. 
 
MCF7 cells were transfected with siRNAs specific to either angiogenin (ANG), RNH1 or 
with a negative control siRNA. Cells were then either treated or not treated with poly(I:C). 
(A) Total RNA was analysed by Northern blot. Full length Y5 RNA was detected in all lanes. 
Y5sRNAs were generated in poly(I:C) cells with or without siRNA knockdown of ANG and 
RNH1, and the stress induced tRNA halves were also produced in all poly(I:C) treated cells 
despite attempted knockdown of angiogenin. Membrane was reprobed for U6 RNA to show 
equal loading. (B) Western blot analysis using two different antibodies raised against 
angiogenin failed to detect the 14 kDa protein.  
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Figure 5.2 Effect of angiogenin overexpression on Y5sRNA generation. 
 
An angiogenin overexpression construct (pcDNA-ANG) was transfected into MCF7 
cells which were then either treated or not treated with poly(I:C). A plasmid expressing 
green fluorescent protein (GFP) was transfected as a negative control. Y5sRNAs were 
generated following poly(I:C) treatment in MCF7 cells alone, and also in cells 
transfected with the negative control plasmid. YsRNA generation appeared mildly 
increased in cells transfected with pcDNA-ANG compared with cells transfected with 
pcDNA-GFP, however tRNA halves were not generated despite the presence of an 
angiogenin overexpression plasmid. Cells with pcDNA-ANG which were treated with 
poly(I:C) did not show a marked increase in YsRNA generation compared to cells 
treated with poly(I:C) alone or with the negative control plasmid. 
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As angiogenin could not be detected by Western blot, and owing to the 
failure to validate expression from transfected pcDNA-ANG, a third and final 
approach was employed. Recombinant human angiogenin was used directly for 
RNA in vitro cleavage experiments – an approach also used in two recent studies 
(Fu et al., 2009; Li et al., 2012). Firstly, a pilot experiment was done to see the 
effect of angiogenin on Y5 RNA in MCF7 cells. Total RNA was incubated either 
with the reaction buffer only, or with the angiogenin enzyme for 10 min and 30 
min at 37 °C (Figure 5.3). RNA was then analysed by Northern blot. The full 
length Y5 RNA appeared to be targeted during angiogenin incubation, but so was 
U6 RNA and ribosomal RNA. However, bands representing Y5sRNAs did not 
show a high production level during angiogenin incubation comparable to those 
usually generated following poly(I:C) treatment. Although no size-marker was 
used for this pilot experiment, 2-4 extra faint bands were detected using a Y5 probe 
for both angiogenin incubations (Figure 5.3). When the same membrane was 
analysed for tRNA Methionine, specific tRNA halves were generated for both 
angiogenin incubation time points, but were absent in both the RNA used for the 
experiment (input) and the buffer only incubation.  
 In order to investigate the role of angiogenin on Y RNA fragmentation 
further, a more comprehensive study was performed. Both purified total RNA and 
total cell lysate (with RNA and bound proteins) were analysed in separate 
experiments for MCF7, incubating with angiogenin or RNase A (control RNase). 
Preliminary experiments found that if the same final concentration of RNase A was 
used as angiogenin (1 µM), all RNA was degraded in the sample rapidly at all 
time-points (data not shown). Therefore, an RNase A serial dilution experiment 
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was used to determine an appropriate concentration of RNase A which could be 
used to have comparable effects on total RNA as angiogenin (Figure 5.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Angiogenin in vitro cleavage of MCF7 RNA (pilot experiment). 
 
Total RNA was incubated with reaction buffer only, or recombinant human 
angiogenin in reaction buffer for 10 min or 30 min at 37 °C. RNA was then 
analysed by Northern blot. Input RNA is the RNA used for the in vitro experiment. 
Y5 RNA showed an overall reduction in abundance following angiogenin (ANG) 
incubation and the level of full length Y5 RNA decreased with ANG incubation 
time compared with incubation with reaction buffer only. No significant signal was 
detected for bands corresponding to YsRNAs. However, when the same membrane 
was analysed for tRNA-Met, a strong specific signal was detected for tRNA halves 
in both angiogenin treated samples. RNA was also analysed on an agarose gel to 
monitor the effect on ribosomal RNA, which showed degradation following ANG 
incubation. The U6 loading control also showed degradation following extended 
(30 min) incubation with ANG. 
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Figure 5.4 RNase A dilution series and effect on RNA degradation. 
 
Mouse total RNA was incubated with varying dilutions of RNase A from a 1 
µg/µL stock (73 µM stock). Reactions were incubated in buffer at two different 
time points. RNA was then analysed by Northern blot and agarose gel. Full length 
Y1 RNA appeared to be completely degraded in the 
 
  
 and 
 
   
 RNase A dilutions, 
but showed only moderate degradation at 
 
   
 (comparing 
 
   
 RNase A for 30 min 
with the RNA incubated with buffer only). This degradation pattern was also 
similar for U6 RNA and also for ribosomal RNA (when analysed on an agarose 
gel). Therefore 
 
   
  dilution RNase A was selected for use in other experiments. 
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 First, MCF7 total RNA was subjected to angiogenin or RNase A in vitro 
cleavage for 2 min, 10 min or 30 min (Figure 5.5). The 1 h time point was omitted 
as preliminary data showed complete degradation of RNA using both enzymes for 
this duration (data not shown). Following incubation with both RNases, total RNA 
was analysed by Northern blot and agarose gel. The full length Y5 RNA showed a 
mild reduction in abundance in a time-dependent manner with both angiogenin and 
RNase A (Figure 5.5). The longer Y5sRNA was only detected at a weak level for 
all reactions, including the input RNA, and did not vary significantly between 
experimental conditions. However, it was noted that a previously unreported 
Y5sRNA fragment longer than 32 nt was detectable in 10 min and 30 min 
angiogenin incubations at a very weak level. When the membrane was analysed for 
tRNA Methionine, tRNA halves were shown to be specifically generated at high 
levels in both the 10 min and 30 min angiogenin treated samples, but not in RNase 
A treated samples. Analysis of ribosomal RNA (rRNA) on an agarose gel showed 
that rRNA was significantly degraded in all angiogenin incubations and to a lesser 
extent by RNase A. As no change was seen in Y5sRNA abundance across the 
time-course, this result suggests that the 32 and 24 nt Y5sRNAs are not generated 
by angiogenin, but angiogenin may specifically generate a longer than 32 nt 
fragment from the Y5 RNA with a very low efficiency. 
 In order to investigate the effect of native RNA binding proteins on YsRNA 
biogenesis, total cell lysates were used for in vitro cleavage reactions. Cell lysate 
from MCF7 cells were treated with angiogenin and RNase A (Figure 5.6). The full 
length Y5 RNA was detected in all samples, and showed a reduction in abundance 
after 1 h treatment with either ANG or RNase A. The Y5sRNA appeared to be 
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increased slightly in all 1 h incubations using buffer alone, angiogenin or RNase A. 
The tRNA halves were specifically generated at high levels in both the 30 min and 
1 h angiogenin incubation reactions, but not with RNase A. This result suggested 
that neither angiogenin nor RNase A could specifically generate the YsRNAs but 
that something in the lysate could produce them instead. 
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Figure 5.5 MCF7 total RNA subjected to angiogenin and RNase A in vitro 
cleavage.  
 
Following incubation of total RNA with recombinant human angiogenin (ANG) or 
RNase A, analysis by Northern blot showed that overall abundance of full length Y5 
RNA decreased slightly in a time-dependent manner with both enzymes. The natural 
endogenous 32 nt Y5sRNA was detectable at a weak level in all samples, including 
the input RNA used for the reactions, and did not increase with ANG incubation. 
However, a previously unreported Y5sRNA fragment which was longer than 32 nt 
was detected at weak levels in both 10 min and 30 min ANG incubations. 
Comparing with tRNA cleavage, tRNA halves from tRNA Methionine were 
specifically generated at high levels in ANG treated samples at both 10 and 30 min 
time points.  
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Figure 5.6 MCF7 cell lysate subjected to angiogenin and RNase A in vitro 
cleavage.  
 
Total cell lysate was prepared from MCF7 cells and incubated with either 
recombinant human angiogenin or RNase A in reaction buffer. Northern blot 
analysis showed that full length Y5 RNA was present in all samples but was at a 
reduced level in the 1 h ANG and RNase A time point. The 32 nt Y5sRNA 
increased slightly during 1hr incubation with ANG, but this was also the case for 
RNase A treatment, and with incubation with reaction buffer alone for 1h. The 
tRNA halves from tRNA Methionine showed specific generation at a high level for 
both ANG 30 min and 1 h incubations, but not for any RNase A incubations. U6 
showed slight degradation in all reactions, and so did rRNA (as demonstrated by 
agarose gel analysis). 
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5.2.2 Ro60 is essential for YsRNA biogenesis 
 
 Considering the integral role of Ro60 and La in forming the Ro-
ribonucleoprotein complex, these proteins were investigated in relation to Y RNA 
fragmentation. First, Ro60 was investigated in a pilot experiment using siRNAs 
against Ro60 (siRo60) (Figure 5.7). MCF7 cells were transfected with Ro60 
specific, or Ago2 specific (control) siRNAs prior to poly(I:C) treatment, or treated 
with poly(I:C) alone. Ago2 knockdown was confirmed by miR-21 levels. Ro60 
protein levels were not assessed in this pilot experiment, although siRo60 
efficiency was confirmed by Western blot in later experiments (Figures 5.8-5.10). 
Northern blot analysis showed that full length Y5 was present at a constant level in 
all three poly(I:C) treated samples. However, in cells where an siRNA against 
Ro60 was transfected prior to poly(I:C) treatment, Y5sRNA levels were greatly 
reduced compared to poly(I:C) treated cells alone or where a siRNA against Ago2 
was used prior to poly(I:C) treatment (Figure 5.7). This suggested that Ro60 
affected YsRNA biogenesis. 
 A more detailed investigation was then undertaken with respect to Ro60, 
and also La. Both Ro60 and La were targeted by siRNA in separate samples prior 
to poly(I:C) treatment. The experiment was repeated three times (Figures 5.8-5.10). 
Protein depletion was confirmed by Western blot for both proteins, and all four Y 
RNAs were analysed by Northern blot. Where siRNAs against La were used prior 
to poly(I:C) treatment, there was no noticeable change in YsRNA production from 
Y1, Y3 or Y4. However, in the case of Y5sRNA, the 24 nt fragment was detected 
at a considerably higher level in La depleted poly(I:C) treated cells compared to 
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where a negative control siRNA was used prior to poly(I:C) treatment, with a slight 
reduction in the longer 32 nt fragment. Strikingly, when an siRNA against Ro60 
was used prior to poly(I:C) treatment, YsRNAs from all four Y RNAs were 
drastically reduced in all three repeat experiments compared to where a negative 
control siRNA, or an siRNA against La was used prior to poly(I:C) treatment. 
 It was noticed that the amount of full length Y RNA in poly(I:C) treated 
samples was at a lower level compared to control cells. Therefore, it was possible 
that the rate of Y RNA cleavage was the same in the absence of Ro60 as in the 
control cells but that there was simply a reduction in the amount of full length Y 
RNA available for cleavage. To test this, the intensity of the signals of full length 
Y RNA and respective YsRNA were quantified in the three independent 
experiments for all four Y RNAs. Following normalisation using U6 RNA for each 
lane for each of the three repeat experiments, the ratio of full length Y RNA to the 
respective principle YsRNA produced in each lane was calculated. This ratio was 
almost identical in the two poly(I:C) control samples (no siRNA or negative 
control siRNA) for all Y RNAs: Y1 (9.7 and 9.3 respectively), Y3 (18.0 and 15.0 
respectively), Y4 (7.1 and 7.3 respectively) and Y5 (14.6 and 14.5 respectively). 
However, the ratio of Y RNA full length to YsRNA in Ro60 knockdown poly(I:C) 
treated samples was significantly higher compared to negative control siRNA 
poly(I:C) treated samples for all four Y RNAs: Y1 (33.9 ; one-tailed Z-test 
p=0.002), Y3 (43.0 ; one-tailed Z-test p=0.05), Y4 (21.2 ; one-tailed Z-test p=0.03) 
and Y5 (20.6 ; one-tailed Z-test p=0.13). This raised the possibility that Ro60 had a 
significant effect on Y RNA cleavage, and not just on the overall level of full 
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length Y RNA. It was therefore decided to investigate the role of Ro60 in YsRNA 
biogenesis further. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Ro60 targeting by siRNA reduces Y5sRNA following poly(I:C) 
treatment (pilot experiment). 
 
MCF7 cells were treated with siRNAs targeting Ago2 or Ro60 prior to 
poly(I:C) treatment, or poly(I:C) alone. Northern blot analysis of miR-21 
confirmed Ago2 knockdown. Ro60 protein level was not assessed in this 
pilot experiment, but the Ro60 siRNA (siRo60) efficiency was confirmed by 
Western blot in later experiments. The Y5sRNA fragment was produced at 
high levels for poly(I:C) only and siAgo2 poly(I:C) treated cells. However 
when an siRNA against Ro60 was transfected, poly(I:C) treatment only 
mildly induced Y5sRNA production. 
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Figure 5.8 Knockdown of Ro60 and La affects the generation of YsRNAs: 
Repeat number 1. 
 
Expression of Ro60 and La proteins was inhibited by RNAi mediated 
knockdown using siRNAs siRo60 and siLa respectively. A negative control 
siRNA was used as a comparison. Accumulation of YsRNAs was measured by 
Northern blot analysis before and after poly(I:C) treatment, with or without prior 
siRNA transfection. Use of siLa only affected Y5sRNA production in poly(I:C) 
treated cells: the 24 nt Y5sRNA fragment was detected at a considerably higher 
level compared to where a negative control siRNA was used, with a slight 
reduction in the longer 32 nt Y5sRNA fragment. When Ro60 was knocked down 
in poly(I:C) treated cells however, YsRNAs from all four Y RNAs were 
significantly reduced compared to control samples. The Northern blot membrane 
was stripped and re-probed with a U6 specific probe to show equal loading. The 
efficiency of the siRNAs was tested by Western blot using Ro60 and La specific 
antibodies. The Western blot membrane was re-probed with a β-actin antibody to 
show equal loading. 
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Figure 5.9 Knockdown of Ro60 and La affects the generation of YsRNAs: 
Repeat number 2. 
 
Expression of Ro60 and La proteins was inhibited by RNAi mediated 
knockdown using siRNAs siRo60 and siLa respectively. A negative control 
siRNA was used as a comparison. Accumulation of YsRNAs was measured by 
Northern blot analysis before and after poly(I:C) treatment, with or without prior 
siRNA transfection. Use of siLa only affected Y5sRNA production in poly(I:C) 
treated cells: the 24 nt Y5sRNA fragment was detected at a considerably higher 
level compared to where a negative control siRNA was used, with a slight 
reduction in the longer 32 nt Y5sRNA fragment. When Ro60 was knocked down 
in poly(I:C) treated cells however, YsRNAs from all four Y RNAs were 
significantly reduced compared to control samples. The Northern blot membrane 
was stripped and re-probed with a U6 specific probe to show equal loading. The 
efficiency of the siRNAs was tested by Western blot using Ro60 and La specific 
antibodies. The Western blot membrane was re-probed with a β-actin antibody to 
show equal loading. 
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Figure 5.10 Knockdown of Ro60 and La affects the generation of YsRNAs: 
Repeat number 3. 
 
Expression of Ro60 and La proteins was inhibited by RNAi mediated knockdown 
using siRNAs siRo60 and siLa respectively. A negative control siRNA was used 
as a comparison. Accumulation of YsRNAs was measured by Northern blot 
analysis before and after poly(I:C) treatment, with or without prior siRNA 
transfection. Use of siLa only affected Y5sRNA production in poly(I:C) treated 
cells: the 24 nt Y5sRNA fragment was detected at a considerably higher level 
compared to where a negative control siRNA was used, with a slight reduction in 
the longer 32 nt Y5sRNA fragment. When Ro60 was knocked down in poly(I:C) 
treated cells however, YsRNAs from all four Y RNAs were significantly reduced 
compared to control samples. The Northern blot membrane was stripped and re-
probed with a U6 specific probe to show equal loading. The efficiency of the 
siRNAs was tested by Western blot using Ro60 and La specific antibodies. The 
Western blot membrane was re-probed with a β-actin antibody to show equal 
loading. 
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To obtain definitive proof for the involvement of Ro60 in YsRNA 
generation, a Ro60
-/-
 mouse embryonic stem cell line (mES) was employed (Chen 
et al., 2003) to investigate how this would affect Y RNA processing. As mice only 
possess the Y1 and Y3 RNA genes, mES wild-type and Ro60
-/-
 cells were 
transfected with a Y5 RNA expression construct (pY5) so that Y5sRNA biogenesis 
could be monitored. The effect of poly(I:C) treatment was then analysed by 
Northern blot (Figure 5.11). As expected, there was no Y5 RNA present in non-
pY5 transfected mES wild-type and Ro60
-/-
 cells either in the presence or absence 
of poly(I:C), whereas Y1 and Y3 RNAs were expressed. In all cells transfected 
with the pY5 expression construct, the full length Y5 RNA was detectable by 
Northern blot but Y5sRNAs were detected only in poly(I:C) treated wild-type and 
not Ro60
-/-
 cells. Similarly, this was the case for Y1sRNAs, which were only 
generated in wild-type and not Ro60 knockout cells (Figure 5.11). Y3sRNAs were 
only detected at weak levels following poly(I:C) treatment in wild-type cells, and 
not at all in Ro60
-/-
 cells. This demonstrated that the presence of Ro60 is essential 
for YsRNA biogenesis.  
 
 
 
 
 
 
 
 
157 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11 YsRNA generation is Ro60 dependent. 
 
Wild-type (wt) and Ro60
-/-
 mouse embryonic stem cells (mES) were transfected with 
a Y5 RNA expressing plasmid (pY5) and treated with poly(I:C) (P(I:C)). Full length 
Y5 RNA was detected only in the pY5 transfected cells because mouse lacks the 
endogenous Y5 gene. Y5sRNA was detected only in the wild-type but not in the 
Ro60
-/-
 cells. This was also the case for Y1sRNA and Y3sRNAs (although 
Y3sRNAs were only weakly detectable in mES wt). The Northern blot membrane 
was stripped and re-probed with a U6 specific probe to show equal loading. The 
absence of Ro60 in the knockout cells was confirmed by Western blot and a β-actin 
antibody was used to show equal loading. For Y1 and Y5 RNAs, different panels are 
shown for the corresponding YsRNAs as different contrast settings were required to 
show bands clearly to avoid signal saturation from the full length molecule. 
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In order to investigate whether Ro60-dependent YsRNA production was 
owing to RNase protection by Ro60, cell lysate in vitro cleavage reactions were 
performed using wild-type mouse embryonic stem cells (mES) and mES Ro60
-/-
 
cells. The two cell lines were genotyped by Western blot (Figure 5.12). Lysates 
from wild-type mES cells were incubated with RNases under the same conditions 
as already described for MCF7 lysates (Figure 5.13). Y1 RNA was analysed by 
Northern blot as mouse cells do not have the gene for Y5 RNA. Full length Y1 
RNA was detected at a high level in all samples except in incubations with 
angiogenin for 30 min and 1 h where it was greatly reduced in abundance and 
almost completely degraded after 1 h. The 27 nt Y1sRNA (see chapter 3 for 
YsRNA size descriptions) was present at a very low level in the input lysate used 
for the cleavage experiments, but was at a higher level in all of the lysate 
incubations (Figure 5.13). The incubation reaction for 1 h with angiogenin showed 
a very high Y1sRNA production, but was at a similar level between buffer only 
and RNase A incubations for the same time point. The tRNA halves were 
generated specifically by angiogenin and not RNase A, but the level of tRNA 
halves was lower at the 1 h incubation compared to the 30 min time point. Similar 
to experiments done using MCF7 cell lysates (Figure 5.6), this result suggested that 
neither angiogenin nor RNase A could specifically generate the YsRNAs but that 
something in the lysate could produce them instead. 
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The same in vitro cleavage experiments were then implemented in mES 
Ro60
-/-
 cells in order to investigate YsRNA generation by RNase protection by 
Ro60 (Figure 5.14). The full length Y RNAs were detected in all but one lane 
(ANG 1 h). However, the Y1sRNA (27 nt) which was detectable in wild-type mES 
cells (Figure 5.13), was not detected in any of the experiments conducted with 
mES Ro60
-/-
 cells under the same RNase and incubation conditions (Figure 5.14). 
This result suggested that RNases in the cell lysate do not specifically generate 
YsRNAs, but generate them via RNase protection owing to Ro60 binding. 
 
 
 
 
 
 
Figure 5.12 Genotyping of wild-type and Ro60 knockout mES cells. 
 
An antibody specific to mouse Ro60 was used to differentiate between the wild 
type and Ro60 knockout mouse embryonic stem cells (mES) by Western blot. 
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Figure 5.13 Wild-type mouse embryonic stem cell (mES) lysate subjected to 
angiogenin and RNase A in vitro cleavage.  
 
Cell lysates were prepared from wild-type mES cells and incubated with either 
angiogenin (ANG) or RNase A in reaction buffer. Northern blot analysis showed that 
full length Y1 RNA was present in most samples, but was at a reduced level in both 
30 min and 1 h ANG treated samples. The 27 nt Y1sRNA increased in abundance in 
reaction samples with increasing incubation time. Y1sRNA levels did not vary 
between ANG and RNase A treatments for each time point. Generation of tRNA 
halves from tRNA methionine occurred in ANG 30 min treatment, but reduced at the 
1 h time point. RNase A incubation did not give rise to tRNA halves. U6 and rRNA 
showed signs of mild degradation in all incubations. 
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Figure 5.14 Ro60 knockout mouse embryonic stem cell (mES Ro60
-/-
) lysate 
subjected to angiogenin and RNase A in vitro cleavage.  
 
mES Ro60
-/-
 cell lysates were prepared from cells and incubated with either 
angiogenin (ANG) or RNase A in reaction buffer. RNA was analysed by Northern 
blot. Full length Y1 RNA was detected in each of the reaction samples, except in the 
lysate incubated with angiogenin (ANG) for 1 h which showed no signal. No 
YsRNAs of 24-31 nts were detected in any sample. tRNA halves derived from tRNA 
methionine were generated in ANG incubated lysates, but not with RNase A. U6 
RNA (northern blot) and rRNA (agarose gel) were mildly degraded in all lysates. 
 
 
 
162 
 
5.2.3 RNase L contributes to YsRNA generation 
 
 RNase L is an enzyme which is activated as part of the interferon induced 
antiviral response. As poly(I:C) treatment induces an immune response, RNase L 
was investigated as a candidate for having a potential role in YsRNA biogenesis. 
An RNase L knockout, mouse embryonic fibroblast cell line (MEF RNase L
-/-
) was 
employed which was used in a previous study (Zhou et al., 1997). The wild-type 
and RNase L
-/-
 cells were genotyped by PCR as described in the materials and 
methods (Figure 5.15). As expected, the wild-type MEF cells had a 900 bp 
amplicon generated from the 5’ end of the RNase L gene whereas the knockout 
cells which had an insertion mutation at the 5’ end of the gene gave a 2.1 kb 
amplicon. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15 PCR genotyping of wild-type and RNase L knockout cell lines. 
 
Mouse embryonic fibroblast (MEF) cells were genotyped by polymerase chain 
reaction (PCR) amplification of the 5’ end of the RNase L gene. Wild-type (wt) 
cells gave rise to a 900 bp amplicon whereas RNase L
-/-
 cells with an insertion 
mutation at the 5’ end of the gene gave rise to a 2.1 kb amplicon. 
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Both wild-type and RNase L knockout cells were subjected to poly(I:C) 
treatment. As mouse cells only have genes for Y1 and Y3 RNA, a Y5 RNA 
expression construct (pY5) was transfected prior to poly(I:C) treatment so that 
Y5sRNA biogenesis could be monitored. RNA was then analysed by Northern blot 
from two independent experiments (Figure 5.16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.16 Analysis of YsRNA biogenesis in RNase L knockout cells. 
 
Both wild-type (wt) and RNase L
-/-
 MEF cells were subjected to poly(I:C) (P(I:C)) 
treatment. As mouse cells only have genes for Y1 and Y3 RNA, a Y5 expression 
construct (pY5) was transfected into a subset of cells prior to stress treatment in order to 
monitor Y5sRNA biogenesis. Experiments were repeated twice. Northern blot analysis 
showed Y5 RNA was present in cells transfected with pY5 but not in non-pY5 
transfected cells. Poly(I:C) treatment only gave Y5sRNAs in wild-type cells which had 
been transfected with pY5, but not in cells which lacked pY5. Y5sRNAs were produced 
at noticeably higher levels in poly(I:C) treated pY5 wild-type cells than in RNase L
-/-
 
cells under the same conditions. Y1sRNAs were highly expressed in wild-type poly(I:C) 
treated cells, but were only very weakly produced in RNase L knockout cells. 
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The full length Y5 RNA was only present in cells transfected with pY5. Wild-type 
cells with pY5 gave rise to the expected Y5sRNAs following poly(I:C) treatment 
(Figure 5.16). However the level of Y5sRNAs was lower in poly(I:C) treated 
RNase L knockout cells with pY5 for both experimental replicates. As the full 
length Y5 RNA was lower in the RNase L
-/-
 cells for one of the replicates, Y1 
RNA was also analysed. Full length Y1 RNA expression was relatively constant 
between wild-type and RNase L knockout samples. Y1sRNAs however showed a 
very high level of production in wild-type MEF cells treated with poly(I:C), but 
were detected at a much lower level in RNase L
-/-
 poly(I:C) treated cells. This data 
suggested that RNase L contributed to YsRNA generation in mouse. 
 YsRNA generation was then investigated in relation to RNase L activity in 
human cells. As no human RNase L knockout was available, RNase L was 
knocked down in MCF7 cells using RNAi (Figure 5.17). Intriguingly, poly(I:C) 
treated cells where RNase L had been depleted by siRNA had similar levels of 
Y5sRNA and Y1sRNA compared to cells where a negative control siRNA was 
used. However, the full length Y1 and Y5 RNAs both appeared more stable in 
RNase L knockout cells following poly(I:C) treatment compared to cells with 
normal RNase L levels. This suggested that RNase L did not affect YsRNA 
production in human MCF7 cells as it did in mouse MEF cells, and could therefore 
indicate either cell line or species specific differences in YsRNA biogenesis. 
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Figure 5.17 YsRNA biogenesis in MCF7 cells following RNase L depletion by 
RNAi. 
 
MCF7 cells were transfected with either no siRNA, a negative control siRNA or an 
RNase L specific siRNA. RNase L knockdown was confirmed by Western blot. 
Cells were then either treated or not treated with poly(I:C) following siRNA 
transfection. Y1sRNAs and Y5sRNAs were still generated in poly(I:C) cells where 
RNase L was targeted by RNAi at levels comparable to where only a negative 
control siRNA was used. Equal loading was confirmed by a U6 specific probe for 
the Northern blot and a β-actin antibody for the Western blot. 
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5.2.4 Nucleolin does not affect the biogenesis of YsRNAs 
 
 As Ro60 and La appeared to contribute to YsRNA production, experiments 
then focused on another Y RNA binding protein as a potential candidate for 
involvement into the maturation of these fragments. Nucleolin has been shown to 
bind to the pyrimidine-rich loop of hY1 and hY3 RNAs (Fouraux et al., 2002). 
Here, nucleolin was targeted using siRNAs prior to poly(I:C) treatment (Figure 
5.18). YsRNA generation was then assessed by Northern blot. Y1 RNA was 
analysed (which has been shown to bind to nucleolin), and so was Y5 RNA. 
Northern analysis showed that both YsRNAs were still generated in Nucleolin 
depleted cells following poly(I:C) treatment at comparable levels to where a 
negative control siRNA was used (Figure 5.18). 
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Figure 5.18 The RNA-binding protein and Ro-RNP subunit, nucleolin, does not 
affect Y RNA cleavage. 
 
Nucleolin mRNA was targeted by RNAi prior to poly(I:C) treatment. Reduced 
nucleolin levels were confirmed by Western blot. The level of Y1sRNA and 
Y5sRNA was analysed by Northern blot. Following nucleolin depletion and 
poly(I:C) stress treatment, YsRNAs from both Y1 and Y5 were still generated. 
Equal loading of RNA and protein was confirmed using U6 and β-actin probes 
respectively. SiNucleolin indicates the Nucleolin targeting siRNA. 
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5.2.5 Investigating the mechanism of YsRNA maturation via Y RNA stem-
loop detection 
 
 Earlier experiments which utilised cell lysates for in vitro cleavage analysis 
with wild-type and Ro60 knockout cell lines (Figures 5.13-5.14), as well as RNase 
L knockout experiments (Figure 5.16) hinted at the possibility that YsRNAs are 
generated via Ro60 protection of the lower region of the full length Y RNAs from 
non-specific, stress-induced RNase degradation. In order to address this hypothesis, 
it was investigated whether the pyrimidine-rich loop region of Y5 RNA could be 
detected by Northern blot. The rationale for this experiment is that if Y RNAs were 
generated by a specific cleavage event, then the ‘loop’ region might be detectable 
by Northern blot (Figure 5.19A). If on the other hand YsRNAs were generated by 
non-specific degradation of non-Ro60 protected regions, the loop sequence would 
not be generated or indeed, be detectable. 
 The 19 nt Y5 RNA loop sequence was not detected in Solexa sequencing 
data of poly(I:C) treated cells, but the size of the loop region falls outside of the 
size-class selected for library preparation. Therefore, a highly sensitive LNA probe 
was used to detect the loop sequence in a range of RNA samples from poly(I:C) 
treated MCF7 cells (Figure 5.19). Only full length Y5 RNA was detected using the 
LNA loop probe in non-treated and poly(I:C) treated cells, whereas an 
oligonucleotide corresponding to the exact sequence of the 19 nt loop region could 
be detected at amounts as low as 1.0 femtomole (Figure 5.19B). A standard DNA 
oligonucleotide probe specific to the Y5 3’ end was able to detect the stress 
induced Y5sRNAs. To investigate whether the loop sequence could be detected in 
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the presence or absence of Ro60, siRNAs were used to knockdown Ro60 in 
poly(I:C) treated and non-treated cells and RNA was then analysed by Northern 
blot (Figure 5.19C). Again, no sequence corresponding to the Y5 RNA loop region 
could be detected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.19 Y5 RNA stem-loop analysis. 
 
(A) Annotated diagram of Y5 RNA structure. If Y RNAs were specifically cleaved by 
an enzyme to generate the 5’ and 3’ YsRNAs (shown in yellow), the pyrimidine rich 
loop region would be produced (shown in blue). (B) Attempt to detect the Y5 RNA loop 
region by Northern blot using LNA ‘loop’ probe (top panel). MCF7 cells were either 
treated or not treated with poly(I:C) and RNA was analysed by Northern blot, along with 
known concentrations of oligonucleotide sequences corresponding to the exact region of 
the expected loop sequence. Only full length Y5 RNA was detected using the LNA loop 
probe and no sequence corresponding to the putative 19 nt loop sequence was detected. 
The poly(I:C) induced Y5sRNAs were detected using Y5 3’ end specific DNA 
oligonucleotide probe (middle panel), and not by the LNA loop probe. (C) MCF7 cells 
were either treated or not treated with siRNAs against Ro60 (siRo60) prior to poly(I:C) 
treatment. Again, no Y5 RNA loop derived sequence was detected by LNA loop probe, 
whereas Y5sRNAs were detected using a Y5 3’ end specific probe. A U6 RNA specific 
probe was used to confirm equal loading (bottom panel). 
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5.3 Discussion 
 
There are three possible models of how YsRNAs might be produced. 
Firstly, the YsRNAs could be specifically transcribed from the gene encoding the 
Y RNA. Although this was not specifically addressed here, based on the fact that 
the YsRNAs increased in abundance in lysates during in vitro cleavage reactions 
where transcription could not take place owing to reaction conditions (Figures 5.6 
& 5.13), and that Y5sRNAs could be produced form a Y5 expression construct in 
poly(I:C) treated cells using only the promoter for the full length Y5 RNA (Figures 
5.11 & 5.16), this scenario seems highly unlikely. Secondly, YsRNAs might be 
generated by a single enzyme which cleaves the full length Y RNA at specific 
regions to give the 5’ and 3’ YsRNAs. And finally, YsRNAs biogenesis could be 
explained by a simple protein protection model whereby the activity of a cocktail 
of cellular RNases which have access to only the non-protein bound regions of the 
Y RNA, would result in Y RNA fragments protected by the proteins being 
produced. This latter scenario will be referred to as the ‘RNase protection 
hypothesis’. As some cellular RNases are upregulated during cell stress and 
apoptosis, this might explain the increase in YsRNAs detected under these 
conditions. 
In this chapter, knockout, knockdown and in vitro cleavage experiments 
have demonstrated that Ro60 is essential for YsRNA production for all four Y 
RNAs (Figures 5.7-5.14). The decrease in YsRNAs was shown to be independent 
of the corresponding reduction in the stability of the full length Y RNA. Indeed, 
others have also shown that the full length Y RNA is stabilised by Ro60 (Labbe et 
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al., 1999; Chen et al., 2003; Sim et al., 2009). The Ro60-dependant YsRNA 
production data shown in this chapter supports the RNase protection hypothesis 
because if Ro60 is absent, then RNases would have access to all regions of the Y 
RNA, resulting in complete degradation. However, previous experiments have 
specifically mapped the Ro60 binding site (Wolin & Steitz, 1984), and the region 
which gives rise to the YsRNAs is not completely encompassed by Ro60. 
Nevertheless, this does not rule out that Ro60 binding can prevent RNases from 
having access to some sequence region which is not directly bound by Ro60. 
Furthermore, the experiments used to determine the Ro60 binding site had to be 
repeated several times before they were successfully published, and used an 
excessive amount of pancreatic RNase to map this binding site (personal 
communication with Professor Sandra Wolin). This in turn might have given an 
exaggerated impression of the exact sequence regions which Ro60 protects. 
Angiogenin, which specifically generates the biological functional tRNA 
halves, did not appear to give rise to YsRNAs based on in vitro cleavage 
experiments (Figures 5.5 & 5.6 and Figures 5.13 & 5.14). Interestingly, in MCF7 
and mES wt cell lysates, YsRNAs from both Y1 and Y5 were shown to increase 
following extended incubation with angiogenin, RNase A or reaction buffer alone 
(Figures 5.6 & 5.13). However, these YsRNA fragments were not detected in Ro60 
knockout cell lysates (Figure 5.14). This data would also support the RNase 
protection hypothesis for YsRNA generation, as RNases within the cellular lysate 
were clearly producing the YsRNAs only in the presence of Ro60, even in the 
absence of RNase A or angiogenin.  
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RNase L specifically had an effect on YsRNA biogenesis, but only in 
mouse cells (Figure 5.16). It is possible that RNAi targeting in the human MCF7 
cells was sufficient to show an RNase L depletion by Western blot (Figure 5.17), 
but some low level of cellular RNase L may have still been present at functionally 
active but undetectable levels. Alternatively, this data could imply a differential 
YsRNA biogenesis pathway between human and mouse. As RNase L depletion 
only reduced YsRNA generation and did not completely eliminate it, this supports 
the hypothesis that a cocktail of RNases contributes to YsRNA production, and no 
one enzyme alone. Unfortunately, the experiments done here have not revealed all 
the RNase(s) involved. This could be investigated in future studies by using a 
comprehensive, genome wide RNAi screen against all the individual cellular 
RNases. 
The relative abundance of the YsRNAs is reflective on the approximate 
molar ratios of full length Y RNAs within the cell, as determined in previous 
studies (Gendron et al., 2001; Christov et al., 2006). Y5 RNA makes up ~ 60 % of 
the total Y RNA population and gives the strongest signal for YsRNA fragments 
on a Northern blot (Figures 5.8-5.10, and see Chapter 4). Y4 is the next most 
abundant Y RNA and also gives rise to the next most abundant YsRNA. Y1 is 
expressed at a slightly lower level than Y3, but Y1sRNAs are more abundant than 
Y3sRNAs. The nature of YsRNA abundance reflecting cellular concentrations of 
full length Y RNAs would further support a case for the RNase protection 
hypothesis, as non-specific degradation of exposed non-Ro60 protected regions 
would be equal for all Y RNAs. Failure to detect the pyrimidine-rich loop region of 
Y5 RNA in poly(I:C) treated cells (Figure 5.19) also supports the proposed model 
173 
 
for YsRNA biogenesis. However, it is possible that if a specific cleavage were to 
occur in order to generate YsRNAs, the half-life of any resulting by-product (the 
loop region) might be too short for the purpose of Northern blot detection. 
Other Y RNA binding proteins did not appear to have the same essential 
role for YsRNA generation as Ro60. Nucleolin depletion did not affect YsRNA 
generation (Figure 5.18). Although, as siRNA targeting did not achieve a complete 
knockdown of the protein, it is possible that the small amount of nucleolin 
remaining was enough to be functional.  
Depletion of La protein levels only appeared to affect Y5sRNA biogenesis 
by resulting in an increase of the shorter, 24 nt Y5sRNA. Considering the 
structures of the Y RNAs, the 3’ tail region which La binds is much longer in Y5 
RNA compared to the other Y RNAs. The longer (32 nt) and shorter Y5sRNA (24 
nt) have identical sequences apart from the 8 nt 3’ tail region (Chapter 3). 
Therefore, one possible explanation is that when La is absent, the 3’ tail region is 
de-protected and therefore vulnerable to degradation from the 3’ end, resulting in 
more 24 mer YsRNA (which remains protected by Ro60). As the other Y RNAs 
have much shorter 3’ tails, depletion of La would not have such a drastic change in 
YsRNA size, as reflected in figures 5.8-5.10. 
Interestingly, YsRNAs were still generated in mouse embryonic stem cells 
despite the fact that the interferon response has been shown not to occur in ES cells 
(Yang et al., 2001). Nonetheless, poly(I:C) treatment still triggered YsRNA 
generation in these cells, which might indicate an immune-independent function of 
the YsRNAs. 
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 Functional sRNAs are usually generated with specificity. For example, 
Dicer generates microRNAs and angiogenin generates tRNA halves. MicroRNAs 
and tRNA halves then go on to serve precise biological functions. If YsRNAs were 
generated by the RNase protection hypothesis, it would not be unreasonable to 
assume that the resulting products are not functional based on the chaotic nature of 
their biogenesis. Having said this, it does not rule out that a biological function has 
evolved to utilise these YsRNAs, which may have originally arisen in ancestral 
cells by chance through RNase protection, but have since become functional. 
Based on the high abundance of YsRNAs within the cell, and the evidence that 
they are specifically incorporated into immune cell-derived vesicles (Nolte-'t Hoen 
et al., 2012), this would certainly hint at biological functionality.  
Future work should aim to characterise the biological role of these YsRNAs. 
Work in our laboratory has started to address this question by subjecting proteins 
in the same biochemical fraction as YsRNAs to mass spectrometry. We identified 
around 160 proteins, including Ro60, La and nucleolin (data not shown). 
Interestingly, many proteins related to proteolysis, including E3 ubiquitin ligase, 
several proteasome subunits and heat shock proteins such as Hsp70 and Hsp90, 
were also found in the same biochemical fraction as YsRNAs. Additionally, we 
found that two proteins which have been shown to antagonise apoptotic pathways, 
nucleophosmin and the 14-3-3 protein (Fu et al., 2000; Dhar & St Clair, 2009), 
also co-purified with the YsRNAs according to our mass spectrometry data. This 
preliminary work would suggest that YsRNAs are associated with pathways related 
to survival following cellular stress, which is perhaps why they show a specific 
increase following apoptosis and viral infection. 
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Chapter 6 
Next-generation sequencing of a novel class of small 
RNAs 
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6.1 Introduction 
 
 Next-generation sequencing (NGS) technologies have allowed high 
throughput analysis of small RNA populations, and facilitated the subsequent 
discovery of novel small RNAs. For example, a recent study has discovered 16-28 
nt RNAs in chloroplasts following deep-sequencing of Arabidopsis (Ruwe & 
Schmitz-Linneweber, 2012). Interestingly, it was shown that these chloroplast 
sRNAs were footprints of the translation related pentatricopeptide repeat proteins 
(PPR) and were generated via RNase protection of intergenic regions of 
chloroplast transcripts. The question of whether these chloroplast sRNAs are 
merely footprints or whether they go on to serve a biological function remains 
unanswered. A different study which analysed non-coding RNAs (ncRNAs) in 
differentiating mouse ES cells via NGS sequencing (Skreka et al., 2012) identified 
a class of differentially expressed 18-30nt RNAs, also derived from intergenic 
regions, most of which were novel ncRNAs lacking characteristic microRNA 
features. Two other size classes were also found in the study, a 45-47 nt class and a 
71-78 nt class. 
 The reasons why these novel sRNAs were missed in previous years is 
owing to firstly; the increased number of reads which can now be analysed in a 
single sequencing reaction (the ‘depth’ of sequencing), and secondly; that gene 
silencing-related RNAs are predominantly 18-24 nt, resulting in specific selection 
of these small RNAs during library preparations, neglecting RNAs of other sizes. 
Indeed, in relation to this project, early Northern blot analysis of Y RNA fragments 
(Chapter 3) revealed unexpected bands of 28-33 nt RNAs, which encouraged 
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specific selection of these additional sRNAs during library preparations in 
subsequent sequencing experiments. In these later experiments, it was noted that a 
peak of ~30 nt found following Illumina (Solexa) sequencing of MCF7 cells 
(Chapter 3, Figure 3.2) contained unknown sRNAs in addition to YsRNAs. These 
~30 nt RNAs did not map to the well characterised 24-31 nt Piwi-interacting RNAs 
(piRNAs) which act in pathways to protect the genome against transposable 
elements (Siomi et al., 2011), indicating that they were from a different class of 
sRNAs. 
The millions of reads generated during sequencing reactions which aim to 
detect novel small RNAs make it very challenging to differentiate functional 
molecules from degradation products. For microRNAs, computer programmes 
exist which can identify functional molecules using a set of well-established 
parameters (Moxon et al., 2008). Obviously, the function and therefore 
characteristic features of putative novel sRNAs is not known prior to their 
discovery. However, several experimental designs can be employed which help to 
filter out background degradation products. Analysis of cells and tissues which are 
treated under different conditions, or are at different stages of development, as well 
as sequencing only RNAs which are protein bound, can all facilitate the 
identification of functional sRNAs over degradation products (Skreka et al., 2012). 
Solexa (Illumina) sequencing is the most widely used deep sequencing 
technique for small RNA detection. Indeed, the majority of miRNAs in miRBase 
have been discovered using Illumina sequencing technology. The current 
sequencing protocol relies on RNA ‘adapter’ molecules ligating to the 3’ and 5’ 
ends of total RNA extracted from a tissue or cell sample. Ligation of adenylated 3’ 
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adapters to the small RNAs is achieved using a truncated form of T4 RNA ligase 2 
(Rnl2) and then 5’ adapters are ligated to the small RNAs using T4 RNA ligase 1 
(Rnl1). Reverse transcription followed by PCR (RT-PCR) then results in 
generation of complementary DNA molecules (cDNA) from the ligated product 
which can then be separated on a polyacrylamide gel. The desired size class of 
small RNA can then be selected for sequencing by purifying the appropriate cDNA 
band from the gel using size markers as a guide. However, recent work has 
demonstrated that a considerable bias exists by which the adapter molecules can 
ligate to target small RNAs of interest (Linsen et al., 2009; Hafner et al., 2011). 
The sequencing bias in small RNA libraries is ligase dependent (Nandakumar & 
Shuman, 2004) and results in failure to detect thousands of non-adapter or reduced-
adapter ligated small RNAs in library preparations. 
In this chapter, in order to better characterise the population of 30-40 nt 
novel sRNAs in which YsRNAs are found, Illumina (Solexa) sequencing was 
employed to identify putative candidates. As poly(I:C) treatment induced the 
generation of stress related YsRNAs, and as Ro60 appeared to be responsible for 
their biogenesis, both wild-type and Ro60 knockout cells either treated or not-
treated with poly(I:C) were subjected to NGS, selecting for molecules between 30-
40 nt. Over 150 sRNAs were identified which were found to be upregulated 
following poly(I:C) treatment, but which were not produced in the absence of 
Ro60 under the same conditions, implying that Ro60 was required for the 
production of these molecules. Intriguingly, most of these sRNAs mapped to 
exonic regions of the genome. Furthermore, the reads of these novel sequences 
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showed a high sequence conservation at their 3’ end, but had a more variable 5’ 
end.  
In addition to testing the Ro60 dependency of the ~30 mer sRNAs, 
experiments were performed to give an indication of the abundance of this size 
class in adult mice. Small RNAs of the ~30 mer class were selected for sequencing 
from a range of six organs in mouse which revealed a specific size peak at 40 nt 
and also 33 nt. Again, these sRNAs primarily mapped to exons. Bioinformatic 
analysis of both these data sets is ongoing. 
In collaboration with others in the laboratory and with the School of 
Computing Sciences, University of East Anglia, a technique of reducing the 
sequencing bias of small RNAs was developed and tested. The new technique 
utilised adapters with degenerate tags (variable sequences) called ‘high definition’ 
adapters (HD adapters). Using quantification of small RNAs by Northern blot as a 
standard, data obtained using HD adapters correlated better with absolute 
quantifications than did standard Illumina adapters. The use of HD adapters will be 
a highly useful tool for future investigations of novel classes of small RNAs. 
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6.2 Results 
 
6.2.1 Deep sequencing of RNA from Ro60 knockout cells reveals novel Ro60-
dependent small RNAs 
 
 As the Ro60 autoantigen is essential for YsRNA biogenesis (see chapter 5), 
this raised the question as to whether other 30-40 nt non-Y RNA related small 
RNAs were also regulated by Ro60. In order to address this, both wild-type mouse 
embryonic stem cells (mES) and mES Ro60 knockout cells (Ro60
-/-
) were either 
treated or not treated with poly(I:C). This was repeated in duplicate, generating 
eight biological samples. Ro60 knockout cells were genotyped by Western blot as 
before (see chapter 5). RNA was then isolated from all cells. Small RNA libraries 
were generated using the latest Solexa protocol (TruSeq Small RNA) using 
different ‘barcodes’ (specific PCR primer sequence to allow for multiplexing) for 
each of the libraries. The Illumina Truseq protocol is optimised for microRNA 
library preparation. As this new size class of 30-40 nt had not specifically been 
investigated before, the protocol had to be modified in order to better select for this 
new size class. It was found that using 2 µg small RNA (rather than 1.0 µg total 
RNA suggested by Illumina) for adapter ligation was optimal for library 
preparation of this size class. Therefore, RNA extracted from cells was enriched 
for the small RNA fraction (RNAs <200 nt) prior to library preparation. 
Additionally, between 17-19 PCR cycles (as opposed to 11 cycles suggested by 
Illumina) was optimal for the generation of libraries for 30-40 nt sRNAs. A 
comparison of the resulting cDNAs generated using either the standard microRNA 
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or 30-40 nt specific library preparation protocols shows that the method developed 
here was highly efficient at selecting for this new size class (Figure 6.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Comparison of small RNA cDNA library preparations for microRNAs and 
30-40 nt sRNAs. 
 
Small RNA libraries were prepared using the TruSeq small RNA kit (Illumina). (A) 
Library preparation optimised for 30-40 nt sRNAs (investigated in this chapter) and 
separated by polyacrylamide gel. Libraries prepared using 2 µg enriched sRNA (<200 
nt) and RT-PCR protocol with high PCR cycle numbers (17-19 cycles). The size of the 
combined barcode and adapter-adapter cDNAs alone is 125 bp. Libraries of 22 nt 
microRNAs therefore gives a 147 bp band. Gel A shows result of second gel 
purification after selecting all cDNAs between 140-170 bp in a previous purification. A 
band representing microRNAs, as well as a larger band of ~160 bp (representing ~35 nt 
sRNAs) is clearly visible. The red bracket shows cDNA which was purified for 
sequencing, or the equivalent region on gel B. (B) An example of standard microRNA 
cDNA library preparation by another researcher in the laboratory, Dr Ping Xu, using 
the advised reaction conditions stated in the Illumina protocol. A band representing 
miRNAs is clearly visible in each of the three lanes representing cDNAs generated 
using different PCR cycles. However, the equivalent ~35 nt sRNA band shown in gel A 
is only detected at low levels in the first lane of gel B. 
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 Following library preparation, samples were sent for Solexa (Illumina) 
sequencing where they were first quantified and then each sample (including 
duplicated repeats) was sequenced on two different lanes on a flow cell using 50 
cycles to account for the longer than usual sRNA size. Data was analysed by firstly 
removing adapter sequences and then removing reads that were less than 16 nt 
(0.4-3 % of total reads) and greater than 45 nt (no reads were actually greater than 
43 nt). Reads mapping to a loci at chromosome 18 representing a highly abundant 
snoRNA fragment (from SNORD58) were also removed, as this sequence was 
overrepresented owing to sequencing bias.  
The resultant reads were then mapped to the GRCm 37 release (genome 
reference consortium for mouse) of the mouse genome using sequences with exact 
matches (Table 6.1). Between 9.9 and 18.1 million redundant reads (non-unique 
reads) were generated for each sample of which 79-89 % mapped to the genome. 
With regards to unique reads, between 7.7-13.1 % mapped to the genome. The 
discrepancy between the percentages of redundant versus unique reads which 
mapped to the genome is explained by the fact that a small number of unique 
sequences had high read numbers (this is a normal result for sequencing of a 
specific size class where there is low degradation or background ‘noise’). To better 
explain this, let us take a theoretical data set where we have 10 reads composed of 
three different sequences: 6 redundant reads with sequence ‘A’ (which map to the 
genome), 3 redundant reads with sequence ‘B’ (which do not map to the genome) 
and 1 redundant read with sequence ‘C’ (which does not map to the genome). In 
this scenario, 60% of redundant reads map to the genome, but only 33 % of unique 
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reads map to the genome, because only one read represented with sequence ‘A’ out 
of the three different sequences in total can map. 
A size distribution was then generated for each of the four biological 
conditions and for each of the biological repeats (Figure 6.2). Results were 
normalised using quantile normalisation which is more appropriate when 
comparing different samples than proportional normalisation (or ‘reads per million’ 
normalisation) (Garmire & Subramaniam, 2012). Briefly, quantile normalisation is 
based on ranking sequences in order of abundance for the different samples. This 
makes sequence distributions more comparable with each other, and does not 
introduce or reduce differential expression in the same way which proportional 
normalisation does. Size distributions for all samples showed clear peaks at 28 nt, 
33 nt and 38 nt (Figure 6.2). No peak at 22 nt representing microRNAs was found, 
as this size class was omitted during library preparation. 
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Table 6.1 Analysis of reads generated from deep sequencing of wild-type and Ro60 
knockout mouse embryonic stem (mES) cells either treated or not treated with 
poly(I:C). 
 
RNA was extracted from cells and enriched for <200 nt molecules. Experiments were 
repeated twice (biological replicates) represented by #. Following cDNA library 
preparation using a modified Illumina protocol optimised for 30-40 nt sRNAs, 
libraries were sequenced and mapped to the GRCm 37 release of the mouse genome. 
The discrepancy between the percentages of redundant versus unique reads which 
mapped to the genome is normal for sequencing of a specific size class, and is 
explained by the presence of a small number of unique reads with high read numbers. 
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Figure 6.2 Size distribution of sequences from wild-type mouse embryonic stem cell 
(mES) and mES Ro60 knockout (Ro60
-/-
) cells either treated or not treated with 
poly(I:C). 
 
Two biological replicates were sequenced using Solexa (Illumina) technology for 
each of the four experiments. Size distribution showed peaks at 28 nt, 33 nt and 38 
nt. As the microRNA size class was omitted during library preparation, there is no 
visible peak at 22 nt. Data was quantile normalised. 
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 As YsRNA biogenesis is dependent on Ro60, sequences derived from mY1 
and mY3 RNAs were first assessed as a positive control to see if the data set could 
reliably be used to find other Ro60 dependent small RNAs. A ‘presence plot’ was 
generated for both Y RNAs which plots the appearance of each nucleotide in all 
sequencing reads against its position in the genome (Figure 6.3). For example, 
taking two theoretical sequences which map to the same locus: GATC (with 4 
reads) and GATCGA (with 6 reads), the ‘abundance’ for each base at a particular 
position in the sequence is calculated as the sum of all reads covering that base. So 
with the example given, the abundance of ‘G’ at position one in both theoretical 
sequences (mapped to the same locus) would be 10  because it appears in both 
sequences at the same position and the sum of the reads of the two sequences gives 
an abundance value of 10. In the case of the last ‘A’ in sequence two; it would only 
have a value of 6 as it only appears in the second sequence which has 6 reads. 
The presence plot revealed that sequences from the 5’ and 3’ ends of mY1 
had a higher abundance in poly(I:C) treated wild-type mES cells than for non-
treated wild-type mES cells (Figure 6.3). The abundance of reads from mY1 in 
Ro60
-/-
 cells (treated and non-treated with poly(I:C)) remained low across the mY1 
locus. The presence plot for mY3 was not as conclusive as high abundance was 
only detected at the 3’ end and the overall abundance mY3 was low (see scale on 
the y-axis). Furthermore, the abundance for one of the non-poly(I:C) treated wild-
type mES cell repeat samples was much higher than for both poly(I:C) treated 
wild-type mES cell repeats. Earlier Northern blot data showed that Y3 RNA 
expression and Y3sRNA production is generally much lower compared to the other 
Y RNAs and does not seem to be representative of YsRNA biogenesis (for 
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example see Figure 4.1, 4.2, 5.9 and 5.11 from previous chapters). However, the 
mY1 presence plot did correlate with Northern blot analysis from Ro60 knockout 
experiments (see chapter 5) confirming that YsRNAs are dependent on Ro60. This 
in turn demonstrated that the sequencing data set could reliably be used to find 
other potential Ro60-dependent small RNAs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 Presence plot for Y1 and Y3 RNA from wild-type mouse embryonic stem 
cells (mES) and mES Ro60 knockout (Ro60
-/-
) cells either treated or not treated with 
poly(I:C). 
 
The presence of each nucleotide in reads which mapped to the loci shown were 
analysed for mY1 (top) and mY3 (bottom) for all four experiments using redundant 
sequences. Data for biological duplicates is also shown. Presence plot for mY1 (top) 
showed that sequences from the 5’ and 3’ ends had higher read counts in wild-type 
poly(I:C) treated cells (mES_polyic) than in non-treated wild-type cells (mES_wt). 
Read counts for mY1 remained low across the locus for all Ro60 knockout (Ro60
-/-
) 
cells. Presence plot for mY3 (bottom) shows only fragments derived from the 3’ end 
of Y3 RNA. One of the replicates for non-poly(I:C) treated cells shows much higher 
read counts compared to wild-type poly(I:C) treated cells. Data was quantile 
normalised. 
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 In order to see if there were other Ro60-dependent small RNAs which were 
upregulated during cell stress, differentially produced sequences were filtered from 
the data set using two different parameters. Sequences were selected which showed 
a four-fold increase in production (2log2 offset fold change using an offset value of 
20) between wild-type mES cells and poly(I:C) treated wild-type mES cells, but 
which did not show differential production between Ro60
-/-
 cells and poly(I:C) 
treated Ro60
-/-
 cells. The most differentially produced sequences mapping to each 
loci were used in the analysis. Subsequently, 177 sequences were found which 
showed at least a four-fold increase during stress, but which specifically required 
Ro60 for their generation. These novel sequences will be referred to as rosRNAs 
(Ro60-dependent small RNAs).  
Interestingly, rosRNAs primarily mapped to exonic regions of the genome, 
implying that they were derived from mRNA transcripts. The list of 177 candidates 
did not include tRNA halves (as expected) but did include the 5’ end Y1sRNA - 
which appeared as the 26
th
 most differentially produced rosRNA. In order to 
further filter the list of candidates, all 25 sequences from loci showing a greater 
Ro60-dependent differential production than Y1sRNA were chosen for analysis, as 
well as 8 sequences which were the next most Ro60-dependent after Y1sRNA. 
These sequences were all between 31-41 nt in length.  
The presence plots for all sequences mapping to these 33 loci were then 
analysed, and only 6 of these sequences were then selected as bona fide rosRNAs 
(Table 6.2) based on more stringent analysis of their differential generation pattern 
between experiments (Table 6.3). The most differentially produced sequence from 
each Ro60-dependent locus was selected as the consensus sequence for each 
189 
 
rosRNA. The change in Y1sRNA-5’ production was also analysed (Table 6.3). 
None of the rosRNAs showed a fold change difference between untreated mES 
wild-type cells and  untreated Ro60
-/-
 cells, whereas Y1sRNA production reduced 
in an untreated Ro60
-/-
 background (-1.6 log2 offset fold change), as this sRNA is 
naturally produced in non-stressed cells and is Ro60 dependent (see Chapters 3 and 
5 respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.2 Ro60 dependent small RNA (rosRNA) candidates. 
 
The sequence and origin of the six putative rosRNAs is shown. The candidates all 
mapped to exonic regions: either the coding regions of genes (CDS) or the 
untranslated regions (UTR). 
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Surprisingly, these six rosRNA sequences shared a common read structure, 
whereby the 3’ end showed high sequence conservation and the 5’ end showed 
greater variation (Figures 6.4-6.5). For example, rosRNA-1 has a very defined 3’ 
end whereas the presence plot for the 5’ end is more sloped with a less defined cut-
off point. This could be due to the rosRNA being derived from the 3’ end of a 
transcript, or due to evolutionary selective pressure at the 3’ end owing to 
conservation of important sequences, which is similar to the asymmetric end 
selection seen with animal microRNAs (but with the opposite end). The ‘seed’ 
region in microRNAs (nucleotide positions 2-8) is at the 5’ end and presence plots 
for microRNAs shows a fixed 5’ end and more variable 3’ end.  
 
Table 6.3 Fold change of rosRNA candidates and Y1sRNA between experimental 
conditions and cell lines. 
 
Table shows the log2 offset fold change values (using an offset value of 20) of 
rosRNAs between mES wild-type and Ro60
-/-
 cells under poly(I:C) treated or untreated 
conditions. Candidates were selected on the conditions that they showed a four-fold 
change between mES wt untreated and mES wt poly(I:C) treated conditions, but did 
not change between Ro60
-/-
 and Ro60
-/-
 poly(I:C) treated conditions. This confirmed 
that they were indeed Ro60 dependent. Fold change differences for Y1sRNA-5’ is 
shown as a comparison. 
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Upon closer investigation, it was noted that there was a ‘kink’ or step in the 
rosRNA presence plots consistently appearing at the 5’ end (Figures 6.4-6.5). This 
kink corresponded with a run of 3-4 T nucleotides at the 5’ end of these sRNAs 
(with the exception of rosRNA-5 where the run of Ts appears at a secondary kink 
in the centre of the sRNA). This is identical to the La binding motif. Indeed, the 
differential length of rosRNAs at the 5’ end may be due to differential La binding 
of these transcripts, which is what we have seen for Y5sRNA-3’. With Y5sRNA-3’, 
a 32 nt fragment is produced when La is present, and in its absence, the 24 nt 
Y5sRNA is preferentially produced (Chapter 5, Figures 5.8-5.10). Differential La 
binding might explain the 5’ end variation seen in rosRNAs. 
These rosRNA candidates are currently being subjected to further 
investigation in the laboratory. 
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Figure 6.4 Ro60-dependent small RNA (rosRNA) 1-3 presence plots.  
 
Sequences mapping to each locus were analysed. Mapped reads showed a highly 
conserved 3’ end and a more variable 5’ end. 
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Figure 6.5 Ro60-dependent small RNA (rosRNA) 4-6 presence plots.  
 
Sequences mapping to each locus were analysed. Mapped reads showed a highly 
conserved 3’ end and a more variable 5’ end. 
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6.2.2 Next-generation sequencing of 30-40 nt sRNAs in mouse organs 
 
 The 30-40 nt small RNA population studied using mouse embryonic stem 
cells was highly informative at revealing Ro60-dependent small RNAs. However 
the experimental design would not reveal the full extent of this novel RNA 
population in animals as only a single undifferentiated cell type was employed. 
Therefore, in order to better characterise this class of sRNAs in animals, 30-40 nt 
RNAs from different organs in mouse were investigated via NGS as described 
before. The brain, heart, kidney, liver, lungs and femoral muscle were all dissected 
from two different adult mice (one male and one female) and cDNA libraries were 
subjected to Illumina sequencing.  
As with rosRNAs, the 30-40 nt sRNAs in mouse organs were primarily 
composed of RNAs derived from exons. Analysis of the redundant size distribution 
of reads for all organs from these two individuals revealed a significant peak 
around 40 nt, and smaller peak at 33 nt (Figure 6.6). The kidney sample extracted 
from the female mouse showed a peak around 22 nt, but this was probably due to 
microRNA contamination during library preparation. Bioinformatic analysis of this 
data set is ongoing, but the initial read distribution results clearly demonstrated that 
a 30-40 nt small RNA population exists in the cell, and shows varied abundance 
between different organs. Small RNAs from this size class were most abundant in 
the brain and kidneys, and showed the lowest production in the heart (Figure 6.6). 
Individual sequences with high read counts showed organ-specific production 
which was reproduced in the two biological replicates (preliminary data not 
shown). 
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Figure 6.6 A population of 30-40 nt small RNAs in mouse organs. 
 
Six different organs (brain, heart, kidney, liver, lung and muscle) were 
extracted from two different mice (an adult male and adult female). RNA 
libraries were prepared using the Illumina protocol, selecting from the 30-40 nt 
size class. Size distribution of redundant sequences revealed specific peaks at 
40 nt and 33 nt. The peak visible at 22 nt for the female kidney sample is 
probably owing to microRNA contamination in that sample. 
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6.2.3 Improving next-generation sequencing of small RNAs by reducing 
sequencing bias 
 
 Current sequencing protocols have been shown to be biased with respect to 
which small RNAs are preferentially sequenced. This in turn could hinder the 
discovery of novel small RNAs and new classes of RNAs. The sequencing bias is 
due to RNA ligases having a preference for certain secondary structures at the 
adapter-small RNA ligation site (Nandakumar & Shuman, 2004). We found that 
the use of commercial adapters with fixed sequences worsened this problem by 
restricting the diversity of possible secondary structures generated between the 
fixed adapters and the small RNA molecules. In order to counteract this problem 
our laboratory developed and patented adapters with degenerate tags (varied 
sequences) called high definition adapters (HD adapters) thereby increasing the 
number of different secondary structures at adapter-small RNA ligation sites for 
each small RNA. Subsequently, this would increase the ligation efficiency and 
therefore the representation of certain small RNAs in cDNA libraries. Here, the 
effectiveness of HD adapters for detecting small RNAs was investigated in 
biological samples. 
RNA was extracted from the colon cancer cell line, DLD-1. Small RNA 
libraries were then prepared by a collaborator in the laboratory, Dr Karim Sorefan 
using the Illumina protocol. Libraries were prepared using either Illumina adapters 
or HD adapters and sent for sequencing. RNA from the same samples was then 
analysed by Northern blot for eight known microRNAs (miR-10a, miR-19b, miR-
21, miR-25, miR-29b, miR-93, miR-375 and let-7i) (Figure 6.7). To quantify these 
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microRNAs, serial dilutions were made with eight oligonucleotide sequences 
corresponding to each respective microRNA. Calibration curves were then 
generated and used to quantify endogenous microRNA concentrations in two 
technical replicates. Absolute quantifications determined from Northern blots were 
then compared to read numbers generated following cDNA library sequencing 
using either HD or Illumina adapters for each microRNA (Figure 6.8). Analysis 
revealed that libraries made using HD adapters correlated better with the cellular 
abundance of each microRNA as determined by quantitative Northern blot 
(R
2
=0.70) than libraries made with Illumina adapters (R
2
=0.12). For example, 
using Illumina adapters, miR-29b had 2,002 reads per million (RPM) whereas 
using HD adapters the read number was calculated as 74,339 RPM in the same 
sample. The high cellular abundance of miR-29b, quantified via Northern blot as 
1.68 femtomoles/µg total RNA, therefore reflected HD adapter data better. 
However, absolute quantification for one of the microRNAs, miR-10a, correlated 
better with Illumina adapter-generated reads than with HD adapter-generated reads. 
Overall, this result demonstrated that HD adapters are better at detecting small 
RNAs than commercially available adapters and will therefore be more effective in 
detecting novel small RNAs in future studies. 
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Figure 6.7 Quantification of known microRNAs in DLD-1 cells (epithelial 
adenocarcinoma cells).  
 
Total RNA (10µg) from DLD-1 cells was analysed via Northern blot in two 
different lanes. Serial dilutions of synthetic oligonucleotide sequences 
corresponding with the microRNA of interest were also generated for each of 
miR-10a, miR-19b, miR-21, miR-25, miR-29b, miR-93, miR-375 and let-7i. A 
calibration curve was then created and used to quantify the endogenous level of 
the corresponding microRNA in the two DLD-1 samples. The average calculated 
concentration for each microRNA is shown as femtomoles/µg total RNA. For 
miRNA quantification, both experimental and serial dilution membranes were 
hybridised together and signal was developed and exposed under the same 
conditions. 
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Figure 6.8 Comparison of HD and Illumina adapter-derived read numbers with 
Northern blot-quantification of microRNAs. 
 
Absolute quantification of eight known microRNAs was achieved by Northern 
blot and values were then compared with the number of times these microRNAs 
were sequenced using either Illumina or HD adapters in the DLD-1 cell line. The 
data obtained using HD adapters (black stripes) correlated better with absolute 
quantification (blue) (R
2
=0.70) than with Illumina adapters (red) (R
2
=0.12). The 
y-axis on the left represents the normalised read numbers calculated for HD and 
Illumina adapter samples. The y-axis on the right represents the absolute 
quantification values for the Northern blot data.  
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6.3 Discussion 
 
The 30-40 nt sRNAs revealed in this chapter are ‘novel’ in the sense that 
they are Ro60 dependent and this has not been reported previously. However the 
general class of 30-40 nt RNAs is itself not novel as small RNAs of this size have 
been reported in multiple studies in recent years. RNA fragments from this 30-40 
nt class have been shown to be primarily derived from tRNAs (Thompson et al., 
2008; Fu et al., 2009; Yamasaki et al., 2009), snoRNAs (Taft et al., 2009) and 
rRNAs (Li et al., 2012). The function of some of these molecules has been 
revealed. For example, tRNA halves have been demonstrated to modulate 
translation of certain transcripts following stress (Ivanov et al., 2011), whilst other 
20-40 nt RNAs from tRNAs, rRNAs and snRNAs can associate with a long form 
of tRNA endoribonuclease Z (tRNase Z
L
) and direct silencing of targets (Elbarbary 
et al., 2009). Indeed some 30-40 nt sRNA fragments still have the potential to bind 
Ago, and could then be trimmed to become functional siRNAs (Tuck & Tollervey, 
2011). 
 In the work done here, rosRNAs were found to primarily map to the exonic 
regions of genes, which is in contrast to the majority of intronic derived sRNAs 
discovered recently (Li et al., 2012; Ruwe & Schmitz-Linneweber, 2012; Skreka et 
al., 2012). Nonetheless, there are several studies which have also uncovered small 
RNAs which are derived from exonic regions. Capped analysis of gene expression 
(CAGE) experiments have shown that RNA transcripts can undergo cleavage and 
secondary capping (Fejes-Toth et al., 2009). Many of these reported mRNA-
derived sRNAs mapped to internal exons with some crossing exon-exon junctions. 
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These small RNAs were proposed to arise due to processing of mRNAs whereby 
spliced transcripts undergo continued cleavage and re-capping, generating a 
hierarchy of increasingly smaller fragments (Fejes-Toth et al., 2009). Another 
similar study found evidence of intraexonic post-transcriptional cleavage which 
generated 15-30 nt RNAs (Mercer et al., 2010). Furthermore, these fragments 
showed tissue and developmental stage specific expression which was not Dicer or 
Ago dependent (Mercer et al., 2010). The study showed that small RNAs produced 
as a result of this post-transcriptional cleavage did not appear to share any common 
structural or sequence motifs.  
Recently, two models have been proposed which explain how some of 
these mRNA-derived sRNAs are produced. Transcription start site-associated 
(TSSa) RNAs arise as a result of RNA polymerase II (RNAPII) stalling, and 
subsequent exonuclease processing by XRN1 and XRN2, generating RNAPII 
‘footprints’ (Valen et al., 2011). The same study also proposed that splice site-
associated (SSa) RNAs are generated owing to decay of upstream exons which fail 
to undergo splicing correctly.  
 It seems unlikely that rosRNAs are produced owing to RNAPII stalling as 
TSSa RNAs are typically ~17 nt long, reflecting the size of the RNA which fits 
inside RNAPII (Valen et al., 2011), and the rosRNAs are 30-40 nt. If the rosRNAs 
are produced as a result of splicing errors then this would imply that Ro60 has a 
role in transcript maturation. Indeed, preliminary mapping analysis indicated that 
rosRNAs are derived from the end of exons where splicing occurs. It is possible 
that when cells undergo stress and subsequent cell death, Ro60 might be recruited 
202 
 
to sRNAs which arise due to aberrant splicing errors because these may resemble 
misfolded RNAs which Ro60 has been shown to regulate (O'Brien & Wolin, 1994).  
Ro60 displays increased nuclear localisation following stress treatment 
(Sim et al., 2009). As the rosRNAs are essentially mRNA fragments, and could 
therefore be remnants of transcript splicing, one exciting hypothesis is that Ro60 
might enter the nucleus following stress and modulate splicing of a subset of genes.  
 Some of the exon derived rosRNAs were derived specifically from the 
untranslated regions of transcripts. One possible role for Ro60 in these transcripts 
could be that Ro60 masks a cellular localisation signal in the UTR which is 
modulated during stress. Ro60 binding would affect whether this signal was 
protected or cleaved and destroyed by RNases. This in turn would control and 
direct where these transcripts are translated in the cell. Looking at the list of UTR 
derived candidates (rosRNAs-2, 3 and 6), the genes seem to have diverse roles, 
including in stress response. For example, the ubiquitin specific peptidase 47 (from 
which rosRNA-6 is derived) catalyses the removal of ubiquitin in order to facilitate 
cell survival (Peschiaroli et al., 2010). Relocation of the translation of this protein 
due to modulated Ro60 binding might be a response to stress. 
 As with YsRNAs, rosRNAs might be produced as a result of Ro60-
mediated protection from RNases upregulated during cell stress. This assumption 
is not only based on YsRNA biogenesis, but also on the biogenesis of other 
recently described sRNAs (Valen et al., 2011; Ruwe & Schmitz-Linneweber, 
2012). This hypothesis would imply that the transcripts from which rosRNAs are 
produced are naturally bound by Ro60, or perhaps only during poly(I:C) treatment. 
Furthermore, the string of T nucleotides at the 5’ end of rosRNAs implies the 
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presence of a potential La binding site, and this might explain the variable 5’ end 
seen on rosRNA presence plots; differential La binding will produce transcripts of 
different length owing to protection/de-protection as seen with Y5sRNA-3’.  
The rosRNAs need to be analysed by Northern blot to validate them as 
specifically produced sequences and not mere degradation products. One other 
possible experiment could be to synthesise and transfect these small RNAs with 
biotin tags and then immunoprecipitate them to investigate possible protein-RNA 
interactions. This might uncover components of any potential biological pathway 
in which the rosRNAs are involved. Ro60 binding should also be validated using 
similar experiments.  
 Although work into the mouse organ 30-40 nt sRNAs is ongoing, it is 
interesting to note that the sequences identified in this experiment were also 
derived from exons. Individual sequences showed highly varied abundances 
between organs which was conserved between replicates. The brain and kidneys 
had the highest number of 30-40 nt sRNAs, with the heart having the lowest. This 
also reflects the complexity of these organs. The differential pattern of production 
of these sRNAs between organs implies functionality. 
Poly(I:C) treatment of human cells results in the increased production of a 
population of RNAs which are principally 31 nt in length (see Figure 3.2). 
However, in mouse cells, the population of small RNAs (in either stressed or non-
stressed cells) appear to have a principal size of 33 nt (Figures 6.2 and 6.6). It is 
therefore possible that the size of stress related small RNAs is species specific. 
 In this chapter, techniques were developed and optimised so that 
identification of novel sRNAs will be more efficient in the future. The Illumina 
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protocol was modified to better select for 30-40 nt sRNAs. Interestingly, during 
library preparation it was noted that several sized bands were present following gel 
electrophoresis of cDNAs which were not adapter-adapter, microRNA or 30-40 nt 
associated. These could represent even more distinct sRNA size classes which have 
yet to be investigated. 
 The work done here also contributed to the development of HD adapters 
which significantly reduce sequencing bias of small RNAs, as demonstrated in 
figure 6.8. The data in this chapter contributed to the publication of this technique 
by our laboratory (Sorefan et al., 2012). The HD protocol could double read 
coverage and uncover previously unidentified microRNAs (Sorefan et al., 2012). 
HD adapters serve as a valuable tool for future investigations into small RNAs. 
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Chapter 7 
Summary and general discussion 
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The aim of this thesis was to characterise the biogenesis of small RNA 
fragments produced from Y RNA molecules (YsRNAs). The purpose of this 
characterisation was to enable further understanding of an emerging class of small 
RNAs which are slightly longer than traditional gene silencing small RNAs.  
In chapter 3, it was found that YsRNAs were produced from both the 5’ 
and 3’ ends of all Y RNA molecules in a cancer-independent manner. This is 
similar to how other recently discovered small RNAs are produced, some of which 
are also derived from the ends of longer molecules (Li et al., 2012). Although 
YsRNAs were produced at high levels following stress treatment, they were also 
present in unstressed cells at levels which are similar to microRNAs.  
In chapter 4, Dicer knockout, Ago immunoprecipitation and anion 
exchange chromatography experiments showed that the YsRNAs did not appear to 
have gene silencing potential. This indicated that YsRNAs do not fall into the same 
category as small RNA fragments derived from miRNA precursors, tRNAs and 
snoRNAs which do have gene silencing activity (Ender et al., 2008; Li et al., 2012). 
In chapter 5, potential enzymes involved in YsRNA biogenesis were 
investigated. A natural assumption was that the enzyme which produces similar 
sized fragments from tRNAs, angiogenin, was responsible for YsRNA production. 
This was shown not to be the case. RNase L did appear to contribute to YsRNA 
production, but only in mouse. However, using a variety of techniques in mouse 
and human cells, the autoimmune protein Ro60 was shown to be essential for 
YsRNA generation. The La protein also seemed to affect the production of one of 
the YsRNAs. Experiments from this chapter appeared to support a model of 
YsRNA biogenesis through RNase protection by Ro60 and indeed, by La. This 
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model is in line with how some other novel small RNAs have been shown to be 
made (Valen et al., 2011; Ruwe & Schmitz-Linneweber, 2012). 
In chapter 6, after establishing that Ro60 was integral to YsRNA biogenesis, 
it was investigated whether other small RNAs in the same 30-40 nt size class were 
also Ro60 dependent. This was indeed found to be the case, and deep sequencing 
experiments led to the discovery of a new, highly abundant class of Ro60 
dependent small RNAs (rosRNAs). This chapter demonstrated that analysis of the 
biogenesis of YsRNAs has resulted in a better understanding of the small RNA 
class in which it resides. Not only was this one of the major aims of the thesis, but 
it increased the impact of the work across many different research disciplines, 
beyond the Y RNA community. Indeed, the additional discovery in chapter 6 of 
other exon derived small RNAs which are differentially produced in mouse organs 
would be of interest to developmental biologists and molecular geneticists alike.  
Although this work did not uncover the biological function of YsRNAs, it 
has uncovered a class of other related molecules, the rosRNAs. Therefore, studying 
these rosRNAs might facilitate the discovery of a biological function in the near 
future. 
Following the RNA ‘renaissance’ which was marked by the discovery of 
gene silencing related molecules, sequencing technologies have unveiled a plethora 
of other small RNAs which were once mistakenly considered to be degradation 
products. The last part of this thesis involved testing a new deep sequencing 
protocol developed in the laboratory using biological samples. The ‘HD’ protocol 
significantly reduced sequencing bias and better reflected absolute quantification 
of small RNAs. As a result, HD adapters will now facilitate the discovery of other 
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small RNAs in the future. Studies have already managed to determine the function 
of some of these small RNAs, such as tRNA halves (Ivanov et al., 2011). However 
others, such as YsRNAs, remain elusive in their function. The small RNA journey 
of discovery continues. 
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